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 Modern DNA profiling techniques have increased in sensitivity allowing for 
higher success in producing a DNA profile from limited evidence sources.  However, this 
can lead to the amplification of more DNA profiles that do not get a hit on a suspect or 
DNA database and more mixture profiles.  The work here aims to address or improve 
these consequences of current DNA profiling techniques.  Based on allele-specific PCR 
and quantitative color measurements, a 24-SNP forensic phenotypic profile (FPP) assay 
was designed to simultaneously predict eye color, hair color, skin color, and ancestry, 
with the potential for age marker incorporation.  Bayesian Networks (BNs) were built for 
model predictions based on a U.S sample population of 200 individuals.  For discrete 
pigmentation traits using an ancestry influenced pigmentation prediction model, AUC 
values were greater than 0.65 for the eye, hair, and skin color categories considered.  For 
ancestry using an all SNPs prediction model, AUC values were greater than 0.88 for the 5 
continental ancestry categories considered.  Quantitative pigmentation models were also 
built with prediction output as RGB values; the average amount of error was 
approximately 7% for eye color, 12% for hair color, and 8% for skin color.  A novel 
sequencing method, methyl-RADseq, was developed to aid in the discovery of candidate 
age-informative CpG sites to incorporate into the FPP assay.  There were 491 candidate 
CpG sites found that either increased or decreased with age in three forensically relevant 
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fluids with greater than 70% correlation: blood, semen, and saliva.  The effects of 
exogenous microbial DNA on human DNA profiles were analyzed by spiking human 
DNA with differing amounts of microbial DNA using the Promega PowerPlex® 16 HS 
kit.  Although there were no significant effects to human DNA quantitation, two 
microbial species, B. subtilis and M. smegmatis, amplified an allelic artifact that mimics a 
true allele (‘5’) at the TPOX locus in all samples tested, interfering with the interpretation 
of the human profile.  Lastly, the number of contributors of theoretically generated 2-, 3-, 
4-, 5-, and 6-person mixtures were evaluated via allele counting with the Promega 
PowerPlex® Fusion 6C system, an amplification kit with the newly expanded core STR 
loci.  Maximum allele count in the number of contributors for 2- and 3-person mixtures 
was correct in 99.99% of mixtures.  It was less accurate in the 4-, 5-, and 6-person 
mixtures at approximately 90%, 57%, and 8%, respectively.  This work provides 
guidance in addressing some of the limitations of current DNA technologies. 
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CHAPTER 1. INTRODUCTION 
 Forensic biology encompasses the application of science to the identification and 
individualization of biological materials found at crime scenes.  Although serological 
techniques are important to be able to identify the types of biological material at hand, 
most forensic biology analyses focus on DNA.  As technology has advanced, the ability 
to amplify DNA from even a single cell is possible [1].  Increased sensitivity can be an 
advantage to successfully amplify DNA from even the smallest source, which may be 
useful in a case that has few items of biological evidence, however, this increased 
sensitivity has consequences.  In some cases, the DNA profile successfully amplified 
from biological evidence does not get a hit on a suspect or a DNA database and therefore 
results in a dead end.  Also, the co-extraction of other sources of DNA such as bacteria or 
other individuals that may or may not be associated with the crime can amplify a mixture 
profile.  The work presented here aims to address these consequences by the development 
of a phenotyping assay that can predict the outward appearance of individual (eye color, 
skin color, hair color, ancestry, and potentially age) from the DNA as additional 
intelligence information, an evaluation of the effects of co-extracted microbial DNA on 
human DNA profiles, and an evaluation on the estimation of the number of contributors 
from mixture DNA profiles using one of the newly expanded amplification kits. 
 The use of DNA for individualization has advanced rapidly, especially in the last 
30 years.  In 1984, Sir Alec Jeffreys developed the DNA fingerprinting technique from 
which modern tests derive, using restriction fragment length polymorphism (RFLP) on 
variable number tandem repeat regions (VNTRs), which are unique repeating regions of 
DNA [2].  DNA fingerprinting was first used in a legal context in an immigration 
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paternity case in 1985 [3], and first used in a criminal case in 1988, both cases in the UK, 
leading to wide acceptance of this technique in the forensic community [4].  By late 
1986, the DNA fingerprinting was applied to casework in the U.S. [5].  During the 1980s, 
Kary Mullis developed the polymerase chain reaction (PCR) that could amplify small 
quantities of DNA [6].  The first PCR-based assay utilized for forensic applications was 
the HLA-DQA1 locus in 1986 [7, 8].  Short tandem repeats (STRs) were adopted by 
laboratories in the 1990s [9].  STRs are highly variable markers that are small in length, 
which increased sensitivity of assays and could successfully be amplified from a range of 
crime scene conditions.  The first national DNA database consisting of STR profiles was 
established by the U.K. in 1995 [9].  The U.S. closely followed with their own national 
database in 1998, the Combined DNA Index System (CODIS) and selected 13 STRs that 
would serve as core loci for DNA profiles within the system [9]. 
 Increased sensitivity leads to a higher probability of amplifying DNA from more 
than one source, resulting in a mixture.  Mixtures can be inherent to the context of a case, 
such as a sexual assault, however, there are more and more cases with ‘touch’ DNA 
evidence, meaning DNA collected from a surface that was just touched by an individual 
[10].  Mixture profiles are a challenge as deducing the number of contributors to a 
profile, a crucial step for an accurate interpretation, can be difficult.  Mixtures between 
human individuals are one aspect of the challenge; extraneous DNA from the 
environment, such as bacteria, may also interfere with a DNA profile interpretation.  
Whenever DNA is extracted from a sample, all sources of DNA are isolated, not just 
human.  The human microbiome has become a target for research [11] spawning studies 
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into forensic arenas such as using skin bacterial communities for identification [12] and 
microbial signatures to aid in determining the stages of decomposition [13]. 
 STRs are the current standard for developing DNA profiles in forensic 
laboratories.  As DNA databases are built on these markers, they will never become 
entirely obsolete; in fact the core STR loci was recently expanded from 13 to 20 to start 
implementation as of January 2017 [14].  Nevertheless, another type of DNA marker, 
single nucleotide polymorphisms (SNPs), have become a focus as additional informative 
markers for identification.  More SNPs are required to reach the same level of 
discrimination as STRs [15], but modern molecular technologies can allow for that level 
of marker inclusion.  Next generation sequencing (NGS), otherwise known as massively 
parallel sequencing (MPS) technologies, can detect thousands of SNPs simultaneously to 
allow for a larger portion of the genome to be analyzed in a single run [16, 17].  Although 
SNPs can be used for individual identification similar to STRs, the biggest advantage of 
SNPs is that they can convey phenotypic information about an individual.  Externally 
visible traits, such as pigmentation, have been a target area of interest for forensic 
interests as knowing this type of information can be used to objectively gain intelligence 
in an investigation.  Further advancements are being made to not just limit these studies 
to the genetic markers of DNA, but are also expanding into epigenetic markers of DNA.  
Age prediction, for example, has become a recent trending research area and there are 
already studies showing it is possible to estimate age by analyzing epigenetic markers, 
specifically methylation, within the human genome [18]. 
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 The work described in this dissertation encompasses many of these advanced 
capabilities of DNA analysis that adds proof to their value for forensic applications: 
 a) The development of a multiplex forensic phenotype profile (FPP) SNP assay 
 and Bayesian Network (BN) models for prediction evaluation of eye color, hair 
 color, skin color, and ancestry. 
 b) The development of methyl-RADseq, a novel method for the discovery of 
 candidate CpG sites for age prediction across the 3 main types of forensically 
 relevant biological material: blood, semen, and saliva. 
 c) An evaluation of the effect of decomposition-related microbial DNA on human 
 DNA profiles. 
 d) An evaluation on the estimation of the number of contributors from theoretical 
 mixtures of 2-, 3-, 4-,  5-, and 6-person mixtures against the expanded CODIS 
 core STR loci using the PowerPlex® Fusion 6C system (Promega Corp., 
 Madison, WI). 
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CHAPTER 2. THE DEVELOPMENT OF A FORENSIC 
PHENOTYPIC PROFILE (FPP) ASSAY FOR PREDICTING 
PIGMENTATION AND ANCESTRY 
2.1 Introduction 
 The main purpose of forensic DNA analysis is to develop DNA profiles from 
biological evidence for identification.  The ultimate goal is determining the source of that 
biological material.  Conventional DNA profiles are comprised of short tandem repeats 
(STRs), however, in some cases, an STR profile generated from a crime scene sample 
does not result in any matches to suspects or to an entry in a DNA database.  The crime 
scene sample donor remains unknown and the evidence cannot be further probative to the 
case.  Forensic DNA phenotyping is the prediction of externally visible characteristics 
(EVCs) from DNA [19].  DNA phenotyping does not utilize STR markers, but rather, 
single nucleotide polymorphisms (SNPs), which are typically associated with informative 
genes of interest for the target phenotypic trait [15].  The inclusion of a DNA-based 
phenotypic profile would complement STR profiles by providing additional information 
on the outward appearance of the contributor for investigators to develop a lead.  This 
could also be useful in identifying individuals in cases of missing persons and mass 
disasters [20].  Essentially, this phenotype profile is an objective, biological eyewitness 
and could also be used to corroborate or contradict actual eyewitness statements [20].  
The EVCs currently being researched and utilized for forensic casework includes traits 
such as pigmentation (eye, hair, and skin color), ancestry, and more recently, age. 
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2.1.1 Melanogenesis 
 The pigmentation of eye, hair, and skin color is the result of melanin production.  
Melanin is produced by melanocyte cells within specialized vesicles called melanosomes 
(Figure 2.1) [21].  Melanin is an indole derivative of 3,4 di-hydroxy-phenylalanine 
(DOPA) formed from a series of enzymatic reactions involving the oxidation of tyrosine 
[22].  Melanin absorbs and scatters UV radiation (sun), as a mechanism to protect against 
UV-induced DNA damage [22].  There are two types of melanin, eumelanin (EM) and 
pheomelanin (PM); the main difference is the dependence of PM on the availability of 
cysteine or other sulphydryl compounds (Figure 2.1) [23].  EM is a brown/black pigment 
and PM is a red/yellow pigment.  Variations in pigmentation expression can be caused by 
differing amounts of each type of melanin, differing concentrations, and the shape, size, 
and transport pathways of melanosomes from melanocytes to the targeted tissues (eye, 
hair, and skin) [24].  Prota et al.[24] characterized cultured iris melanocytes and found 
that darker eye colors have greater amounts of EM, intermediate eye colors have greater 
amounts of PM, and lighter eye colors have little amounts of both pigments [24]. 
 The pathway of the formation of melanin, or melanogenesis, is illustrated in 
Figure 2.1.  The α-melanocyte stimulating hormone (α-MSH) binds to the melanocortin 1 
receptor (MC1R), a G-protein coupled receptor with 7 transmembrane domains [22].  
Cyclic adenosine monophosphate AMP (cAMP) is activated by the binding of α-MSH to 
MC1R (G-protein dependent).  Increased levels of cAMP activate protein kinase A 
(PKA), and increased PKA induces the microphthalmia transcription factor (MITF) [22].  
MITF upregulates the transcription of tyrosinase by targeting the tyrosinase (TYR) gene 
[21].  Tyrosinase then acts on tyrosine to make dopaquinone, which is the same 
intermediary in both melanin types [25].  The agouti-signaling protein (ASP), transcribed 
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by the ASIP gene, acts as an agonist to the α-MSH and can bind to MC1R and block α-
MSH, which limits cAMP levels and leads to favored production of pheomelanin [25].  
MATP is involved in tyrosinase trafficking, OCA2 encodes the P protein, a melanosomal 
membrane protein, and SLC24A5 codes for a potassium dependent sodium/calcium 
exchange also along the melanosomal membrane [25].  It is thought that calcium 
activates the production of the Pmel17 protein, which is responsible for maturation of 
eumelanosomes [25]. 
Figure 2.1 Simplified melanogenesis pathway.  The production of the two types of melanin, 
eumelanin and pheomelanin, are illustrated.  Adapted from Tully [25]. 
 
 This pathway of melanin production is the same for eye, hair, and skin 
pigmentation.  Melanocytes are present in the stromal layer of the iris. The melanin gets 
expressed in melanosomes within the stromal melanocytes.  Melanosomes are what are 
primarily observed when looking at the eye color of an individual [26].  However, 
melanosomes must be transported from melanocytes for hair and skin cell melanin 
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expression.  Melanocytes are oval dendritic cells that are smaller than keratinocytes, the 
cells that make up hair and skin [27].  For skin, melanocytes in the basal layer of the 
epidermis form a melanin unit, where a single unit is comprised of 1 melanocyte 
associated to 30-40 keratinocytes [27].  Melanosomes are transported to the keratinocytes 
through the dendritic ends of the melanocyte (Figure 2.2).  The exact mechanism of 
melanosome transfer to keratinocytes is still not fully known [27], however, it is 
suggested that transport of melanosomes from melanocytes to keratinocytes is very 
similar in hair follicles.  The ratio of melanocyte to keratinocyte is denser in hair follicles 
(1 melanocyte for 5 keratinocytes), and the dendritic ends extend between the cortical and 
medullar keratinocytes [27]. 
 
 
 
 
 
 
 
 
 
Figure 2.2 Example of Melanosome Transport.  This illustrates melanosomes being transported 
via the dendritic ends of the melanocyte into skin keratinocytes.  Adapted from Cichorek et al. 
[27]. 
 
2.1.2 Predicting Pigmentation: Hair, Eye and Skin Color 
 There have been numerous studies focused on discovering biological markers that 
explain normal variation in human phenotypes, specifically, DNA markers associated 
with pigmentation.  Most DNA markers (typically associated with disease) have been 
9 
 
discovered through genome-wide association studies (GWAS) looking for significantly 
correlated SNPs [28-34].  Grimes et al. [35] published the first example of a phenotype 
prediction test in 2001 in which variants in the MC1R gene were found to be informative 
for the red hair phenotype [35].  MC1R encodes for a transmembrane G-coupled protein 
receptor that activates the melanin synthesis in melanocytes (see 2.1.1).  Polymorphisms 
in MC1R predominantly result in the phenotype consisting of red hair, blue eyes, and fair 
skin [36].  Most of the pigmentation informative SNPs are associated with genes whose 
functions are known to be involved in the synthesis of melanin and its transport.  One 
SNP in particular, rs12913832, is located in a conserved intronic region of the HERC2 
gene upstream from the OCA2 gene promoter, and was found to have the highest 
association to predicting pigmentation traits despite the lack of the functional 
understanding of the HERC2 gene [37].  This SNP has a regulatory effect on the 
expression of OCA2.  OCA2 was thought to be the highest associated gene related to 
pigmentation up until the discovery of the HERC2 silencing interaction.  Specifically, 
rs12913832 has been found to be the main causative SNP for the lack of brown eye color 
expression [38]. 
 Initial successful work in predicting eye color was based on SNPs analyzed using 
a multinomial logistic regression model to predict eye color [39].  A multiplex assay was 
developed using statistically correlated SNPs isolated from a GWAS for eye color, 
termed IrisPlex [20], which accurately predicted blue and brown eye colors in a small 
European population (N = 40, 91.6% and 87.5%, respectively).  The predictions were 
based on six SNPs: rs12913832 (gene: HERC2), rs1800407 (OCA2), rs12896399 
(SLC24A4), rs16891982 (SLC45A2), rs1393350 (TYR), and rs12203592 (IRF4).  We 
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evaluated the IrisPlex assay in a Midwest United States population, a population 
consisting of a greater proportion of ancestral descent variation than the original study 
(N=200), and genotypes using the same model suffered in accuracy with respect to brown 
eye color prediction, with 91% and 79% for blue and brown eye color, respectively [40, 
41].  The reduction in accuracy of brown eye color predictions is likely due to an increase 
in the heterozygosity of the HERC2 SNP (rs12913832) in a more admixed population.  
Furthermore, a weakness is inherent in the prediction of the intermediate eye color (not 
brown or blue), thus additional SNPs are necessary to improve prediction in those eye 
color categories [42].  Towards that goal of improving intermediate eye color predictions, 
a study by Pośpiech et al. [43] focused on the interactions between genes that could 
contribute to eye color expression and found an additional SNP,  rs1408799 (TYRP1), 
that was associated with green eye color when considering its interaction with HERC2.  
Following the discovery of these eye color SNPs, Branicki et al. [44] developed a DNA-
based model for genotypes of a set of 13 SNPs to predict hair color in 4 categories: black, 
brown, red, or blonde, with prediction accuracies of 87.5%, 78.5%, 80%, and 69.5%, 
respectively.  This study led to the inclusion of these significantly associated hair color 
SNPs in a multiplex assay combining the eye and hair color SNPs, termed HIrisPlex [45].  
HIrisplex includes the original 6 IrisPlex SNPs along with 18 additional SNPs that are 
correlated to hair color variation.  Among these 24 SNPs, 11 are associated with the 
MC1R gene, polymorphisms that interact with each other  through what is called 
compound heterozygosity; and some SNPs have a stronger effect on the phenotype 
(penetrance) than others [44].  The initial results of the HIrisPlex genotyping assays 
revealed accuracy for hair color prediction in European populations. 
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 Because phenotypes resulting from pigmentation genes are related, many of the 
above-mentioned SNPs can be used in tandem to predict skin pigmentation.  Han et al. 
[31] found that rs12203592 (IRF4) and rs12896399 (SLC24A4), both included in the 
IrisPlex panel for eye color, are associated with the tanning response of skin.  Another 
study by Lamason et al. found rs1426654 (SLC24A5) to be correlated to light skin 
pigmentation for Europeans [46].  Interestingly, there is evidence that light skin 
pigmentation derived separately in European and East Asian populations, and a SNP 
associated in the OCA2 region, rs1800414, was found to be only informative of light skin 
in East Asian population [47].  A study by Maroñas et al.[48] screened African and 
European populations from the 1000Genomes database and found 10 significant SNPs 
for skin color differences based on allele frequencies to test in their own dataset of 
individuals: rs1426654 (SLC24A5), rs6119471 (ASIP), rs6058017 (ASIP), rs1408799 
(TYRP1), rs1448484 (OCA2), rs16891982 (SLC45A2), rs10777129 (KITLG), rs3829241 
(TPCN2), and rs13289 (SLC45A2) [48].  A SNP located upstream of the KITLG gene, 
rs642742, is found to be in a conserved region and shows skin pigmentation 
differentiation between Europeans and West Africans [49].  Another study had already 
found the same ASIP SNP, rs6119471, to be informative for the expression of darker skin 
(greater melanin) [50].  The ASIP SNP along with 6 additional SNPs were used to predict 
both eye and skin color in diverse populations, although accuracy was observed in the 
European samples and only when homozygous genotypes were used for skin color 
predictions (without evaluating heterozygote genotypes) [50].  Hart et al. [51] developed 
an assay using 8 SNPs for eye and skin color prediction which included 4 of the IrisPlex 
SNPs: rs12913832 (HERC2), rs12203592 (IRF4), rs12896399 (SLC24A4), rs1426654 
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(SLC24A5), rs16891982 (SLC45A2),  rs885479 (MC1R), rs6119471 (ASIP), and 
rs1545397 (OCA2).  These results were impressive with 1% error in their test set for skin 
color prediction (light vs dark), however, this was not an accurate measure of error, 
similarly, as in the study by Spichenok et al. [50], it is based on homozygous genotypes 
only; they reported inconclusive results for heterozygous outcomes. 
2.1.3 Predicting Ancestry 
 There has been a wealth of research in finding ancestry informative SNPs, also 
known as ancestry informative markers (AIMs), for determining the genetic ancestry of 
an individual [52-59].  One of the earlier ancestry assays to be considered for forensic use 
was the SNPforID assay that incorporated 34 AIMs for the distinction of three major 
population groups: Europeans, Africans, and East Asians [56].  Phillips et al. [58] 
developed a 23-SNP assay, termed Eurasiaplex, which distinguishes European and South 
Asian ancestries.  For a more comprehensive analysis of genetic ancestry, Kidd et al. [57] 
found a set of 128 AIMs to be useful in discriminating between samples from 119 
different populations.  The Kidd lab [60] created and maintains an online frequency 
database, the ALlele FRequency Database (ALFRED) that contains SNP frequency data 
for many populations, including AIMs and other phenotypic informative SNPs [61]. 
 Previous ancestry studies have either focused on specific population 
discrimination (e.g., Nigerian vs. Kenyan) or more broad continental distinctions (e.g., 
European vs. African).  Halder et al. [62] conferred a panel of 176 AIMs for admixture 
discrimination at the major four continental origins: European, West African, Indigenous 
American, and East Asian, and found it to be most informative for discriminating African 
vs non-African and least informative for Indigenous American and East Asian.  Nassir et 
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al. [63] evaluated 93 AIMs for determining continental origin, and found this panel was 
particularly useful in providing admixture proportions in even the largest admixed 
population groups – for example, African-American and Mexican-American in the 
United States.  Nievergelt et al. [55] developed a discriminative AIM panel for 
geographical origin using 41 SNPs with distinction between seven continental 
populations: Africa, Middle East, Europe, Central/South Asia, East Asia, the Americas, 
and Oceania.  Kosoy et al. [64] found that using a subset of 24 SNPs, originally isolated 
from a panel of 128 SNPs, had the same power of discrimination for continental ancestry 
groups, highlighting that more SNPs are not necessarily more powerful for such a broad 
level of ancestral discrimination.  In general, there are few SNPs that overlap between 
published panels, mostly because of the methodology used in selecting SNPs, and 
because the purpose of panels may differ (regional vs. more specific) [57].  Kidd et al. 
recently published a panel of 55 SNPs combining the data from previous published 
panels, efficient for distinction of eight biogeographic regions [65].  This is further 
evidence that panels with a smaller number of SNPs continue to be developed with 
similar powers of discrimination. 
 As previously mentioned, pigmentation traits are sometimes associated with 
ancestral origins, geographically speaking, and some of the same genes from 
pigmentation studies may also be useful for ancestry studies, therefore reducing the 
number of overall SNPs that would need to be included into a multiplex assay.  This 
relationship exists because the differences in melanosome qualities can be distinctive for 
different ethnic groups (Figure 2.3) [66].  Generally, the number of melanocytes are the 
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same, but the manner in which melanosomes are transported and distributed to the 
keratinocytes, as well as the quantity and shape, differs [66]. 
 
 
 
 
 
 
Figure 2.3 Differences in melanosome distribution attributed to ethnic groups.  Reprinted with 
permission from Sturm et al. [66]. 
 
For example, rs1426654 (SLC24A5) is informative for European ancestry as it is an 
informative marker for light skin derived in Europeans [56].  The SNP rs16891982 
(SLC45A2) is used in IrisPlex for eye color and is also useful for European ancestry [58], 
and rs6119471 (ASIP) is informative for African ancestry and relates to dark skin 
expression [50].  Because of the inter-relatedness of each of these traits to genes 
specifically related to pigmentation, it may be possible to develop a multiplex SNP assay 
that is capable of predicting each of these traits with some degree of accuracy without the 
need for hundreds of SNPs. 
2.1.4 Quantitative Color Classification 
 Most of the studies discussed in the previous sections had based their color 
phenotype predictions on qualitative determinations – where human observers visually 
evaluated the samples to determine the color.  A more objective way to evaluate each 
phenotype color is to measure it quantitatively; this will reduce the visual perception 
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differences of human observers.  Color is a function of 3 variables, known as matching 
stimuli or tristimulus values, and can be designated as:  Red (R), Green (G), and Blue 
(B).  This is partly based on the fact that there are 3 types of spectrally different cones in 
the retina of the eye for perceiving color [67].  Brightness is the attribute of visual 
perception in which something appears to exhibit more or less light, and hue is the 
attribute to which something appears to be similar to red, yellow, green, and blue – the 
basic chromatic colors [67].  The relative colorfulness of an object in proportion to the 
brightness is called chroma [67].  The Commision Internationale de l’Éclairage (CIE) is 
an international commission responsible for standardization of lighting, color, imaging, 
and vision [68].  This commission creates different standardized color models that can 
describe color quantitatively.  Three CIE color models were considered to objectively 
measure the color in this work:  RGB, XYZ, and LUV.  The RGB space is device 
dependent and therefore its range can vary depending on which type of display is 
transmitting the color [69]; however, it can be advantageous to be able to represent colors 
on technological displays such as computer or television screens.  RGB color is similar to 
the XYZ color space, although XYZ is device independent.  These color spaces can be 
normalized to reduce three variables to two, for example, XYZ can be normalized to 
create the xyY space which corresponds to relative tristimulus values, or chromaticity 
coordinates.  Y remains the same as it still correlates with the brightness or luminance 
[67].  A chromaticity diagram shows the proportion of the tristimulus values in two 
dimensions and therefore a plot of all possible color chroma (Figure 2.4).  Light and dark 
colors plot at the same point in a chromaticity diagram if they have the same ratio [67]. 
16 
 
Also for this reason, white, black, and all shades of gray are represented by the same 
point in the center (SE in Figure 2.4). 
 
 
 
 
 
 
 
Figure 2.4 A Simple Chromaticity Diagram.  The xy and RGB spaces are shown in relation to 
each other.  Adapted from Hunt [67]. 
 
All color coordinates can be converted between color spaces, so why consider different 
color models?  Some color spaces have certain advantages or disadvantages depending on 
the proposed use.  For example, the xy chromaticity diagram does not have a uniform 
distribution of colors (the green gamut is larger than purple), and therefore the 
normalized LUV (Lu’v’), diagram was developed as it reduces this distortion [67].  The 
u’v’ diagram is useful for showing the relationships between colors and their 
discrimination [67].  And as mentioned, the RGB space represents color on digital 
displays, which are an important tool for viewing digital photographs and images. 
 In this work, the RGB, XYZ, and LUV color models were evaluated as possible 
models to quantitatively measure color from digital eye, hair, and skin photos of the 
sample population.  Consensus qualitative (visual) determinations were also collected and 
used to gauge the accuracy of the quantitative measurements to human perception. 
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If a quantitative color model can accurately reflect predicted color, it eliminates human 
perception bias and can then reliably corroborate or contradict actual eye witness 
accounts. 
2.2 Methods 
2.2.1 Sample Collection 
 Buccal swabs, hair, digital photos, and a self-reporting survey were collected from 
200 volunteers who were randomly assigned 4 digit numerical identifiers (Indiana 
University IRB Approved Protocol #1407693464).  Digital photos included a profile 
picture and an upper inner arm picture taken with a SpyderCHECKR 24 color calibration 
card (Datacolor, Lawrenceville, NJ) from a fixed distance of 130 cm using a Canon EOS 
Rebel T5 digital camera using aperture setting of F5.6, 1/25 shutter speed, ISO 800, and 
enabling flash.  Hair samples included plucking or cutting of 2-3 hair strands near the 
crown of the head and stored in individual plain white envelopes labeled with the sample 
number.  Buccal swabs were stored at -20°C until DNA extraction.  A copy of the self-
reporting survey can be found in Appendix A. 
2.2.2 DNA Extraction and Quantitation 
 An organic DNA extraction protocol was used to isolate DNA from the collected 
buccal swabs.  Each buccal swab tip was incubated in a 1.5mL tube at 56°C in 500 μL of 
ChargeSwitch lysis buffer (Thermo Fisher Scientific, Waltham, MA) with 25 μL of 
proteinase K (Thermo Fisher Scientific) for 8-12 hours.  After incubation, the swab was 
placed into a spin basket in the tube and centrifuged to remove all liquid from the swab; 
the swab was subsequently discarded.  To the tube, 500 μL of phenol: chloroform: 
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isoamyl alcohol (25:24:1) (Thermo Fisher Scientific) was added and mixed by inversion.  
The tube was centrifuged for 1 minute at 13,000rpm.  The aqueous layer was removed 
into a new 1.5 mL tube and the remaining layer was discarded.  To the new tube, 500 μL 
of chloroform: isoamyl alcohol (24:1) (Thermo Fisher Scientific) was added and inverted 
to mix.  The tube was centrifuged for 1 minute at 13,000 rpm.  The aqueous layer was 
removed into a new 1.5mL tube and 25 μL of 0.2M NaCl and 500 μL of cold 95% 
ethanol was added.  The tube was centrifuged at 4°C for 15 minutes at 15,000 rpm.  The 
liquid was removed, being careful not to disturb the pellet on the bottom of the tube.  The 
pellet was washed with 500 μL of 70% ethanol and centrifuged at 4°C for 5 minutes at 
15,000rpm.  The liquid was removed and the pellet was allowed to air dry for 20-30 
minutes.  The DNA was re-suspended in 50 μL of TE buffer (Thermo Fisher Scientific) 
and stored at -20°C.  Quantitation of the extracted DNA was performed with the 
Quantifiler® Human DNA quantification kit (Thermo Fisher Scientific) following the 
manufacturer’s protocol.  The DNA samples were diluted to working solutions of 1 
ng/μL. 
2.2.3 Digital Color Measurement 
 All collected digital photos were color calibrated using SpyderCHECKR 1.2.1 
software (Datacolor) in Adobe Lightroom 5 (Adobe Systems, San Jose, CA).  The 
collected hair strands were cut to mount 1-2 hairs onto microscope slides using 
Permount® fixative (Thermo Fisher Scientific).  Microscope photos were taken with 
Leica DFC290 HD digital camera (Leica Microsystems Inc, Buffalo Grove, IL) on an 
Olympus BX51 microscope (Olympus, Waltham, MA) at 100X magnification.  A 
ChromaCalTM microscope calibration slide (Datacolor) was also used to apply color 
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correction to the photos, as well as ChromaCalTM monitor calibration (Datacolor).  This 
monitor-calibrated computer was further used by 6 anonymous photo raters, 3 male and 3 
female, to rate the visual color of all digital photos for hair, eye, and skin color for each 
of the 200 samples to determine a visual consensus rating.  Where there was a split rating 
(3 votes for one color, 3 for another), the self-reported color was used as a 7th rating.  
RGB values were measured from the extracted digital photos using Adobe Photoshop 
Elements (Adobe Systems).  For eye color, only the iris portion was extracted and the 
average color of the entire extracted iris was digitally measured.  For skin color, an 
approximate 1x1 inch square was extracted from the inner arm area and the average color 
was measured.  For hair color, an approximate 1 inch section was cut from 2 of the hair 
strands near the root from each individual (3 of the samples had 1 strand collected) and 
the average color was measured.  The RGB values were averaged between the two 
strands (if two were able to be collected).  Color model transformations were performed 
in R v3.1.3 [70] using the grDevices package.  The following equations were used to 
transform the xy to u’v’ coordinates: 
 
  u’ = Equation 2.1 
 
      v’ =          Equation 2.2 
 
2.2.4 Multiplex Phenotypic Assay 
 The 24 pigmentation and ancestry informative SNPs chosen from literature for 
inclusion in this study are shown in Table 2.1 and Table 2.2, respectively.  The eye and 
4X 
X+15Y+3Z 
9Y 
X+15Y+3Z 
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hair SNPs were primarily chosen from the HIrisPlex assay [45], but as a reduced set 
where some of the less influential SNPs were not included (i.e., rs1393350 for eye color 
was excluded).  And to conserve panel space for other trait SNPs, only one of the higher 
penetrating MC1R SNPs was chosen from the 11 MC1R SNPs included in HIrisPlex.  As 
previously discussed, some SNPs are informative for more than one trait, especially the 
skin and ancestry SNPs.  For the ancestry SNPs, at least 2 SNPs were chosen for the main 
continental groups being evaluated: African, European, Asian, and Amerindian 
(Hispanic).  The additional SNPs used for ancestry prediction were in common with the 
skin informative SNPs.  The chosen SNPs were also based on successful primer design 
and allele discrimination.  The first step in building the assay was to get successful single 
SNP discrimination with designed allele-specific primers.  Allele-specific PCR (AS-
PCR) involves the design and use of 3 primers and utilizes size discrimination for 
genotyping (Figure 2.5).  Two of the primers are allele-specific (AS) and therefore 
mutually exclusive for amplification of the two possible bases at the SNP site.  The allele 
specific primers are complementary to the DNA directly adjacent to the SNP site, with 
the 3’ base of the corresponding to the target SNP.  A poly T-tail of 4 or 10 base pairs 
(bp) was added to one of the AS primers for size discrimination between the two alleles.  
The third primer is located further upstream or downstream of the SNP site as a common 
primer that pairs with both allele-specific primers.  Therefore, for each forensic 
phenotypic profile (FPP), each homozygous genotype is represented by a single peak 
discriminated by different fragment sizes, differing by either 4 or 10 bp, and a 
heterozygous genotype is represented as two peaks separated by 4 or 10 bp (Figure 2.5).  
PCR products in the assay range from 120-365 bp. 
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Figure 2.5 Allele-specific PCR design.  A) This illustrates the design and location of the allele-
specific primers (Primer 1, Primer 2) in relation to the common primer (Primer 3) along the target 
SNP sequence.  B) The electropherogram peak output interpretation from this primer design. 
 
Table 2.1 Pigmentation informative SNPs used in this study. 
SNP Gene Pigmentation Trait Previous Studies 
rs12913832 HERC2 Eye, Hair, Skin [20, 37-39, 44, 45, 71-73] 
rs1800407 OCA2 Eye, Hair [20, 39, 43-45, 71, 72, 74] 
rs12896399 SLC24A4 Eye, Hair [20, 39, 44, 45] 
rs16891982 SLC45A2 Eye, Hair, Skin [20, 39, 44, 45, 48, 71-73] 
rs12203592 IRF4 Eye, Hair [20, 39, 44, 45] 
rs3829241 TPCN2 Eye, Hair, Skin [43, 44, 48]  
rs1408799 TYRP1 Eye, Hair, Skin [43, 44, 48, 75] 
rs1805007 MC1R Hair [44, 45, 74, 76] 
rs28777 SLC45A2 Hair [45] 
rs12821256 KITLG Hair [44, 45, 77] 
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Table 2.1 continued 
rs4959270 EXOC2 Hair [45] 
rs2378249 ASIP Hair [44, 45] 
rs683 TYRP1 Hair [44, 45, 76] 
rs6119471 ASIP Skin [48, 50, 51] 
rs1800414 OCA2 Skin [47, 78] 
rs10777129 KITLG Skin [48] 
rs1426654 SLC24A5 Skin [48, 73, 79, 80] 
 
Table 2.2 Ancestry informative SNPs used in this study. 
SNP Gene FST Value[65] Ancestry Trait Previous Studies 
rs1426654 SLC24A5 0.73 European [56, 65, 79-82] 
rs3827760 EDAR 0.71 E. Asian [59, 65, 80, 82, 83] 
rs16891982 SLC45A2 0.69 European [56, 65, 79, 80, 82] 
rs3916235 CD226 0.63 African [65, 82] 
rs4918664 intergenic 0.53 Amerindian/Asian [55, 65, 82] 
rs12498138 GOLGB1 0.48 Amerindian [55, 65] 
rs3737576 S1PR1 0.44 Amerindian [64, 65, 80] 
rs1229984 ADH1 0.43 E. Asian [64, 65, 82] 
rs6119471 ASIP --* African [50, 51] 
rs1800414 OCA2 0.57 E. Asian [65, 78, 80] 
rs12913832 HERC2 0.52 European [65, 80, 82] 
rs7657799 TACR3 0.44 African [64, 65] 
* = not found 
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 Primer concentrations were optimized for each SNP set within each dye channel.  
There were 3 PCR multiplex reactions per sample, one for each dye color set.  Qiagen 
Multiplex PCR Master Mix (Qiagen, Hilden, Germany) was used in the PCR setup for 
the AS-PCR reactions.  Touchdown PCR was used to perform PCR, which can help 
increase specificity of primer annealing, where the annealing temperature in the first 6 
cycles differs and decreases by 1°C.  The optimized PCR conditions are listed in Table 
2.3.  All PCR was performed on an Eppendorf Mastercycler Pro thermal cycler 
(Eppendorf, Hamburg, Germany).  PCR products were separated on an ABI 3500 Genetic 
Analyzer (Thermo Fisher Scientific) following the same injection parameters as listed by 
the manufacturer for the Identifiler Plus kit (Thermo Fisher Scientific).  The FPP profile 
electropherograms generated for all 200 samples are in Appendix B. 
 To ensure accuracy of the FPP assay genotypes, a subset of 20 samples were 
sequenced at all loci.  Initial PCR for the sequencing was setup according the PCR 
cycling conditions listed in Table 2.3 and the primer sequences used are listed in 
Appendix C.  Samples were then treated with ExoSAP-IT (Thermo Fisher Scientific) 
before cycle sequencing was performed.  Cycle sequencing reactions were set up using 
the BigDye Terminator v3.1 Cycle Sequencing kit (Thermo Fisher Scientific) following 
the manufacturer’s protocol.  The sequencing products were cleaned with the BigDye 
XTerminator purification kit (Thermo Fisher Scientific) following manufacturer’s 
protocol.  Cycle sequencing was detected on an ABI 3500 Genetic Analyzer (Thermo 
Fisher Scientific). 
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Table 2.3 PCR thermal cycling conditions. 
PCR programs 
AS-PCR: Temperature,  
Time 
 
Cycles (#): 
95°C, 
15 min 
94°C, 30s 
61-56°C, 40s 
72°C, 1:35 min 
1 cycle each 
94°C, 30s 
55°C, 40s 
72°C, 1:35 min 
25 cycles 
72°C, 
15 min 
4°C, 
hold 
Sequencing  
PCR: 
Temperature,  
Time 
 
Cycles (#): 
95°C, 
10 min 
95°C, 30s 
59°C, 30s 
33 cycles 
 59°C, 
5 min 
4°C, 
hold 
 Sequencing  
PCR (MC1R): 
Temperature, 
Time 
 
Cycles (#): 
95°C, 
10 min 
95°C, 30s 
59°C, 35s 
72°C, 40s 
32 cycles 
  4°C, 
hold 
 
2.2.5 Statistical Models 
 The goal of DNA phenotyping is to determine a genotype that can accurately infer 
the phenotype of the individual.  These inferences are determined from statistical models.  
Model building methods can be used to find the best fitting model to describe the 
relationship between the outcome and predictor variables [84].  Three types of statistical 
analyses were performed: discriminant analysis; Bayesian networking; and multinomial 
logistic regression. 
2.2.5.1 Discriminant Analysis 
 Linear discriminant analysis (LDA) is a supervised technique that was first 
described by Fisher in 1936 [85].  It is a method that describes, classifies, and predicts 
multivariate data into separated qualitative groups.  A new set of axes that best separates 
the data into groups is created, which are also called canonical variates, and are just linear 
combinations of the original values [85].  LDA places members of the same group as 
close as possible together while at the same time moving all other groups as far as 
possible by maximizing the variance between groups by the variance within groups [85].  
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LDA was performed on the RGB, xyY, and Lu’v’ color coordinates using the consensus 
color ratings as the classifications for the samples.  Discriminant analysis was performed 
using JMP Pro 12 (SAS Institute Inc., Cary, NC). 
2.2.5.2 Bayesian Networks 
 A Bayesian Network (BN) is a specific type of directed acyclic graph (DAG).  It 
is a pictorial representation of the probabilistic relationship between variables based on a 
set of conditional probability distributions [86].  Nodes represent the variables and the 
directed arcs represent the dependencies between them.  There is a conditional 
probability distribution associated with each node.  Simple Bayesian classifiers (naïve 
Bayes) assign a class label based on the set of attributes, in this case, the SNP genotypes.  
The probability theory used to compute the posterior probabilities in these models is 
based on Bayes’ Theorem [87, 88].  BNs have been applied to clinical studies to analyze 
variables in disease developments [89] and have been applied in forensic phenotype 
predictions, for example, eye color [40, 90].  Figure 2.6 shows the basic equation of 
Bayes’ Theorem as it applies to phenotype predictions.  Discrete BNs were designed and 
built within R v3.1.3 [70] using the bnlearn, and gRain packages.  Each of the 24 SNPs 
was a child node of the parent trait (eye color, hair color, skin color, ancestry).  
Additionally, alternative models where ancestry was considered as an additional child to 
each of the pigmentation traits were also tested. 
 For the continuous RGB coordinate predictions, hybrid BN models and functions 
were designed and performed by using the HydeNet package within R v3.1.3[70].  The 
SNP inputs were binary coded as 0, 1, and 2 corresponding to each possible genotype (0 
and 2 as the homozygotes, and 1 as the heterozygote).  The functions generated were 
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used in Microsoft Excel to calculate the predicted R, G, and B values.  Absolute error 
was calculated between the predicted and actual digitally measured RGB values using the 
distance formula as follows: 
 
 
Percentages were calculated out of the total possible error.  RGB values range from 0-
255, and therefore the maximum error is 441.673. 
 
 
 
 
 
 
 
 
 
 
2.2.5.3 Multinomial Logistic Regression 
 Logistic regression involves relating a categorical response (e.g., eye color) to a 
set of explanatory variables (e.g., SNPs).  Multinomial logistic regression (MLR) 
involves more than 2 categories as possible outcomes.  A set of parameters are estimated 
that fit the maximum likelihood of the observed data [84].  These parameters can then be 
used to estimate the probability of classification of new observations into each of the 
 
√{(predR-R)2 + (predG- G)2 + (predB- B)2 } Equation 2.3 
Figure 2.6 Simplified Bayes’ Theorem applied to phenotype predictions.  The 
posterior odds are the frequency of the trait given the observed genotype based 
on the prior odds of the trait within the population and the likelihood of all the 
other possible versions of that trait. 
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possible categories.  The probability outcomes may be evaluated using a certain threshold 
to estimate the goodness of fit of the model to the data.  MLR has been previously used in 
pigmentation prediction models, especially in the IrisPlex and HIrisPlex assays [20, 45] 
and it does not need prior known data, e.g., ancestry, to generate model parameters.  
MLR was performed using MATLAB R2016a (The MathWorks Inc., Natick, MA) and 
macros were modified as designed by Walsh et al. [20, 45] to adjust for the sample 
population allele frequencies using Microsoft Excel to determine the probabilities of the 
validation set for each pigmentation category using similar models as with the BN 
analysis for comparison. 
2.2.5.4 Model Evaluation 
 Evaluation of the each prediction model performance was done by generating 
confusion matrices of the validation set to measure the area under the receiver operating 
characteristic (ROC) curve (AUC), which utilizes the sensitivity and specificity of the 
model performance.  Sensitivity is the true positive rate and specificity is the true 
negative rate [91].  A ROC curve shows the true positive rate at varying false positive 
thresholds (which is 1- specificity) [91].  The AUC of this curve is a value usually 
between 0.5 and 1; AUC values near 1 are accurate predictors whereas AUC values near 
0.5 are characteristic of a model with no predictive value and therefore not any more 
informative for prediction than random guessing [91]..  Model evaluations were 
measured using the caret and ROCR packages in Rv3.1.3 [70].  A model prediction 
threshold of 70% was selected for two reasons:  1) the highest optimal average threshold 
across all pigmentation models (optimal being the point balanced between a high true 
positive rate and low false positive rate) was determined to be approximately 65%, and 2) 
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a 70% threshold was found optimal in previously designed and tested pigmentation 
models (e.g., IrisPlex [20, 40] and HIrisPlex [45]) and using the same threshold here 
would allow for direct comparison. 
2.3 Result and Discussion 
2.3.1 Sample Collection 
 An analysis of the 200 individuals based on the self-reported categories was 
performed to examine the overall composition of each phenotype for each trait being 
evaluated for predictions.  Table 2.4 shows the distribution of the sample population.  
There was a high proportion (68%) of individuals who identified as European.  
Additionally, when looking at the distributions of the possible phenotypes, Europeans 
have the most eye and hair color diversity; they are the only individuals who reported 
having blue eye color and red or blonde hair (Table 2.4).  This is not surprising as blue 
eye color is proposed to have originated from Europe [37].  FPP profiles of all 200 
samples can be seen in Appendix B. 
Table 2.4 Sample population trait frequencies based on self-reported data for pigmentation and 
ancestry. 
Ancestry (N) Eye Hair Skin 
 BLU BRN INT BRN RED BLD BLK LIT INT DRK 
European (135) 35% 27% 38% 70% 7% 21% 2% 90% 10% -- 
African (16) -- 91% 9% 55% -- -- 45% 9% 36% 55% 
Other Asian (12) -- 100% -- 8% -- -- 92% -- 75% 25% 
Hispanic (15) -- 87% 13% 27% -- -- 73% 26% 67% 7% 
East Asian (7) -- 100% -- 29% -- -- 71% 43% 57% -- 
Legend: BLU= blue, BRN = brown, INT= intermediate, BLD= blonde, BLK= black, RED= red 
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2.3.2 Discriminant Analysis Color Measurement 
 Three color models were considered: RGB, xyY, and Lu’v’.  LDA was performed 
on the RGB coordinates extracted from the digital photos of the eye, hair, and skin color.  
Three categories were evaluated for eye color – blue, intermediate, or brown.  
Intermediate colors are those not classified as blue or brown and would include colors 
such as green or hazel.  Skin color also had three categories – light, intermediate, and 
dark, where intermediate color was similar to eye color in that it represents those not 
classified as light or dark.  Hair color was evaluated in four categories – black, blonde, 
brown, or red.  For eye and skin color, the training set was composed of 150 of the 200 
samples, and the remaining 50 samples were used as the validation set, no overlap of 
samples occurred between the two sets.  Because there were some samples without hair 
samples (bald individuals) or where the hair collected was gray or white, those samples 
were not considered and therefore for hair color, there were 148 samples in the training 
set, and 46 in the validation set.  The RGB coordinates were classified with 2 different 
color classification groups: self-reported (SR) color and consensus color.  The consensus 
color had fewer misclassifications than SR color: 12% vs. 22% for eye color, 8% vs. 24% 
for skin color, and 30% vs. 38% for hair color (Consensus-RGB vs SR-RGB in Tables 
2.5-2.7).  Evaluating concordance of the consensus ratings from the 6 individuals, there 
was 82% concordance for hair color, 80% for eye color, and 89% for skin color; this 
generally equated to 4 or 5 out of 6 individuals rating the color in the same category.  
Therefore the consensus classifications were used to evaluate the RGB color model 
against the xyY and Lu’v’ color models.  The results are summarized in Tables 2.5-2.7 
for eye color, skin color, and hair color, respectively.  Hair color was the most difficult 
category to classify, especially between brown and red.  This may be due to the method 
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of hair and digital photo collection as only 1 or 2 strands of hair were used for the color 
ratings.  Comparing all 3 color models between all the traits, the Lu’v’ model was chosen 
as the optimal quantitative classification scheme as it had the similar percentage of 
overall misclassifications across all traits as the RGB model, but is device independent 
and a more uniform color scale than RGB (see section 2.1.4) (Tables 2.5-2.7).  The LDA 
Lu’v’ classifications were henceforth used as the known color categories for the samples 
for evaluating the prediction models. 
2.3.3 Pigmentation Prediction Model Evaluation 
 Bayesian networks were built for each pigmentation trait and ancestry using the 
discrete Lu’v’ categories as determined by LDA.  There were 4 different BN models 
developed and tested.  The first BN model consists of a naive Bayes classifier using all 
24 SNPs (all SNPs) as child nodes with arrows directed from each trait parent node, an 
example of which can be seen in Figure 2.7.  The second and third BN models have a 
reduced number of SNPs:  the second model (pigment SNPs only) uses the 17 SNPs as 
found informative for any of the pigmentation traits (Figure 2.8) and the third model was 
further reduced in the number of SNPs to those only found informative for each 
pigmentation trait in the literature (trait SNPs only) (Figure 2.9).  There were 10, 7, and 6 
SNPs for hair, eye, and skin color, respectively. 
 As previously discussed, pigmentation can be influenced by ancestry.  Therefore 
the fourth model considered for the pigmentation predictions included ancestry as an 
additional factor (pigment + ancestry) (Figure 2.10).  The directionality of arrows differs 
slightly in this classifier to allow the ancestry SNP information to influence the 
pigmentation trait SNPs through the inclusion of an ancestry node, the arrows are 
31 
 
reversed as according to the Bayes-Ball algorithm [92].  In addition to the BN models, 
multinomial logistic regression (MLR) was performed using the all SNPs model.  The 
MLR parameters calculated for the all SNPs prediction model are listed in Table 2.8.  All 
prediction models were evaluated and compared based on the AUC and classification 
performance in terms of correct, incorrect, and inconclusive predictions in each category 
using the same 70% threshold (Table 2.9). 
 
Figure 2.7 Example BN with all 24 SNPs for one trait (skin color). 
 
 
Figure 2.8 Example BN with the 17 pigmentation informative traits (skin color). 
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Table 2.5 Eye color LDA confusion matrices for the self-reported (SR) classifications with the RGB model, the consensus rating classifications by 
the 6 independent individuals with the RGB model, the consensus rating classifications with the LUV model, and the consensus rating 
classifications with the XYZ model.  Correct classifications are shown in bold. 
 
         Legend:  SR= self-reported, consensus= consensus rating, BLU= blue, BRN= brown, INT= intermediate 
  
EYE SR-RGB Consensus-RGB Consensus-Lu’v’ Consensus-xyY 
 Count 
Number  
misclassified  
N (%) 
Count 
Number  
misclassified 
 N (%) 
Count 
Number  
misclassified  
N (%) 
Count 
Number  
misclassified  
N (%)  
Validation Set 
(N=50) 50 11 (22) 50 6 (12) 50 7 (14) 50 11 (22) 
 Predicted Predicted Predicted Predicted 
Actual BLU BRN INT BLU BRN INT BLU BRN INT BLU BRN INT 
BLU 11 0 1 14 0 0 14 0 0 14 0 0 
BRN 0 23 2 0 22 0 0 21 1 2 19 1 
INT 4 4 5 2 4 8 3 3 8 4 4 6 
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Table 2.6 Skin color LDA confusion matrices for the self-reported (SR) classifications with the RGB model, the consensus rating classifications 
by the 6 independent individuals with the RGB model, the consensus rating classifications with the LUV model, and the consensus rating 
classifications with the XYZ model.  Correct classifications are shown in bold. 
Legend:  SR= self-reported, consensus= consensus rating, LIT= light, DRK= dark, INT= intermediate 
  
SKIN SR-RGB Consensus-RGB Consensus-Lu’v’ Consensus-xyY 
 Count 
Number  
misclassified 
 N (%) 
Count 
Number  
misclassified  
N (%) 
Count 
Number  
misclassified 
 N (%) 
Count 
Number  
misclassified  
N (%) 
Validation Set 
(N=50) 50 12 (24) 50 4 (8) 50 3 (6) 50 5 (10) 
 Predicted Predicted Predicted Predicted 
Actual DRK INT LIT DRK INT LIT DRK INT LIT DRK INT LIT 
DRK 3 2 0 3 1 0 3 1 0 2 2 0 
INT 0 1 10 0 1 3 0 2 2 0 1 3 
LIT 0 0 34 0 0 42 0 0 42 0 0 42 
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Table 2.7 Hair color LDA confusion matrices for the self-reported (SR) classifications with the RGB model, the consensus rating classifications by 
the 6 independent individuals with the RGB model, the consensus rating classifications with the LUV model, and the consensus rating 
classifications with the XYZ model.  Correct classifications are shown in bold. 
HAIR SR-RGB Consensus-RGB Consensus-LUV Consensus-XYZ 
 Count 
Number  
misclassified  
N (%) 
Count 
Number  
misclassified 
 N (%) 
Count 
Number  
misclassified  
N (%) 
Count 
Number  
misclassified  
N (%) 
Validation Set 
(N=50) 46 18 (38) 46 14 (30) 46 15 (33) 46 16 (35) 
 Predicted Predicted Predicted Predicted 
Actual BLD BLK BRN RED BLD BLK BRN RED BLD BLK BRN RED BLD BLK BRN RED 
BLD 5 0 3 0 10 0 1 0 8 0 3 0 7 0 4 0 
BLK 0 5 4 0 0 9 4 1 0 8 5 1 0 8 5 1 
BRN 4 3 20 0 1 0 12 0 1 0 12 0 1 0 12 0 
RED 0 0 4 0 0 1 6 1 0 1 4 3 0 1 4 3 
     Legend:  SR= self-reported, consensus= consensus rating, BLD= blonde, BLK=black, BRN= brown, RED= red 
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Figure 2.9 Example BN with selective trait SNPs only (eye color). 
 
 
 
 
Figure 2.10 Example of pigment + ancestry BN model (skin color). 
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Intercept EYE COLOR HAIR COLOR SKIN COLOR 
α1 -2.23 17.01 -7.03 
α2 -1.05 15.31 -12.9 
α3  -- 19.61  -- 
SNP Minor Allele β1 β2 β1 β2 β3 β1 β2 
rs12913832 C 4.52 2.94 -2.25 -3.76 -3.19 0.14 2.82 
rs16891982 C -3.57 -9.80 -13.54 -7.23 -10.76 1.70 8.44 
rs12203592 A 1.87 2.55 -4.30 -4.54 -4.41 -1.64 -0.43 
rs1800407 T 2.11 2.03 -0.53 -4.24 -1.55 -0.74 -2.13 
rs3829241 A -0.15 -0.74 -1.91 -3.39 -0.93 -0.20 -11.63 
rs1805007 T -1.43 -0.70 -2.48 -2.92 -2.84 0.18 -6.02 
rs1408799 A -1.12 -1.14 -3.03 -3.96 -3.51 -1.64 -4.38 
rs683 T -0.47 -0.27 -2.02 -2.89 -2.39 -1.53 4.37 
rs3737576 T 0.82 -0.19 -3.48 -3.79 -4.10 -0.54 1.80 
rs1229984 A 0.02 1.89 3.80 5.91 4.02 0.35 1.80 
rs12498138 A -2.16 -2.51 -10.20 -8.69 -9.29 0.37 -4.66 
rs7657799 C -4.60 -4.19 16.63 19.15 18.93 2.65 0.53 
rs3916235 T -3.67 -3.71 -1.91 -3.00 -1.66 2.57 7.28 
rs4918664 G 1.47 1.19 4.11 5.53 3.38 -0.54 3.88 
rs3827760 C -4.14 -2.14 10.03 7.91 9.50 -1.55 -6.19 
rs28777 C 0.29 8.29 5.11 5.49 6.14 -0.24 -2.65 
rs12896399 T 1.82 1.93 -0.11 -0.46 -0.88 -0.37 -1.12 
rs10777129 G 2.33 3.00 -6.25 -6.46 -5.66 2.75 -6.00 
rs1800414 G 2.50 -3.72 -4.40 -8.98 -6.52 -1.77 6.44 
rs6119471 G 5.95 4.65 -4.38 -5.38 -10.46 8.86 1.04 
rs4959270 A 0.55 0.09 2.06 0.83 2.50 -0.94 1.68 
rs2378249 A -1.07 -1.05 1.59 3.72 1.94 0.69 -0.58 
rs12821256 C 1.17 1.36 12.92 12.58 13.23 0.23 -12.53 
rs1426654 G -10.82 -4.87 -3.20 0.63 -0.87 -14.30 -9.51 
 
 For determining the optimal model, a more conservative evaluation where a 
higher number of inconclusive predictions with a smaller number of incorrect predictions 
was considered the more appropriate model.  In a forensic context, an inconclusive result 
would be better than an incorrect classification.  For eye color, the AUC values for blue 
Table 2.8 Multinomial logistic regression parameters. a) The alpha intercept values (α), and b) 
the beta coefficients (β) for the all SNPs model. 
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and brown colors were similar across all models, however, the pigment + ancestry BN 
model had a higher AUC for the intermediate colors and although slightly more 
inconclusive predictions, fewer incorrect predictions (Table 2.9).  Comparing the models 
across all possible categories of each trait, the pigment + ancestry BN model was 
considered optimal with similar AUC values for all pigmentation traits.  Similar trends 
were seen with hair color, where the AUC values were relatively the same across all 
models (Table 2.9).  For skin color, the light and dark predictions have similar AUC 
values across all models, however, for the intermediate category, the AUC is the highest 
in the pigment + ancestry BN model with 0.79 indicating prediction capability of the 
model, whereas all the other models have AUC values below 0.50 indicating the other 
models are not informative for predicting intermediate skin (Table 2.9). 
2.3.4 Pigmentation Prediction Model Likelihood Ratio Evaluation 
 As Bayesian networks utilize Bayes’ rule to determine the posterior probabilities, 
likelihood ratios (LR) can also be calculated and evaluated.  For all pigmentation models, 
a 70% threshold was applied; a single category with a 70% probability equated 
approximately to a likelihood of 2.33 that the single highest predicted category was the 
classification versus the other remaining possible categories.  For example, it is 2.33 
times more likely an individual has blue eye color over brown or intermediate eye color 
given the genotypes observed.  This highest single probability over the remaining 
categories is labeled as the single LR in Table 2.9.  In other words, it is 500 times likely 
to not have brown eye color), but for the sake of brevity, we are demonstrating a single 
method. 
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Table 2.9 BN and MLR prediction model parameters for the pigmentation traits.  The model that best predicts most accurately across all traits is 
highlighted in green. 
    EYE COLOR HAIR COLOR SKIN COLOR 
Model Parameter 
BLU 
(n=17) 
BRN 
(n=24) 
INT 
(n=9) 
BLD 
(n=9) 
BLK 
(n=9) 
BRN 
(n=24) 
RED 
(n=4) 
DRK 
(n=3) 
INT 
(n=2) 
LIT 
(n=45) 
Pigment + 
Ancestry 
AUC 0.92 0.89 0.72 0.81 0.92 0.66 0.73 0.96 0.79 0.97 
CORRECT(%) 82 71 11 22 89 50 0 67 50 80 
INCORRECT(%) 6 4 33 33 0 33 75 0 50 13 
INCONCLUSIVE(%) 12 33 56 44 11 17 25 33 0 7 
Pigment 
SNPs 
only 
AUC 0.91 0.90 0.66 0.81 0.91 0.64 0.76 0.95 0.47 0.96 
CORRECT(%) 82 67 11 22 100 46 0 100 0 73 
INCORRECT(%) 6 0 44 33 0 29 75 0 50 0 
INCONCLUSIVE(%) 12 33 44 44 0 25 25 0 50 18 
Trait SNPs 
only 
AUC 0.92 0.88 0.63 0.87 0.92 0.71 0.73 0.98 0.31 0.92 
CORRECT(%) 82 67 0 11 89 33 0 100 0 84 
INCORRECT(%) 6 0 33 11 11 21 25 0 100 2 
INCONCLUSIVE(%) 12 33 67 78 9 46 75 0 0 13 
All SNPs 
AUC 0.92 0.89 0.71 0.83 0.92 0.70 0.77 0.96 0.43 0.95 
CORRECT(%) 82 67 11 33 89 50 0 100 0 78 
INCORRECT(%) 6 8 44 44 0 29 75 0 50 20 
INCONCLUSIVE(%) 12 25 44 22 11 21 25 0 50 2 
MLR (all 
SNPs) 
AUC 0.90 0.85 0.73 0.83 0.88 0.61 0.56 0.97 0.31 0.87 
CORRECT(%) 65 71 11 11 67 54 0 100 0 96 
INCORRECT(%) 12 13 44 44 33 25 100 0 100 2 
INCONCLUSIVE(%) 24 17 44 44 0 21 0 0 0 2 
    Legend:  BLU= blue, BRN= brown, INT= intermediate, BLD= blonde, BLK= black, RED=red, DRK= dark, LIT= light, AUC= area under the ROC curve, 
MLR= multinomial logistic regression
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 By combining 2 possible categories, generating an exclusion LR, this decreases the 
amount of classification error, although there is not a definitive assignment of a category 
to the individual.  For example, it is 300 times more likely that the individual does not 
have brown eyes.  Only categories with possible confusion were combined which included 
brown and intermediate and blue and intermediate; blue and brown against intermediate 
were not considered as it is not perceptually likely for an individual to confuse blue and 
brown color; they are on opposite ends of the melanin content spectrum.  For eye color in 
the pigment + ancestry BN model, there were 7 more correct classifications, 42/50 correct 
vs 36/50 correct, when considering a two category LR over the single LR, respectively 
(Table 2.10).  Of the 8 samples that were incorrect for both sets of LR calculations, 6 were 
confusions of blue and brown (5 of which were predicted blue when they were actually 
brown), and 2 were predicted intermediate where the consensus was either brown or blue.  
Looking at the strongest linked SNP predictor of blue and brown eye color, rs12913832 
(HERC2), for the 6 individuals that were predicted as blue but visually rated as brown, 3 
were homozygous TT and 3 were heterozygous CT.  These genotypes suggest inaccuracy 
in the model for brown predictions at another SNP in the panel (or more) or due to the 
genotypes of the samples used in the training set, as TT at rs12913832 is strong evidence 
for brown eye color expression whereas heterozygous individuals have a lower 
predictability and can be either brown or blue.  Overall, while considering the other 
misclassified samples, there is a higher margin of error in the prediction model and not the 
classification method, as 7 of the 8 had incorrect prediction classifications and only one 
was misclassified according to the consensus rating.  Additionally, as an exclusion 
probability is being considered with the probabilities of multiple categories, the LR values 
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are higher (Tables 2.10-2.12).  In a forensic context, this is still useful information as 
individuals with the denominator category can be eliminated from being the possible 
contributor. 
 For hair color, with 4 possible categories, different combinations can be considered 
for the LRs.  For the pigment + ancestry BN model, 2 categories against 2 and 3 categories 
against 1 were considered (Table 2.11).  The categories again were grouped as those 
possibly to be confused perceptually.  For the 2 against 2 categories, blonde and red, 
brown and red, and brown and black were calculated.  For the 3 categories, it would only 
seem likely to eliminate the extreme categories of blonde and black as all the others can be 
perceptually confused.  When compared to the 3 categories, which had the higher LRs, 
there were no misclassifications.  The single LR had 24/46 correct predictions while the 2-
category LR improved accuracy with 36/46 correct predictions (Table 2.11).  Exclusion 
LR calculations are especially useful for the hair color predictions as it was the most 
confused trait overall.  There were 9 samples that were incorrect for the 2-category 
classification between brown and blonde, and 1 sample between black and red (sample 
9451, Table 2.11).  Sample 9451 was misclassified as red by the consensus rating.  The 
remaining 8 samples were misclassified as either brown or blonde by the model.  Again, 
this is in part due to method for the hair collection as only single strands of hair were 
analyzed, not the overall shade of head.  Individuals with brown or blonde hair may have 
red mixed in, and individuals with black may have some brown.  Furthermore, blonde hair 
has already been known to be difficult to predict due to age-dependent changes especially 
during adolescence [45]. 
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 For skin color, the 2 category combinations considered were dark and intermediate 
and light and intermediate.  Light and dark was not considered as those categories would 
unlikely be confused.  When comparing single LRs with the exclusion LR, there were 
41/50 and 45/50 correct predictions, respectively.  There were 5 samples that were 
incorrect for both LR calculations.  For these samples, 2 of them were incorrect in their 
consensus rating, not the predictions (sample 6329 was self-reported and predicted dark 
but the consensus rating was light; sample 7181 was self-reported and predicted 
intermediate but the consensus rating was light, Table 2.12).  The other 3 samples were 
predicted as intermediate or dark and were actually light (samples 1654, 9717, and 7814, 
Table 2.12).  Of these samples, 2 of the individuals were East Asian, and one was a light-
skinned northern African.  These samples indicate how ancestry’s influence on 
pigmentation may not always be the most accurate prediction, and that further ancestry or 
skin SNPs would need to be included to avoid this classification confusion in the model. 
2.3.5 Quantitative Color Pigmentation Prediction Models 
 In addition to discrete, qualitative category prediction as discussed above, it was a 
goal of this work to develop a BN that would be able to predict continuous, or, 
quantitative color coordinates (RGB values).  This eliminates the subjectivity in binning 
color coordinates into a discrete color classification.  A BN that has both discrete and 
continuous variables is a hybrid BN.  A recently developed R package, HydeNet, was used 
to design similar BN structures as the discrete BNs.  All 4 of the models were tested here: 
all SNPs, pigment SNPs only, trait SNPs only, and pigment + ancestry.  The difference is 
that R, G, and B nodes were created in place of the single phenotype trait node; an 
example of the networks used can be seen in Figure 2.11.
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Table 2.10 LR comparison for eye color in the pigment + ancestry BN model.  The probabilities for each category (shaded by strength of 
probability in green) and the likelihood ratio (single LR) of the highest predicted category are shown, and also the 2-category exclusion LR (LR 
values are also shaded by strength of LR in blue).  The misclassifications (N=No, Y=Yes) are highlighted in red. 
Sample BLU BRN INT Predicted Consensus Single LR 
BLU+INT/ 
BRN LR 
BRN+INT/ 
BLU LR 
Single LR  
correct? 
2 category  
LR  
correct? 
1370 0.521 0.068 0.412 BLU BRN 1.09 13.75 0.92 N N 
1654 0.000 0.997 0.003 BRN BRN 314.78 0.00 4775.65 Y Y 
1736 0.000 1.000 0.000 BRN BRN 928797.45 0.00 5259532.10 Y Y 
1784 0.000 1.000 0.000 BRN BRN 310986.32 0.00 1173639.90 Y Y 
1892 0.805 0.000 0.194 BLU BLU 4.13 2462.58 0.24 Y Y 
1902 0.000 1.000 0.000 BRN BRN 1098686.53 0.00 2220987.68 Y Y 
1905 0.905 0.002 0.093 BLU BLU 9.48 487.39 0.11 Y Y 
2079 0.134 0.736 0.130 BRN BRN 2.79 0.36 6.44 Y Y 
2093 0.869 0.012 0.119 BLU BLU 6.66 82.98 0.15 Y Y 
2435 0.726 0.000 0.274 BLU BLU 2.64 6707.11 0.38 Y Y 
3187 0.786 0.016 0.198 BLU BLU 3.68 62.89 0.27 Y Y 
3471 0.922 0.002 0.077 BLU BLU 11.74 664.99 0.09 Y Y 
3542 0.393 0.446 0.161 BRN INT 0.81 1.24 1.54 N Y 
4063 0.000 1.000 0.000 BRN INT 16210.92 0.00 76848.49 N Y 
4069 0.467 0.119 0.413 BLU BRN 0.88 7.38 1.14 N N 
4258 0.590 0.019 0.391 BLU BLU 1.44 50.58 0.70 Y Y 
4389 0.222 0.002 0.776 INT BRN 3.47 453.56 3.51 N N 
4635 0.961 0.000 0.039 BLU BLU 24.62 2689.50 0.04 Y Y 
4710 0.000 1.000 0.000 BRN BRN 263248.42 0.00 1124157.56 Y Y 
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Table 2.10 continued 
4819 0.907 0.001 0.092 BLU BLU 9.70 987.12 0.10 Y Y 
5168 0.521 0.011 0.468 BLU BRN 1.09 91.06 0.92 N N 
5230 0.000 0.999 0.001 BRN BLU 1299.17 0.00 8163.06 N N 
6084 0.000 0.997 0.002 BRN BRN 362.83 0.00 2845.85 Y Y 
6149 0.819 0.001 0.181 BLU INT 4.52 1564.23 0.22 N Y 
6305 0.053 0.835 0.112 BRN BRN 5.05 0.20 17.93 Y Y 
6329 0.000 1.000 0.000 BRN BRN 29846.23 0.00 135334.19 Y Y 
6347 0.942 0.000 0.058 BLU BLU 16.23 5973.22 0.06 Y Y 
6789 0.116 0.021 0.863 INT INT 6.29 46.28 7.62 Y Y 
7181 0.000 1.000 0.000 BRN BRN 8155.13 0.00 88055.64 Y Y 
7263 0.335 0.149 0.516 INT INT 1.07 5.71 1.99 Y Y 
7280 0.001 0.960 0.039 BRN BRN 23.69 0.04 925.43 Y Y 
7294 0.365 0.517 0.118 BRN INT 1.07 0.93 1.74 N Y 
7482 0.863 0.007 0.130 BLU BLU 6.31 137.15 0.16 Y Y 
7632 0.789 0.000 0.211 BLU BLU 3.74 6833.49 0.27 Y Y 
7659 0.379 0.238 0.382 INT BRN 0.62 3.20 1.64 N N 
7814 0.000 1.000 0.000 BRN BRN 3704309.86 0.00 9653528.54 Y Y 
7890 0.004 0.991 0.005 BRN BRN 109.87 0.01 231.50 Y Y 
8395 0.000 1.000 0.000 BRN BRN 928696.71 0.00 1654763.16 Y Y 
8539 0.000 0.999 0.001 BRN BRN 936.39 0.00 74122.85 Y Y 
8709 0.798 0.000 0.202 BLU INT 3.95 61810.78 0.25 N Y 
8730 0.557 0.261 0.182 BLU INT 1.26 2.83 0.80 N Y 
8934 0.954 0.000 0.046 BLU BLU 20.74 2729.38 0.05 Y Y 
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Table 2.10 continued 
8972 0.963 0.000 0.037 BLU BLU 25.82 4149.62 0.04 Y Y 
9167 0.200 0.207 0.592 INT BLU 1.45 3.82 3.99 N N 
9345 0.471 0.265 0.265 BLU BRN 0.89 2.78 1.12 N N 
9451 0.000 0.999 0.000 BRN BRN 1380.37 0.00 2628.49 Y Y 
9628 0.593 0.077 0.330 BLU BRN 1.46 12.06 0.69 N N 
9717 0.000 1.000 0.000 BRN BRN 1664447.76 0.00 4818491.00 Y Y 
9785 0.918 0.004 0.079 BLU BLU 11.19 284.32 0.09 Y Y 
9981 0.572 0.010 0.419 BLU INT 1.34 101.87 0.75 N Y 
TOTALS 36/50 correct 
42/50 
correct 
 
 
Table 2.11 LR comparison for hair color in the pigment + ancestry BN model.  The probabilities for each category (shaded by strength of 
probability in green) and the likelihood ratio (single LR) of the highest predicted category are shown, and a 2- and 3- category exclusion LR (LR 
values also shaded by strength of LR in blue).  The misclassifications (N=No, Y=Yes) are highlighted in red. 
Sample BLD BLK BRN RED Predicted Consensus 
Single 
LR 
BLK+BRN/ 
BLD+RED 
LR 
BLD+RED/ 
BLK+BRN 
LR 
BRN+RED/ 
BLD+BLK 
LR 
BLK+BRN 
+RED/ 
BLD LR 
BLD+RED 
+BRN/ 
BLK LR 
Single LR 
correct? 
3 category 
LR 
correct? 
2 category 
LR 
correct? 
1370 0.142 0.000 0.849 0.008 BRN BRN 5.64 5.64 0.18 6.03 6.03 93456.94 Y Y Y 
1654 0.000 0.998 0.002 0.000 BLK BRN 429.87 33771.37 0.00 0.00 709218.86 0.00 N Y Y 
1736 0.000 0.996 0.003 0.000 BLK BLK 264.91 3293.34 0.00 0.00 90908.10 0.00 Y Y Y 
1784 0.000 0.998 0.001 0.000 BLK BLK 615.3 8115.88 0.00 0.00 24212.07 0.00 Y Y Y 
1892 0.451 0.000 0.549 0.001 BRN BLD 1.21 1.21 0.82 1.22 1.22 146626.57 N Y N 
1902 0.000 1.000 0.000 0.000 BLK BRN 22023.35 22169.08 0.00 0.00 
171232875.
34 0.00 N Y Y 
1905 0.206 0.000 0.793 0.001 BRN BRN 3.84 3.84 0.26 3.85 3.86 8646.90 Y Y Y 
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Table 2.11 continued 
2079 0.640 0.005 0.354 0.002 BLD BRN 1.78 0.56 1.79 0.55 0.56 208.75 N Y N 
2093 0.277 0.000 0.720 0.003 BRN RED 2.57 2.57 0.39 2.61 2.61 2286.68 N Y Y 
2435 0.241 0.000 0.699 0.060 BRN BLD 2.32 2.32 0.43 3.15 3.15 225224.23 N Y N 
3187 0.639 0.001 0.359 0.001 BLD BLD 1.77 0.56 1.78 0.56 0.56 1047.76 N Y Y 
3471 0.263 0.000 0.734 0.003 BRN BRN 2.76 2.76 0.36 2.80 2.80 19568.47 Y Y Y 
4063 0.000 1.000 0.000 0.000 BLK BLK 5241.13 35004.43 0.00 0.00 1763667.41 0.00 Y Y Y 
4069 0.170 0.000 0.829 0.001 BRN BRN 4.84 4.84 0.21 4.88 4.89 5560.27 Y Y Y 
4258 0.015 0.004 0.901 0.080 BRN BRN 9.13 9.56 0.10 52.32 66.58 251.70 Y Y Y 
4635 0.254 0.000 0.729 0.017 BRN BRN 2.69 2.69 0.37 2.94 2.94 31644.57 Y Y Y 
4710 0.000 1.000 0.000 0.000 BLK BLK 8784.52 8930.06 0.00 0.00 
92592591.1
1 0.00 Y Y Y 
4819 0.330 0.000 0.666 0.004 BRN BRN 2 2.00 0.50 2.03 2.03 13421.82 Y Y Y 
5168 0.000 0.988 0.010 0.002 BLK BRN 81.47 562.58 0.00 0.01 65788.47 0.01 N Y Y 
5230 0.001 0.747 0.234 0.018 BLK BRN 2.95 50.21 0.02 0.34 732.09 0.34 N Y Y 
6084 0.041 0.370 0.587 0.002 BRN BLK 1.42 22.34 0.04 1.43 23.29 1.70 N Y Y 
6149 0.572 0.001 0.336 0.092 BLD RED 1.34 0.51 1.97 0.75 0.75 1876.12 N Y Y 
6305 0.136 0.004 0.851 0.010 BRN RED 5.69 5.86 0.17 6.19 6.37 281.36 N Y Y 
6329 0.000 1.000 0.000 0.000 BLK BLK 3788.14 4023.51 0.00 0.00 
29154516.9
4 0.00 Y Y Y 
6347 0.874 0.000 0.125 0.000 BLD BLD 6.96 0.14 6.98 0.14 0.14 72462.77 Y Y Y 
6789 0.076 0.000 0.913 0.011 BRN BLD 10.46 10.46 0.10 12.15 12.16 33556.05 N Y N 
7181 0.000 1.000 0.000 0.000 BLK BLK 10050.41 74598.03 0.00 0.00 9523808.68 0.00 Y Y Y 
7263 0.156 0.000 0.844 0.000 BRN BLD 5.4 5.40 0.19 5.40 5.41 13868.63 N Y N 
7280 0.001 0.247 0.747 0.005 BRN BRN 2.95 183.18 0.01 3.03 1632.75 3.04 Y Y Y 
7294 0.140 0.000 0.859 0.001 BRN BRN 6.08 6.10 0.16 6.10 6.13 2348.68 Y Y Y 
7482 0.388 0.000 0.596 0.016 BRN BLD 1.47 1.48 0.68 1.57 1.58 4376.73 N Y N 
7632 0.729 0.000 0.267 0.004 BLD BLD 2.69 0.36 2.75 0.37 0.37 36230.88 N Y Y 
7659 0.048 0.000 0.946 0.005 BRN BRN 17.61 17.65 0.06 19.61 19.66 8862.76 Y Y Y 
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Table 2.11 continued 
7814 0.000 1.000 0.000 0.000 BLK BRN 44429.08 78130.10 0.00 0.00 
10101008.9
2 0.00 N Y Y 
8395 0.000 1.000 0.000 0.000 BLK BLK 164612 174992.74 0.00 0.00 
222717147.
66 0.00 Y Y Y 
8539 0.000 1.000 0.000 0.000 BLK BRN 27933.09 42362.39 0.00 0.00 
189035917.
01 0.00 N Y Y 
8709 0.829 0.000 0.170 0.001 BLD BRN 4.85 0.20 4.88 0.21 0.21 56178.78 N Y N 
8730 0.336 0.000 0.659 0.004 BRN BRN 1.93 1.94 0.52 1.97 1.98 3626.12 Y Y Y 
8934 0.352 0.000 0.645 0.002 BRN BRN 1.82 1.82 0.55 1.84 1.84 245699.25 Y Y Y 
8972 0.933 0.000 0.065 0.002 BLD BRN 13.98 0.07 14.34 0.07 0.07 59522.81 N Y N 
9167 0.056 0.000 0.937 0.007 BRN BRN 14.96 14.98 0.07 16.92 16.93 21550.72 Y Y Y 
9451 0.000 0.970 0.029 0.001 BLK RED 32.47 1570.84 0.00 0.03 95237.10 0.03 N Y N 
9628 0.268 0.000 0.728 0.003 BRN BRN 2.68 2.68 0.37 2.73 2.73 101831.99 Y Y Y 
9717 0.000 1.000 0.000 0.000 BLK BLK 39275.34 117480.20 0.00 0.00 3424656.37 0.00 Y Y Y 
9785 0.304 0.000 0.694 0.002 BRN BLD 2.27 2.27 0.44 2.29 2.29 26384.22 N Y N 
9981 0.164 0.000 0.832 0.003 BRN BRN 4.97 4.98 0.20 5.07 5.08 2156.59 Y Y Y 
TOTALS 
24/46 
correct 
46/46 
correct 
36/46 
correct 
 
Table 2.12 LR comparison for skin color in the pigment + ancestry BN model.  The probabilities for each category (shaded by strength of 
probability in green) and the likelihood ratio (single LR) of the highest predicted category are shown, and a 2-category exclusion LR (LR values 
also shaded by strength of LR in blue).  The misclassifications (N=No, Y=Yes) are highlighted in red. 
Sample DRK INT LIT Predicted Consensus 
Single 
LR 
DRK+INT/ 
LIT LR 
LIT+INT/ 
DRK LR 
Single LR 
correct? 
2 category 
LR 
correct? 
1370 0.000 0.000 1.000 LIT LIT 41894.73 0.00 35102641.87 Y Y 
1654 0.358 0.617 0.026 INT LIT 1.607942 38.09 1.79 N N 
1736 0.060 0.742 0.198 INT INT 2.876198 4.04 15.76 Y Y 
1784 0.107 0.702 0.191 INT LIT 2.356587 4.25 8.31 N Y 
1892 0.000 0.000 1.000 LIT LIT 299003 0.00 110827758.79 Y Y 
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Table 2.12 continued 
1902 0.997 0.003 0.000 DRK INT 381.275 9728819.27 0.00 N Y 
1905 0.000 0.000 1.000 LIT LIT 36703.95 0.00 5075376.97 Y Y 
2079 0.000 0.000 1.000 LIT LIT 3270.189 0.00 76665.74 Y Y 
2093 0.000 0.000 1.000 LIT LIT 16795.8 0.00 266737.47 Y Y 
2435 0.000 0.000 1.000 LIT LIT 17904.27 0.00 13980847.10 Y Y 
3187 0.000 0.000 1.000 LIT LIT 32070.61 0.00 282815.64 Y Y 
3471 0.000 0.000 1.000 LIT LIT 34594.33 0.00 112733939.19 Y Y 
3542 0.000 0.000 1.000 LIT LIT 28539.13 0.00 2709170.90 Y Y 
4063 0.315 0.673 0.012 INT LIT 2.06009 81.52 2.18 N Y 
4069 0.000 0.000 1.000 LIT LIT 5227.807 0.00 996047.13 Y Y 
4258 0.000 0.003 0.997 LIT LIT 286.2847 0.00 1034014.10 Y Y 
4389 0.000 0.000 1.000 LIT LIT 12314.71 0.00 26104012.07 Y Y 
4635 0.000 0.000 1.000 LIT LIT 83681.08 0.00 228656472.46 Y Y 
4710 0.994 0.006 0.000 DRK DRK 174.7681 327418.79 0.01 Y Y 
4819 0.000 0.000 1.000 LIT LIT 37094.39 0.00 82038145.13 Y Y 
5168 0.015 0.748 0.237 INT LIT 2.961556 3.22 64.63 N Y 
5230 0.006 0.189 0.805 LIT LIT 4.116254 0.24 164.94 Y Y 
6084 0.000 0.019 0.981 LIT LIT 51.03596 0.02 2301.33 Y Y 
6149 0.000 0.001 0.999 LIT LIT 961.6165 0.00 5232.87 Y Y 
6305 0.000 0.003 0.997 LIT LIT 377.7958 0.00 84081.56 Y Y 
6329 0.854 0.146 0.000 DRK LIT 5.849223 22249.06 0.17 N N 
6347 0.000 0.000 1.000 LIT LIT 74314.97 0.00 983159.98 Y Y 
6789 0.000 0.000 1.000 LIT LIT 9321.736 0.00 6688300.05 Y Y 
7181 0.129 0.863 0.008 INT LIT 6.285268 127.33 6.72 N N 
7263 0.000 0.000 1.000 LIT LIT 118225.2 0.00 2841668.30 Y Y 
7280 0.000 0.100 0.900 LIT LIT 8.969565 0.11 2068.94 Y Y 
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Table 2.12 continued 
7294 0.000 0.000 1.000 LIT LIT 44822.28 0.00 19126769.26 Y Y 
7482 0.000 0.000 1.000 LIT LIT 4819.091 0.00 3494296.88 Y Y 
7632 0.000 0.000 1.000 LIT LIT 131797.3 0.00 1600379.37 Y Y 
7659 0.000 0.000 1.000 LIT LIT 5047.092 0.00 41150620.49 Y Y 
7814 0.975 0.025 0.000 DRK LIT 38.84789 2077.96 0.03 N N 
7890 0.001 0.084 0.915 LIT LIT 10.7108 0.09 1008.70 Y Y 
8395 0.975 0.025 0.000 DRK DRK 39.52512 1125150.70 0.03 Y Y 
8539 0.436 0.564 0.000 INT DRK 1.292076 932436.39 1.29 N Y 
8709 0.000 0.000 1.000 LIT LIT 76289.17 0.00 38908532.70 Y Y 
8730 0.000 0.000 1.000 LIT LIT 41327.64 0.00 1045479.93 Y Y 
8934 0.000 0.000 1.000 LIT LIT 109375.1 0.00 394892169.19 Y Y 
8972 0.000 0.000 1.000 LIT LIT 31617.57 0.00 1023395.30 Y Y 
9167 0.000 0.000 1.000 LIT LIT 15829.61 0.00 53311166.25 Y Y 
9345 0.000 0.000 1.000 LIT LIT 57933.48 0.00 24935776.32 Y Y 
9451 0.001 0.477 0.522 LIT LIT 1.089973 0.92 746.39 Y Y 
9628 0.000 0.000 1.000 LIT LIT 128532.8 0.00 313671781.77 Y Y 
9717 0.959 0.040 0.001 DRK LIT 23.29524 1127.20 0.04 N N 
9785 0.000 0.000 1.000 LIT LIT 220011.2 0.00 20086150.74 Y Y 
9981 0.000 0.000 1.000 LIT LIT 6445.191 0.00 3664266.00 Y Y 
TOTALS 
41/50 
correct 
45/50 
correct 
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Figure 2.11 HydeNet built BN models.  a) The trait SNPs only hybrid BN model (eye color).  b) The pigment + ancestry BN model (skin color). 
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The following equations are examples of the HydeNet BN model output to calculate the 
predicted RGB values.  Each genotype possibility is coded and inputted as 0, 1, or 2 at 
each SNP for each color value equation.  The examples shown were used to calculate the 
eye color R, G, and B predictions for the trait SNPs only model (coded as ER, EG, and 
EB): 
 Equation 2.4 
 
 
 Equation 2.5 
 
 
 Equation 2.6 
 
 
As the Lu’v’ color model was used for classification in the discrete BN models, it was 
applied for the hybrid models as well; however, to be able to visualize the RGB output as 
a color on a computer, the Lu’v’ values were transformed to RGB values.  It was 
performed for eye color in one model and there was no significant difference in error 
measurements between the transformed Lu’v’ values and those where RGB was used as 
the input.  Therefore, to eliminate the need of computational effort for color coordinate 
transformations, RGB values were used as input for these models.  Table 2.13 shows the 
average error for each model for all 3 pigmentation traits.  All RGB value comparisons 
can be seen in Appendix D, but Table 2.14 shows a subset as an example. 
 For eye color, the trait SNPs model had the least amount of error overall and for 
blue and intermediate eye colors; the all SNPs model had a slightly lower error value for 
ER = 52.94984 + 8.03904 * rs12913832 + -12.47638 *rs16891982 + 
4.98515 *rs1800407 + -3.9789 * rs3829241 + 1.30806 *rs1408799 + -
0.56048 * rs12896399 + 3.39914 * rs12203952 
EG = 32.31058 + 14.1561 *rs12913832 + -11.51611 *rs16891982 + 
4.79901 *rs1800407 + -3.66421 *rs3829241 + 1.82756 *rs1408799 + 
0.46773 *rs12896399 + 2.34781 * rs12203592 
EB = 28.57741 + 15.21519 *rs12913832 + -10.65358 * rs16891982 + 
3.28254 * rs1800407 + -2.53158 *rs3829241 + 2.09347 *rs1408799 + 
0.8793 *rs12896399 + 1.06664 *rs12203592 
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brown eye color.  The pigment SNPs model had the least amount of error for hair color 
overall and for black and red hair color (Table 2.13).  The all SNPs model had slightly 
lower error for brown hair, while the least amount of error for blonde was with the trait 
SNPs only model.  For skin color, the pigment + ancestry model had the least amount of 
error overall and for all three skin color phenotypes, with high accuracy especially for 
light and dark skin with only a 1.1% error (Table 2.13).  Hair color was the trait with the 
highest error.  Again, this could be due to collection and analysis method of the hair, also 
as hair can be a mix of more than one shade of color and may not be accurately 
represented as a single RGB coordinate.  Overall, the predicted RGB coordinates are in 
higher ranges than the measured values.  Although the average error values were low for 
some phenotypes (1.1% for dark and light skin color), it was as high as 25.6% for blonde 
hair color (Table 2.13). 
Table 2.13 Error rates of the RGB value predictions. 
  Average Absolute Error (Average Error %) 
 
Trait SNPs 
only 
Pigment 
SNPS only All SNPs 
Pigment+ 
Ancestry 
Eye Color- Overall 28.66 (6.5%) 30.61 (6.9%) 31.05 (7.0%) 30.96 (7.0%) 
BLU (n=17) 6.34 (1.4%) 8.19 (1.9%) 7.56 (1.7%) 7.97 (1.8%) 
BRN (n=24) 15.66 (3.6%) 19.27 (4.4%) 13.84 (3.1%) 37.63 (8.5%) 
INT (n=9) 26.47 (6.0%) 27.34 (6.2%) 32.90 (7.5%) 52.73 (11.9%) 
Hair Color -Overall 52.08 (11.8%) 50.03 (11.3%) 52.34 (11.9%) 55.50 (12.6%) 
BLD (n=9) 108.60 (24.6%) 111.15 (25.1%) 110.49 (25.0%) 113.03 (25.6%) 
BLK (n=9) 41.61 (9.4%) 38.93 (8.8%) 43.63 (9.9%) 35.46 (8.03%) 
BRN (n=24) 8.54 (1.9%) 7.96 (1.8%) 7.45 (1.7%) 8.05 (1.82%) 
RED (n=4) 45.56 (10.3%) 32.14 (7.28%) 37.99 (8.6%) 30.69 (7.0%) 
Skin Color - Overall 35.24 (8.0%) 33.29 (7.5%) 33.23 (7.5%) 33.57 (7.6%) 
DRK (n=3) 9.15 (2.1%) 5.43 (1.2%) 11.99 (2.7%) 4.80 (1.1%) 
INT (n=2) 71.65 (16.2%) 49.81 (11.3%) 50.48 (11.4%) 47.33 (10.7%) 
LIT (n=45) 7.65 (1.7%) 5.12 (1.2%) 7.60 (1.7%) 4.86 (1.1%) 
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Table 2.14 Subset of RGB value comparison from HydeNet BN models.  The highlighted columns are the RGB measurements extracted from the 
digital skin photo collection.  Only the pigmentation SNPs only model predicted RGB values are fully shown, and the percent error shown for all 
models tested. 
Sample SR SG SB Actual 
Predicted 
SRpig 
Predicted 
SGpig 
Predicted 
SBpig 
Pigmentation 
 SNPs only, 
Error % 
All 
SNPs, 
 Error % 
Trait  
SNPs only, 
Error % 
Ancestry+ 
Pigmentation, 
Error % 
1370 200 156 125   223 186 151 10.47% 9.60% 8.47% 10.56% 
1654 212 174 133   208 163 121 3.76% 7.96% 2.37% 3.85% 
1736 187 134 83   208 165 124 12.56% 14.51% 17.81% 11.54% 
1784 200 161 123   207 157 104 4.84% 5.07% 6.69% 5.39% 
1892 228 183 128   220 181 144 4.07% 4.02% 4.95% 3.95% 
1902 172 121 68   185 142 104 10.06% 8.86% 14.78% 10.04% 
1905 231 201 170   213 172 137 10.65% 8.57% 7.45% 10.62% 
2079 224 175 120   209 171 136 5.01% 5.22% 4.98% 5.23% 
2093 208 168 127   207 170 142 3.44% 3.56% 4.75% 3.55% 
2435 207 178 159   225 192 166 5.45% 4.59% 3.77% 5.37% 
3187 213 155 131   212 174 139 4.71% 5.69% 6.08% 4.77% 
3471 217 178 146   209 171 136 3.40% 4.21% 0.82% 3.23% 
3542 216 164 113   218 181 145 8.19% 8.06% 6.89% 8.48% 
4063 194 154 110   234 191 142 14.24% 18.06% 23.30% 14.56% 
4069 200 175 140   218 179 145 4.36% 4.41% 4.62% 4.39% 
4258 225 192 156   212 171 130 8.24% 8.96% 4.66% 7.52% 
4389 207 165 118   217 179 145 7.43% 4.15% 6.66% 7.60% 
4635 196 158 124   217 181 146 8.62% 11.23% 7.98% 8.67% 
4710 148 87 53   185 135 90 16.09% 14.31% 24.58% 16.41% 
4819 212 174 164   213 176 142 4.95% 5.07% 5.05% 4.93% 
5168 203 155 115   196 151 112 1.79% 2.00% 2.44% 1.74% 
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2.3.6 Ancestry Prediction Model Evaluation 
 Ancestry was evaluated similarly to the discrete pigmentation phenotypes.  There 
were 2 BN models considered, one with all SNPs, and one with the ancestry informative 
SNPs alone which consisted of 13 SNPs (Figure 2.12). 
 
Figure 2.12 Ancestry trait SNPs BN model. 
 
The known ancestry of the sample population samples is based on the self-reported 
information collected from the volunteer survey.  To simplify classification, only single 
categories by continental group was considered.  For the individuals who listed more than 
one ancestry, and as the majority of the sample population was of European descent, the 
minority group was used (e.g., if reported as African/European, African was used).  There 
were 7 individuals in the training set that reported unknown as their ancestry.  LDA was 
used to group these samples into one of the 5 possible ancestral categories:  European, 
East Asian (E. Asian), Other Asian (O. Asian), Hispanic, and African.  E. Asian 
encompassed individuals from the eastern regions of Asia such as China, Japan, Korea, 
and Taiwan whereas O. Asian included countries such as India and Pakistan.  The 
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prediction model performance parameters can be seen in Table 2.15, a 70% threshold was 
applied similarly as the pigmentation models. 
Table 2.15 Prediction Model parameters for ancestry.  The model with best overall accuracy is 
highlighted in green. 
    ANCESTRY  
Model Parameter 
African 
(n=6) 
E. Asian 
(n=4) 
European 
(n=33) 
Hispanic 
(n=4) 
O. Asian 
(n=3) 
All SNPs 
AUC 0.99 0.96 1.0 0.99 0.89 
CORRECT(%) 83 50 97 75 67 
INCORRECT(%) 17 50 0 0 33 
INCONCLUSIVE(%) 0 0 3 25 0 
Trait SNPs 
only 
AUC 0.84 0.83 0.88 0.99 0.91 
CORRECT(%) 83 75 100 50 33 
INCORRECT(%) 17 25 0 0 33 
INCONCLUSIVE(%) 0 0 0 50 33 
 
The BN models classified the ancestry groups with a high rate of correct predictions.  The 
all SNPs model performed better overall for all ancestry groups than the trait SNPs only 
model (Table 2.15).  Most confusion of classifications happened for O. Asian individuals, 
as well as between Hispanic and E. Asian groups.  This is not surprising as E. Asian and 
Hispanic ancestry are most similarly related when considering the out of Africa theory of 
human migration [93]; the SNPs chosen to classify E. Asian and Hispanic had similar 
minor allele frequencies when compared to the other ancestral groups.  There was one 
individual classified as O. Asian who was actually from North Africa (Egypt).  One E. 
Asian, one O. Asian, and one Hispanic were also misclassified between those three 
ancestry groups, but none were classified as European or African.  Further SNPs should 
be included to discriminate the Asian ancestral groups from Hispanic. 
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2.4 Conclusions 
 The goal of this work was to develop a SNP assay that can be informative for eye 
color, hair color, skin color, and ancestry simultaneously not only based on discriminant 
color categories but on a quantitative approach, while also developing an accurate model 
to perform the predictions.  The SNP assay itself being based on allele-specific PCR is a 
simpler protocol than single-based extension methods, eliminating the need for multiple 
PCR and clean-up steps and reducing human error in pipetting and transfer between 
tubes.  Overall, the selected SNPs predict eye and skin color fairly accurately with an 
ancestry influenced pigmentation model; with the exception of intermediate eye color at 
11% correct prediction rate, all other phenotypes of these traits had correct prediction 
rates ranging from 50-82%, with blue eye color as the most accurate trait with an 82% 
correct prediction rate.  Hair color predictions were the least accurate in all the models 
tested, however, the collection method retrospectively was not the optimal way to 
measure hair color.  Although calibrated color measurement of digital photos was a 
reliable tool, a more representative portion of hair needs to be evaluated as individual 
strands have a lot of variation.  Furthermore, inclusion of more known hair informative 
SNPs would improve prediction accuracies, especially for red hair. 
 Quantitative color measurement was successful.  This work shows that a 
consensus of multiple individuals in rating pigmentation colors is more accurate and 
reliable than a single individual (self-reported rating), likely due to bias in self-reporting, 
and also as the use of consensus ratings incorporates differences in human perception of 
the same color.  The LUV color model should be considered for quantitative color 
measurement as it measured color similarly to the photo-measured RGB color, is a more 
objective color space with a perceptually uniform color space, and is device independent.  
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BN models could be developed to predict quantitative color coordinates.  This eliminates 
the need to bin colors into discriminant categories and the color can be assessed as an 
objective numerical value.  One limitation of the color measurements in this study was 
the use of the average color – the whole iris was extracted and measured as a whole.  
Because of this, the quantitative RGB representation of the color does not necessarily 
portray the true shade of the visually-percepted iris.  One way to work around this would 
be to extract and measure only a small portion of the iris.  Conversely, for hair color, only 
a small section was measured, it might be beneficial to measure the entire strand or a 
photo of the entire head of hair to be able to assess the overall shade more accurately.  
Although error rates were determined for the color coordinate predictions, further 
analysis into what range of error would actually have an effect on the human perception 
of the color is necessary to further evaluate these models. 
 For ancestry, there were 97% correct predictions, with 83% for African, 75% for 
Hispanic, 67% for Other Asian, and 50% for East Asian when using the entire SNP panel.  
These are relatively accurate predictions, especially when considering they are only based 
on 24 SNPs.  There were no well-established and highly informative SNPs for Other 
Asian populations found in literature at the time of the assay SNP selection, although 
Eurasiaplex includes 23 SNPs found to have high likelihoods of discrimination between 
European and South Asian populations [58].  For improvement in the Other Asian 
ancestries in this FPP panel, perhaps some of those SNPs should be considered for 
inclusion.  The collected sample population was lacking in many of the ancestry groups 
other than European, especially in East Asian samples (with 7/200), and therefore, the 
model may not reliably reflect the power of prediction for the more minor ancestry 
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groups assessed.  Furthermore, admixture of biracial individuals was not fully addressed.  
Individuals were categorized into a single ancestry group for ease of model building, 
however, further development of the models should be done to be able to consider levels 
of admixture that would have a conflicting result when trying to categorize as a single 
ancestry. 
 For eye color, there was 82% correct predictions for blue, 71% for brown, and 
11% for intermediate.  For skin color, there was 80% correct predictions for light skin, 
67% correct predictions for dark, and 50% for intermediate.  Not unexpected, as it is seen 
with eye color, the intermediate skin had the lowest percent of correct predictions within 
the skin color phenotypes.  For hair color, there was 89% correct predictions for black 
hair, 50% correct predictions for brown, 22% for blonde, and 0% for red.  More work 
needs to be done to improve this assay.  This was clearly needed for the red hair 
phenotype.  Red hair was the first trait identified for prediction from DNA [35] and yet 
had very poor prediction power in the developed BN models.  This is in part due to 
selecting only one of the MC1R SNPs.  As discussed in section 2.1.2, there is a 
compound effect between the several mutations within the MC1R gene for red hair 
expression; some with a stronger or weaker contribution to that expression.  Not every 
red-haired individual will have the same haplotype of MC1R mutations and selecting only 
one of the SNPs with a strong effect has shown to be insufficient.  There was also only a 
small set of red haired individuals in the sample population (8/200), so similarly to the 
East Asian ancestry, more individuals representing this phenotype would be ideal to 
include.  Including a few more MC1R SNPs and optimizing the hair collection method 
would likely improve the accuracy of these predictions. 
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 In terms of the prediction modeling accuracy, the BN model was shown to 
perform more accurately than MLR.  This is not to say the MLR model was not accurate, 
it had comparable AUC values with the BN models (Table 2.9).  However, the BN 
models had overall less incorrect and more inconclusive predictions.  This is the best 
conservative approach to be used in the forensic context, as it would be better to have an 
inconclusive result than an incorrect one.  The pigment + ancestry BN model was 
selected as the optimal model for this reason.  However, this may not be the most optimal 
model for all datasets; a larger sample population with higher frequencies of the lesser 
represented traits should be evaluated.  The likelihood ratio statistic that can also be 
calculated is favorable for reporting purposes.  In fact, even if a probability is not strong 
enough in one category, a broader conclusion can still be drawn if you group categories 
together to still have an accurate prediction statement.  For example, one can state that it 
is 100 times more likely that an individual has blue eyes.  But stating more broadly that it 
is 100 times more likely that an individual has blue or intermediate eyes can still 
eliminate brown-eyed individuals.  The phenotypic information from these predictions, as 
of now, is to be used to help gather intelligence for an investigation.  Any reduction in 
possible suspects to help solve a case is a desired goal. 
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CHAPTER 3. METHYL-RADSEQ: A NOVEL METHOD FOR 
THE DISCOVERY OF CANDIDATE DNA MARKERS FOR AGE 
PREDICTION 
3.1 Introduction 
 Pigmentation traits are not the only phenotypes that would aid the intelligence for 
an investigation.  Another important phenotype is age.  Age can also relate to 
pigmentation; for example, an individual may be predicted to have brown hair, but after a 
certain age, hair color can change, and thus investigators may not be looking for an 
individual with brown hair, but with white or grey hair.  In addition, knowing the age 
range of an unknown DNA sample found at a crime scene would certainly reduce the 
number of possible contributors.  One mechanism in place for aging phenomena is due to 
epigenetic changes to the genome over time. 
 Epigenetics refers to the inherited patterns of gene expression without changes in 
the DNA sequence [94].  Epigenetic regulation plays a role in animal and plant 
development and regulates the activation or repression of genes within specific cells that 
may be tissue specific and occur during different stages of development [94].  The best 
known types of epigenetic modifications include: methylation, phosphorylation, 
acetylation, and ubiquitination [95].  Each of these mechanisms produce changes in gene 
expression, thus effecting the production of specific gene products or proteins. 
 DNA methylation is an epigenetic factor that has potential use in forensic 
investigations.  DNA methylation involves the addition of a methyl group (CH3) to the 
aromatic ring of a DNA base.  The most common methylation is the methyl group 
addition to the 5’-carbon structure of cytosine bases (5-mC) [95].  In particular, these 
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methylated cytosines are found in dinucleotide patterns with guanines and are termed 
CpG sites or islands, if they occur in long stretches of > 500bp [96], and are typically 
located in gene promoter regions.  There are roughly 20 million CpG sites in the human 
genome, and at present there is no defined set of CpG markers with predictive relevance 
[97].  However, age-associated differentially methylated regions (DMRs) have been 
found to be conserved in several tissues, indicating age-dependent methylation is not 
random [97].  The association of these sites to age is based on either a positive 
(hypermethylated) or negative (hypomethylated) correlation as age increases. 
 One of the proposed panels to be included in the FPP assay is a panel of 
epigenetic methylation markers (each CpG site as a C/T ‘SNP’) that will be informative 
for chronological age prediction and thus represent an age phenotype profile. 
3.1.1 Predicting Age 
 There have been some developments in which a few studies have identified 
potential useful age-associated CpG markers, most of which have been with microarray 
platforms, or bead chip arrays, which can analyze hundreds of thousands of SNPs at 
once.  A challenging aspect is that regulation of methylation, and thus rate of methylation 
at specific sites, has been found to be mostly tissue-specific.  However, markers that 
correlate in common across all tissues are known [98].  Additionally, with the use of a 
prediction model for specific tissue markers, a correction can be applied when comparing 
samples from different tissues [99]. 
 Bocklandt et al. [100] found significant correlation between 88 CpG sites with 
age from saliva samples and describe a predictive model using CpG sites within the 
promoter regions of three genes: NPTX2, TOM1L1, and EDARADD.  This model was 
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accurate for an age range of 18-70 within 5.2 years and explained 73% of age variance.  
However, the study is limited in that the CpG sites were found correlated in saliva 
samples only, therefore not broadly applicable in forensic samples.  Furthermore, sex was 
an influencing factor, as NPTX2 sites were not significant in the analysis of females 
[100].  Sex was previously found to influence methylation states between males and 
females, especially X-chromosome sites [101].  The correction of any gender-related 
influences should be included in the final selection of age-related sites used for age 
predictions.  Florath et al. [102] used a model with 17 CpG sites that explained 71% of 
the variance of age with an average accuracy of 2.6 years from blood samples.  The most 
statistically significant CpG sites (with known associated genes) found were: cg06784991 
(ZYG11A), cg06639320 (FHL2), cg04875128 (OTUD7A), cg19283806 (CCDC102B), 
cg17110586, and cg07547549 (SLC12A5), cg09809672 (EDARADD), cg16867657 
(ELOVL2) [102].  It was also reported that cg16867657 (ELOVL2) alone describes 47% 
of the variance of age [102].  More recently, ELOVL2 was further analyzed on its own for 
age determination, where 7 CpG sites within ELOVL2 in blood samples was able to 
predict age within 7 years with a 60-78% correct prediction rate [18].  Hannum et al. [99] 
developed a model that predicted age at 91% with an error of 5 years, adding that 
cg16867657 and cg23606718, both associated to ELOVL2, were a common significant 
age correlating marker for multiple tissue models [99].  Zbieć-Piekarska et al. [103] 
further investigated the top 8 candidate loci from Hannum et al. [99] via pyrosequencing 
and developed a prediction model with a standard error of 4.5 years, where 86.7% of 
samples had correct predictions within 5 years for ages 2-19, which gradually decreased 
as age increased to 50% for 60-75 years. 
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 There are a few issues to be aware of when analyzing methylation status.  There 
are environmental factors that influence the methylation state at certain CpG sites [101].  
Factors such as sex and lifestyle choices such as the use of tobacco, nutrition, and fitness 
[94, 104] are correlated and could thus result in an inaccurate age prediction.  Another 
issue to take caution of in the current studies is the reliance on selection of markers which 
are based on microarray analysis.  As it is a more recently explored area, coverage of as 
many loci as possible initially is desirable.  Bead chip arrays allow for that, and most 
published studies have used the Illumina HumanMethylation27 or HumanMethylation450 
arrays, with coverage of 27,578 or 485,577 sites, respectively [96, 105].  However, the 
arrays are limited by the available probes as defined by the company that developed the 
chip array, targeting CpG islands, shores, or shelves (approximately 85% of CpG content 
in HumanMethylation450 array) [106].  Shores are genomic regions between 0-2kb from 
a CpG island, and shelves are those within 2-4kb from the island [96].  These arrays are 
important for discovering methylation patterns related to human diseases, especially 
cancer, as many cancer-related genes and their promoter regions are preferentially 
targeted and therefore there exists some selection bias in the panel of array markers 
[105]. 
 The objective of this work is to develop a novel genome-wide sequencing method 
to find candidate CpG sites that can be potentially informative for age prediction for a 
broad range of forensically relevant tissues: saliva, blood, and semen. 
3.1.2 Methyl RAD Sequencing 
 To discover further candidate age informative CpG sites, we propose to use a 
novel method termed methylation restriction-site associated DNA sequencing, or, 
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methyl-RADseq.  This method is based on the analysis of restriction-site associated DNA 
(RAD) at high resolution using a sequencing platform.  Traditional RADseq combines, 
typically, Illumina sequencing with the use of restriction enzymes and the ability to use 
barcodes to associate sequencing reads to a particular individual or sample [107].  It 
allows for genome-wide, high density SNP genotyping and genetic mapping, but is less 
expensive and faster than whole genome re-sequencing efforts [108, 109].  Other 
methods, including the Infinium arrays, utilize bisulfite conversion of the DNA 
(conversion of unmethylated cytosines to uracil and ultimately to thymine during PCR 
[110]), which can be difficult for mapping.  The method developed here differs from 
conventional RADseq method in the use of the isoschizomeric methylation sensitive and 
insensitive enzymes, HpaII and MspI, respectively.  Therefore potential methylated CpG 
sites are differentiated by fragments produced where the methylated cytosines are cut by 
MspI, and not cut by HpaII (Figure 3.1).  The reads are mapped to a reference genome, 
and the methylation state at CpG sites across the genome are computed.  The first step is 
the restriction enzyme digest of the DNA sample to generate the target DNA fragments 
(Figure 3.2 shows a schematic of methyl-RADseq).  For this method, a double digest is 
performed with EcoRI and either HpaII or MspI.  Following digestion, the fragments are 
ligated with two custom-designed adaptor oligonucleotides containing complementary 
sequences to the enzyme cut sites on each fragment end, with a 5bp barcode adaptor and 
a common adaptor (Figure 3.2).  Following ligation, PCR is performed to amplify the 
adaptor-ligated restriction digest fragments.  The PCR primers were designed with 
phosphothiolate-modified bases on the first two bases on the 5’ end that inhibit 
endonuclease and exonuclease from acting on the ligated DNA fragments during 
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amplification (Figure 3.2).  The PCR primers also have Illumina sequences incorporated 
to be recognized during sequencing.  Following PCR, the fragments are purified, size 
selected, and quantified for sequencing. 
3.2 Methods 
3.2.1 Sample Collection 
 Three samples (semen, buccal (saliva), and blood) were collected from 5 male 
volunteers aged 25, 33, 41, 45, and 69 years old (Indiana University IRB Approved 
Protocol #1402819847).  Buccal swabs were taken from each volunteer for the saliva 
samples.  Blood was collected by using single-use blood sampling devices (Unistik 2 
Extra, Owen Mumford, Oxford, UK) on a finger of the volunteer’s choice.  Volunteers 
were provided a sterile falcon tube to take home and return with a semen sample.  All 
samples were stored at -20°C upon collection or receipt. 
 
 
 
 
 
 
Figure 3.1 Schematic diagram illustrating the principle of methylation 
status using methyl-RADseq. MspI will cut at the recognition site and 
generate fragments regardless of the methylation status of the cytosine 
(right) whereas HpaII will not cut at the recognition site and no fragment 
will be generated if the cytosine is methylated (left). 
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3.2.2 DNA Extraction and Quantitation 
 The organic DNA extraction protocol as described in section 2.2.2 was used to 
extract the DNA from the buccal samples.  For the blood samples, 50 μL of blood was 
added to a 1.5mL tube with 50 μL of proteinase K and 200μL of ChargeSwitch lysis 
buffer (Thermo Fisher Scientific) and incubated for only 4 hours at 56°C and extracted as 
described in section 2.2.2.  For the semen samples, 50 μL of semen was added to a 1.5mL 
tube with 200 μL of sperm lysis buffer which was prepared as follows: 350 μL 
ChargeSwitch lysis buffer (Thermo Fisher Scientific), 25 μL proteinase K, and 40 μL of 
390mM dithiothreitol (DTT) (Sigma-Aldrich Corp., St. Louis, MO), and incubated for 8-
12 hours at 56°C and extracted as described in section 2.2.2.  Quantitation of all the 
extracted DNA samples was performed in duplicate with the Quantifiler® Human DNA 
quantification kit (Thermo Fisher Scientific) following the manufacturer’s protocol. 
3.2.3 Methyl-RADseq Sample Preparation 
 The methyl-RADseq sequencing protocol was a modification of an existing RAD 
protocol from the University of Wyoming [111].  The semen, saliva, and blood samples 
for each individual were pooled in equal amounts for approximately 400 ng of DNA in 6 
μL for digestion.  Sample 6972 (69 year old) did not have sufficient DNA extraction from 
the semen sample, and therefore only the blood and saliva were used.  For each 
individual, two digest reactions were set up (Table 3.1).  The 10X T4 buffer (New 
England Biolabs Inc., Ipswich, MA), BSA (Promega Corp., Madison, WI), EcoRI 
(Promega Corp.), and NaCl (Acros Organics, Thermo Fisher Scientific) all have the same 
input amount, the only difference is the use of MspI (New England Biolabs Inc.) or HpaII 
(New England Biolabs Inc.) (Table 3.1). 
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Table 3.1 Double digestion protocol setup f or each sample. 
Reaction Component EcoRI + MspI  
reaction (μL) 
EcoRI +HpaII  
reaction (μL) 
DNA (398 ng) 6.0 6.0 
10X T4 buffer 1.0 1.0 
1M NaCl 0.5 0.5 
BSA (10 mg/mL) 0.05 0.05 
EcoRI (5,000 U) 0.7 0.7 
MspI (20,000 U) or 
HpaII (10,000 U) 0.2 0.4 
H2O 0.2 0.0 
Total Volume 8.65 8.65 
 
 Following digestion, the EcoRI and MspI/HpaII double stranded adaptors were 
ligated to the digested fragments.  For the adaptor preparation (Table 3.2), 10μM of each 
adaptor was produced using an Eppendorf Mastercycler Pro (Eppendorf) thermal cycler 
to heat the oligonucleotide to 95°C for 5 minutes, then slowly cooled to room 
temperature by decreasing the temperature by 2°C every 50 seconds.  Ligation was 
performed using 10X T4 buffer (New England Biolabs Inc.), 1M NaCl (Acros, Thermo 
Fisher Scientific), BSA (Promega Corp.), and T4 DNA ligase (400,000 U/mL, New 
England Biolabs, Inc.) using an Eppendorf Mastercycler Pro thermal cycler (Eppendorf) 
at 16°C for 2 hours with heated lid at 20°C followed by a 4°C hold.  The ligated products 
were diluted by adding 90 μL of TE buffer (Thermo Fisher Scientific).  PCR (Table 3.3 
for primer sequences) was performed using iProofTM High-Fidelity PCR kit (Bio-Rad 
Laboratories, Hercules, CA) on an Eppendorf Mastercycler Pro thermal cycler 
(Eppendorf) with the following conditions: 98°C for 30 seconds, followed by 30 cycles 
of 98°C for 20 seconds, 60°C for 30 seconds, and 72°C for 40 seconds, a final extension 
at 72°C for 10 minutes, followed by a 4°C hold. 
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Table 3.2 Methyl-RADseq Adaptor Sequences 
Adaptor Adaptor Sequence 
ComAd1 CGGATCGGAAGAGCACACGTCTGAACTCCAGTCAC 
ComAd2 GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC 
Bar1a ACACTCTTTCCCTACACGACGCTCTTCCGATCTTGCGA 
Bar1c AATTTCGCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT 
Bar2a ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGCTT 
Bar2b AATTAAGCGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT 
Bar3a ACACTCTTTCCCTACACGACGCTCTTCCGATCTTCACC 
Bar3b AATTGGTGAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT 
Bar4a ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTAGC 
Bar4b AATTGCTAGAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT 
Bar5a ACACTCTTTCCCTACACGACGCTCTTCCGATCTACAAA 
Bar5b AATTTTTGTAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT 
Bold = barcode identifier 
Table 3.3 Methyl-RADseq PCR Primer Sequences 
PCR 
Primer 
Primer Sequence 
Ill-pcr1b A*T*TGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCC
GATCT 
 
Ill-pcr2b C*A*AGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTG
CTCTTCCGATC 
 
* = phosphothiolated base 
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The PCR products of the digested, ligated DNA were pooled into a single library and 
purified using Agencourt AMPure XP beads (Beckham Coulter Inc., Brea, CA), QC 
analysis on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) and 
size selection on a BluePippin (Sage Science, Inc., Beverly, MA) (Genomics and 
Bioinformatics Core Facility at the University of Notre Dame). 
3.2.4 Methyl-RADseq MiSeq Preparation 
 The MiSeq sequencing was performed in duplicate.  To prepare the library for 
massively parallel sequencing, the Illumina MiSeq System Denature and Dilute Libraries 
Guide was followed, available on the Illumina website [112].  Briefly, the library was 
diluted to a final concentration of 2pM.  The library was then spiked with Illumina Phi-X 
sequencing control v3 (Illumina, San Diego, CA) at 35% for run 1 and 20% for run 2.  
The spiked library was then loaded onto an Illumina MiSeq Reagent Kit v2 cartridge 
(Illumina) and loaded onto an Illumina MiSeq FGx System (Illumina) following the 
manufacturer’s protocol and set to collect FastQ only.  There were 2 paired-end runs 
performed, producing 4 FASTQ files, 2 forward read files and 2 reverse read files.  
However, the reverse run failed during run 1 and was not further analyzed. 
3.2.5 Methyl-RADseq Computational Analysis 
 Several programs were used to extract the potential candidate CpG sites from the 
sequencing data.  The first phase of analysis was to convert the MiSeq generated FASTQ 
files to BAM files.  This was performed using Galaxy (https://usegalaxy.org), an open 
source, web-based platform with many bioinformatics tools for data analysis [113].  
Within Galaxy, the FASTQ files of run 1 forward reads and run 2 forward and reverse 
reads were uploaded.  The forward and reverse reads from run 2 were merged using 
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PEAR [114] with the following parameters: a minimum overlap of 5 bases, maximum 
length of 302 bases, a minimum length of 150 bases, and an upper bound quality score of 
30.  This reduced the data from 3 files to 2: forward reads for run 1 and run 2.  Barcode 
Splitter, a component of the FASTX-Toolkit, was then used to parse out the two FASTQ 
files into the different aged individuals based on the barcodes.  The resulting files were 
then trimmed and filtered for quality using the Filter FASTQ tool [113] with the 
following parameters: minimum length of 50 bases, minimum quality score of 30, and 
maximum number of bases outside of quality range of 15 bases (90%).  The quality 
trimmed and filtered reads were then concatenated between the 2 runs into one FASTQ 
file for each age and enzyme, creating 10 files: 25Hpa, 25Msp, 33Hpa, 33Msp, 41Hpa, 
41Msp, 45Hpa, 45Msp, 69Hpa, and 69Msp, corresponding to the age and restriction 
enzyme.  Each FASTQ file was then mapped against the human genome (hg38) using 
Bowtie2 [115], generating BAM files for each of the 10 files.  The BAM files were 
uploaded to the Mason cluster at Indiana University.  Within Mason, BEDTools v2.26.0 
[116] was used to convert the BAM files to BED files, as well as compute genome 
coverages and read counts.  BEDOPS v2.4.26 [117] was then used to find the MspI-cut 
regions that were in common between all 5 ages; these are considered the control regions.  
The MspI regions where HpaII fragments were either found in common or found to be 
unique (where HpaII did not map) from the control regions were extracted.  The MspI 
control regions were used to compare against 35 known age informative CpG sites that 
were found in multiple studies or between multiple tissues that used Infinium 
HumanMethylation27 or HumanMethylation450 arrays (Table 3.4).  The MspI regions of 
interest were combined and read counts were normalized between the MspI and HpaII 
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regions for each age.  The regions were filtered using Excel to find those where at least 
one age had at least 10 reads (10X coverage).  The regions were also filtered to those that 
either decreased or increased in methylation when comparing the HpaII to MspI read 
counts from the youngest to oldest ages and the final list were those which had an r2 
value of at least 0.7 (70% correlation).  The 0.7 threshold was chosen as it is a similar to 
the 70% threshold used in the pigmentation prediction modeling, however, a more 
stringent threshold can be considered during validation.  The final list of regions were 
then viewed via the BAM files on the UCSC genome browser (http://genome.ucsc.edu) 
[118], and annotated to the NCBI RefSeq database within the browser.  Gene ontology 
(GO) terms of the biological processes were identified for the genes using the PANTHER 
database, as well as GO term enrichment analysis [119]. 
3.3 Results and Discussion 
 The number of reads mapped to the human genome, following quality filter and 
trimming, and genome coverages can be seen in Table 3.4 along with the normalization 
factors between the MspI and HpaII reads for each age.  After filtering by the 0.7 
correlation threshold and exclusion of the sex chromosomes, there were 491 candidate 
CpG sites (Appendix F); an example of the correlation seen with 5 sites can be seen in 
Figure 3.3.  When comparing the 35 known CpG sites (Table 3.5) to the regions of the 
sample data, there was one found in common: cg08097417 within the KLF14 gene.  
There are two reasons as to why more known sites may not have been found.  The first is 
that most of the known CpG sites are within CpG islands (Table 3.5), which again are 
generally defined as genomic regions with long stretches (> 500 bp) that have a GC 
content of greater than 55% and excludes Alu elements [120].  The Infinium 
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HumanMethylation arrays were designed to specifically emphasize genomic regions that 
included genes and CpG islands [96].  The methyl RADseq method does not target any 
specific feature within the human genome, however it is limited to regions where there is 
enzyme cut site recognition, of which only one end of the fragment is a CpG recognition 
site (MspI or HpaII).  Secondly, many of the known sites are specific for only one type of 
tissue analyzed, mostly blood, and the data generated here was between 3 combined 
tissue types: blood, saliva, and semen.  Many sites have been found to be tissue specific 
and therefore may not correlate beyond one tissue type.  The CpG site in common, 
designated by the Infinium array as cg08097417, showed an increase in methylation with 
an r2 value of 0.43.  Again, previous studies have only showed this to be significant in 
blood [99, 121] and the signal for each individual fluid may not be optimally expressed as 
they are pooled together in this data; individual fluid correlations cannot be identified. 
Table 3.4 Mapped read count and normalization factors 
Age Enzyme Number of 
mapped reads 
Average 
Genome 
Read 
Coverage 
Median 
Genome 
Read 
Coverage 
Normalization 
Factor (MspI/HpaII) 
25 HpaII 562862 6.3 2 1.5 
25 MspI 858317 5.7 3  
33 HpaII 415208 5.9 2 1.9 
33 MspI 777150 5.4 3  
41 HpaII 503236 6.0 2 1.4 
41 MspI 683160 4.8 3  
45 HpaII 428555 6.0 2 1.4 
45 MspI 599591 4.5 2  
69 HpaII 467287 5.9 2 1.7 
69 MspI 787406 5.0 3  
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Table 3.5 Known age-associated CpG sites from previous studies. 
CpG Site Gene Chr Start-End 
Human 
Methylation 
Chip 
CpG Pattern 
Methylation 
Pattern (if 
reported) 
Previous Studies Tissue Type 
cg07533148 TRIM58 1 247857510-247857511 27 ISLAND hyper [100, 122] Saliva and Blood 
cg09809672 EDARADD 1 236394382-236394383 27 none hypo [99, 100, 123] Saliva and Blood 
cg19945840 B3GALT6 1 1232656-1232657 27 ISLAND hyper [100, 124] Saliva and Blood 
cg06639320 FHL2 2 105399282-105399283 450 ISLAND hyper [99, 102, 121, 125] Blood 
cg11176990 LOC375196 2 38960392-38960393 450 ISLAND hyper [102, 121] Blood 
cg16232126 SLC5A7 2 107986549-107986550 27 ISLAND hyper [100, 124] Saliva and Blood 
cg22158769 LOC375196 2 38960398-38960399 450 ISLAND hyper [102, 121] Blood 
cg22454769 FHL2 2 105399310-105399311 450 ISLAND hyper [99, 121, 125] Blood 
cg24079702 FHL2 2 105399314-105399315 450 ISLAND hyper [99, 121, 125] Blood 
cg27320127 KCNK12 2 47571257-47571258 27 ISLAND hyper [100, 124] Saliva and Blood 
cg07553761 TRIM59 3 160450189-160450190 450 ISLAND hyper [99, 102, 121] Blood 
cg25148589 GRIA2 4 157220784-157220785 27 ISLAND hyper [100, 122] Saliva and Blood 
cg00059225 GLRA1 5 151924796-151924797 27 ISLAND hyper [100, 121, 124] Saliva and Blood 
cg19885761 CPLX2 5 175796643-175796644 27 ISLAND hyper [100, 124] Saliva and Blood 
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Table 3.5 continued 
cg16867657 ELOVL2 6 11044644-11044645 450 ISLAND hyper [18, 99, 121, 125, 126] Blood 
cg215572722 ELOVL2 6 11044661-11044662 450 ISLAND hyper [121],[18, 125] Blood 
cg24724428 ELOVL2 6 11044655-11044656 450 ISLAND hyper [18, 121, 125] Blood 
cg22736354 NHLRC1 6 18122488-18122488 27 ISLAND hyper [123, 127] Blood 
cg08097417 KLF14 7 130734372-130734373 450 ISLAND hyper [99, 121] Blood 
cg12799895 NPTX2 7 98617340-98617341 27 ISLAND hyper [100, 122] Saliva and Blood 
cg12837463 ZC3H12A 7 35260617-35260618 450 N_SHORE hypo [128] Semen 
cg19594666 LEP 7 128241227-128241228 27 ISLAND hyper [124] Saliva and Blood 
cg23571857 BIRC4BP 7 6593466-6593467 27 none hypo [122] Saliva and Blood 
cg15747595 TSPYL5 8 97277652-97277653 27 ISLAND hyper [124] Saliva and Blood 
cg16219603 PENK 8 56448027-56448028 450 ISLAND hyper [121, 125] Blood 
cg18898125 NEFM 8 24912868-24912869 450 N_SHORE hyper [102] Blood 
cg01530101 KCNQ1DN 11 2869868-2869869 27 ISLAND hyper [122] Saliva and Blood 
cg06979108 NOX4 11 89589683-89589684 450 ISLAND hyper [128] Semen 
cg01820374 LAG3 12 6772917-6772918 450 N_SHORE hypo [121, 123] Blood 
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Table 3.5 continued 
cg18236477 ATP8A2 13 25468928-25468929 27 ISLAND hyper [100, 124, 129] Saliva and Blood 
cg06304190 TTC7B 14 90817262-90817263 450 S_SHORE hypo [128] Semen 
cg04875128 OTUD7A 15 31483692-31483693 450 ISLAND  [99, 102] Blood 
cg21801378 BRUNOL6 15 72319784-72319785 27 ISLAND hyper [100, 124, 129] Saliva and Blood 
cg19283806 CCDC102B 18 68722183-68722184 450 none  [99, 102] Blood 
cg07547549 SLC12A5 20 46029586-46029587 450 ISLAND  [99] Blood 
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Figure 3.3 Example of individual CpG site age correlations.  The variation in methylation 
correlation (r2 > 0.70) and type of methylation (hyper or hypo) can be seen in the 5 sites shown, as 
well as the linear regression correlation values (R2). 
 
One of the most highly significant age-correlated CpG sites found in blood is cg16867657 
in the ELOVL2 gene, and our data did have reads that mapped to this gene, however, they 
were not located at this specific site and were not found to correlate in a linear pattern with 
age.  Distribution of the candidate CpG sites by chromosome and genomic features can be 
seen in Figure 3.4.  Interestingly, only chromosome 10 did not have hypermethylated sites, 
only hypomethylated sites were found correlated to age. 
 There were 222 genes found with at least one candidate CpG site located near 
(flanking region of 1000bp or less) or within the gene (45% of sites, Figure 3.4b).  
Thirteen of these genes were uncharacterized, and three genes had 2 CpG sites found: 
CDH11, NLGN1, and PPARGC1B. 
77 
 
 
 
Figure 3.4 Candidate CpG site distribution. a) The number of hypermethylated and 
hypomethylated CpG sites by chromosome, and b) genomic features represented by CpG sites. 
  
Gene ontology (GO) analysis resulted in 197 genes clustered into biological process GO 
terms, a breakdown of these categories can be seen in Figure 3.5.The largest group of 
clustered genes related to cellular processes (88 genes).  Cell communication was the 
largest subsection (43 genes) which includes cell-cell signaling (8 genes) and signal 
transduction (37 genes).  Further breaking down the signal transduction genes shows an 
almost equal split between two categories: cell surface receptor signaling pathways (17 
genes) and intracellular signal transduction (19 genes), which includes G-protein coupled 
receptor signaling, transmembrane receptor serine/threonine kinase and tyrosine kinase, 
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and cytokine-mediated signaling.  Aging is considered a time-dependent functional 
decline mainly caused by the accumulation of cellular damage [130].  Many of these 
highlighted genes associated with intercellular communication, which is thought to be one 
of the hallmarks of aging [130]. 
 Metabolic processes was the next largest category (56 genes) with most related to 
primary metabolic processes (42 genes), followed by responses to a stimulus (29 genes) 
which includes responses to stress, cellular defense, external stimulus, and immune 
response.  There were 10 genes relating to immune system processes.  One of these genes, 
MAP3K13, was found related not only to immune response, but stress response, cell death, 
cell morphogenesis, phosphate-containing metabolic process, and NF-kappaβ cascade.  
Immune response decreases with age as there is a decline in both T- and B-cell function 
and the development of a chronic inflammatory state, referred to as “inflammaging” [130, 
131].  The NF-kappaβ signaling pathway regulates developmental processes, host defense 
(innate immunity), and cell survival functions e.g., inhibition of apoptosis [132].  The 
methylation of the CpG site at this gene was found to increase, suggesting inactivation of 
the pathway which would lead to more cell apoptosis, and downregulation of immune 
response, both which are expected due to aging. 
 Other cellular processes important in aging can be related to transcription 
regulation, nuclear trafficking and organization, protein translation, proteostasis, 
autophagy, mitochondrial dysfunction, and cytoskeleton and membrane integrity [133].  
There were 14 genes were found associated to cellular component organization, e.g., 
chromatin and cytoskeleton organization and protein complex assembly.  There were 22 
genes associated to both multicellular organismal processes and biological regulation 
which includes processes such as blood circulation, muscle contraction, sensory and visual 
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perception, calcium ion homeostasis, catalysis, and DNA/RNA binding transcription 
activity.  These categories are logical when considering the physiological changes that 
occur with aging, many different factors are controlled by different cell signaling 
pathways, ion channel transporters, and transcriptional regulators.  GO enrichment 
analysis of these categories showed that only the cell communication category had 
significant enrichment (p < 0.05) when compared to the human genome.  As discussed 
above, altered intercellular communication, which can include deregulation of signaling 
and increase in inflammation, is considered a hallmark of aging [130].  Furthermore, it has 
been shown that senescent cells can induce senescence in neighboring cells via gap 
junction-mediated cell-cell contact, which may contribute to the overall aging process 
[134]. 
 Approximately half (45%) of the candidate CpG sites were associated with a gene.  
However, there were other genomic features abundantly represented within the candidate 
sites including: short interspersed nuclear elements (SINEs), long interspersed nuclear 
Figure 3.5 GO terms of the biological processes of the genes associated with the candidate CpG 
sites. 
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elements (LINEs), long terminal repeats (LTRs), and long intergenic non-protein coding 
RNA (LINCs).  Of the regions in which the candidate CpG sites were located, 31% were 
SINEs, 6% LINEs, 10% LTRs, and 2% LINCs.  SINEs, LINEs, and LTRs are the three 
major families of transposable elements that are abundant in mammalian genomes [135]. 
 The most common SINE in the human genome and also found in the candidate 
CpG sites is the Alu family of elements.  Transposable elements are a significant source of 
regulating signals for transcription [136] and therefore it is not surprising they would have 
an impact on gene regulation which may be important during the aging process.  It has 
also been shown that DNA methylation of the heterochromatin of major retrotransposon 
elements decreases during senescence, and the chromatin structure becomes more open, 
leading to an increase in transcription and ultimately transposition [137].  While these 
heterochromatic regions, which includes transposable elements, become more open in 
gene-poor regions, it is also found that euchromatin in gene-rich regions become more 
closed [137].  In further support of this, the expression of LINEs and SINEs has been 
found to increase with normal aging in humans and mice [135].  As for LINCs, they have 
been found to be influential in the molecular processes of age-associated phenotypes by 
impacting cellular processes including proliferation, differentiation, senescence, and 
response to stress and immune agents [138].  LINCs can serve as recruiters of chromatin-
modification factors, assemblers of transcriptional activators or repressors, maintenance of 
nuclear compartmentalization, and regulators of post-transcriptional gene expression 
[138].  One well known example is Xist, which is responsible for inactivating the X 
chromosome [139].  There was a candidate CpG site found within the LINC-PINT region, 
which has been found responsible for histone modifications and eliciting the TGF-β, 
MAPK, and p53 pathways which are associated with senescence and aging [138, 140].  
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Many LINCs have been identified but not yet characterized and this can also be seen in 
the data. 
 One last feature of known importance for aging are CpG islands.  Within the 
candidate CpG sites, 25 (5%) sites were near or within CpG islands.  Again, many of the 
known age-associated CpG sites are found in CpG islands, shores, or shelves as those are 
the targets of interest for the Infinium arrays typically used.  CpG islands are typically 
located in promoter regions near the transcription start sites (TSSs) and can regulate the 
transcriptional activity of the gene by increasing in methylation to inhibit transcription of 
the gene as most CpG islands are inherently non-methylated regions [141, 142].  CpG 
islands found within the gene body may enhance transcription elongation or play a role in 
alternative splicing and inhibiting transposable elements [142].  Several studies show that 
methylation patterns typically increases within CpG islands, but decreases at non-island 
CpG sites with age [142, 143].  This pattern is not reflected in the data, however, as only 8 
CpG sites (32%) of all the sites found within CpG islands or shores were hypermethylated 
with age. 
3.4 Conclusions 
 The methyl RADseq method developed here has generated data locating potential 
candidate CpG sites that may be correlated with age-related changes and therefore age 
prediction.  Many of the genes associated with the candidate CpG sites have been found 
related to cellular processes and functions that influence aging.  Other genomic features 
include CpG sites in sites of repetitive elements, such as SINEs and LINEs, which has also 
been found to regulate processes important in the aging process.  Unlike the Infinium 
array studies, only a small proportion of the data was found within or near CpG islands.  
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The Infinium arrays target CpG islands and promoter regions, however, it has been shown 
that methylation levels that correlate to gene expression levels are concentrated in non-
CpG island regions [142]; therefore hypomethylated sites outside of CpG islands and 
promoter regions should be further investigated. 
 Methylation changes are critical in normal human development and aging, but as 
previously discussed, variation in methylation may also indicate diseases, especially 
cancer, as well as be influenced by environmental factors.  In this study, 5 healthy male 
individuals were used to provide proof of concept and generate this preliminary data.  To 
be able to control the results more with environmental factors, additional information 
regarding the volunteers’ lifestyle should be collected, and therefore this data is 
promising, but further testing of the candidate CpG sites found with a larger cohort of 
individuals will be necessary.  This method is not without limitations; the candidate CpGs 
found are restricted to those recognized by the enzyme recognition sites, and some regions 
did show incomplete enzyme digestion.  Furthermore, as the 3 biological fluids were 
initially pooled, individual fluid correlations cannot be identified.  However, this method 
is versatile and may be adapted for single tissue assessment if that is the desired goal.  
Furthermore, it is an alternative to the selection bias of the Infinium HumanMethylation 
arrays to explore and discover other potential age-correlated CpG sites.  Recently, the next 
level of Infinium bead chip array has been developed, MethylationEPIC, which covers 
over 850,000 CpG sites and extends coverage to a larger proportion of non-CpG island 
regions to CpG islands and therefore reduces the selection bias of the earlier arrays [144].  
For those laboratories without the resources to invest in microarray methods, or if they 
have interest in investigating methylomes of species other than human, methyl-RADseq is 
an alternative sequencing method for discovering methylated differences in genomes. 
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CHAPTER 4. EFFECTS OF MICROBIAL DNA ON HUMAN DNA 
PROFILES 
*This work has been submitted for publication and is currently under review to the 
Journal of Forensic and Legal Medicine. 
4.1 Abstract 
 Most crime scenes are not sterile and therefore may be contaminated with 
environmental DNA, especially if a decomposing body is found.  Collecting biological 
evidence from this individual will yield DNA samples mixed with microbial DNA.  This 
also becomes important if postmortem swabs are collected from sexually assaulted 
victims.  Although genotyping kits undergo validation tests, including bacterial screens, 
they do not account for the diverse microbial load during decomposition.  We investigated 
the effect of spiking human DNA samples with known concentrations of DNA from 17 
microbe species associated with decomposition on DNA profiles produced using the 
Promega PowerPlex® 16 HS system.  Two species, Bacillus subtilis and Mycobacterium 
smegmatis, produced an extraneous allele at the TPOX locus.  When repeated with the 
PowerPlex® Fusion kit, the extra allele no longer amplified with these two species.  This 
experiment demonstrates that caution should be exhibited if microbial load is high and the 
PowerPlex® 16 HS system is used. 
4.2 Background 
As the sensitivity of human DNA profiling has increased, the types of samples 
being successfully profiled has also increased, including samples with little human DNA 
(“touch” DNA) [145], genotyping as little as single cells [1], or samples which may be 
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degraded [146].  Similarly, decomposed tissues often produce low template and degraded 
DNA samples in addition to the increased microbial presence.  However, little attention 
has been paid to the effects of the high microbial load on the resulting DNA profiles.  
Increased sensitivity of DNA genotyping, along with the increased ability to amplify even 
single cells of human DNA, may also increase the possibility of amplifying environmental 
DNA sources, such as bacteria, that may have been co-extracted with the evidentiary 
sample.  This is especially pertinent for swab collection when sexual assaults are 
suspected.  When DNA is extracted from a substrate, all DNA is extracted; it is not limited 
to only human DNA.  Before DNA amplification, the amount of human DNA must be 
determined.  Since forensic DNA quantitation kits are human specific, it remains unknown 
how much non-human DNA is present in a forensic sample [147].  This exogenous DNA 
is not typically a problem because human forensic identification tests are also designed to 
be human-specific [147].  Furthermore, an important step in validating new forensic DNA 
profiling kits is performing a developmental validation, which includes amplification of 
other common species’ DNA (such as domestic animals), and microbial pools of extracted 
DNA [148-151].  With such an obvious abundant source of external DNA present in 
forensic samples, it is surprising how little research has been done.  The majority of 
scholarly articles associated with this type of DNA contamination are related to the 
identification of the pathogen rather than its effect on forensic DNA profiles [152-154].  
The proliferation of microbes during decomposition should be of interest to the forensic 
community if the presence can possibly affect the outcome of human identification 
analysis, especially in sexual assault cases.  Most sexual assault samples are collected 
from orifices such as the mouth and genital regions [155], and many microbial 
communities already thrive in these areas while the body is alive. 
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There are many species of bacteria present on a living human body; in fact the 
ratio of microbial to animal cells is 10:1 [11, 156].  In the mouth alone, 200 species have 
been found [156].  Other systems in humans, such as the intestinal tract, naturally contain 
300-500 species of bacteria [157], which can translate to 100 trillion bacterial cells [156].  
Some types of bacteria are still found in tissue and bone samples following death [158].  
These living populations will grow rapidly at the onset of decomposition, which starts 
occurring 4 minutes after death [159].  This does not account for bacteria found in external 
environments, such as soil, that may also contribute to DNA collected from a 
decomposing body.  In some cases, 50,000 microbial species can be found in one gram of 
soil [156]. 
In one study, the effect of 30 different microbial species on human DNA profiles 
(based on single locus amplifications) was examined [160].  Three of the 10 loci produced 
no artifacts (TPOX, TH01 and CSF1PO), and two produced non-specific artifacts (HLA-
DQA1 and PM).  However, at the D1S80 locus, fragments were produced within the range 
of true D1S80 alleles with six of the tested microbial species [160].  The artifact was 
present when only 100 pg of microbial DNA was amplified.  However, this study does not 
offer much value today as D1S80 is no longer a locus of interest in current human DNA 
typing kits.  Furthermore, the current STR multiplex kits are not tested against a 
comprehensive set of microbial species, although most validations include some microbial 
species specificity testing.  For example, in the developmental validation study for the 
PowerPlex® 16 HS system, a small panel of microbial species is included to test for 
species cross-reactivity, however, it is a small subset: only 5 species (2 fungi, 3 bacteria) 
were assessed [149].  This small number of species is insufficient for testing a sample if 
collected from a decomposed individual. 
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A possible solution to handling the co-isolation of bacterial DNA with human 
DNA is simply cataloging the bacterial DNA that shows up in human profiles, which was 
the basis of this work.  The ability to recognize and categorize any artifact will allow for 
reasonable and justified identification of extraneous peaks that may be present in DNA 
profiles.  This becomes increasingly important as samples with low DNA concentrations 
are amplified, or more importantly, with mixtures.  In this work, we intentionally spiked 
human DNA samples with microbial DNA and amplified them to analyze any effects the 
microbial DNA may have on the interpretation of the human DNA profile. 
4.3 Methods 
A total of 17 microbial species were analyzed as part of this pilot study (Table 
4.1).  Eleven species were cultured (American Type Culture Collection, ATCC, Manassas, 
VA).  Lyophilized cultures (ATCC) were re-suspended in 5 mL of Tryptic Soy broth 
(DOT Scientific Inc., Burton, MI) and incubated overnight at 37°C.  Cultures were 
streaked on Tryptic Soy plates (Tryptic Soy broth with 2% agar) to grow isolated colonies 
and incubated at 37°C.  Cultures for DNA extraction were started by inoculating 5 mL 
Tryptic Soy broth (DOT Scientific Inc.), followed by overnight incubation at 37°C, then 
centrifuged and measured by weight (70 mg -130 mg).  For each culture, an organic 
extraction was performed to extract the DNA.  Briefly, the pellets were re-suspended in 
200 μL of water, and incubated at 37°C for 1 hour with 5 μL of lysozyme (50 mg/mL, 
Thermo Fisher Scientific Inc., Waltham, MA).  Following cell lysis, 25 μL of proteinase K 
(20mg/mL, Thermo Fisher Scientific Inc.) in 500 μL of lysis buffer (Invitrogen Corp., 
Carlsbad, CA) was added and the samples were incubated at 56°C overnight.  Then, 500 
μL of phenol/chloroform/isoamyl alcohol (25:24:1) (Thermo Fisher Scientific Inc.) was 
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added, gently inverted, and then centrifuged at 13,000 rpm for 1 minute.  The aqueous 
layer was removed to a new tube and 500 μL of chloroform:isoamyl alcohol (24:1) 
(Thermo Fisher Scientific Inc.) was added, inverted, and centrifuged at 13,000 rpm for 1 
minute.  The aqueous layer was removed to a new tube and 25 μL of 0.2 M NaCl and 500 
μL of 95% ethanol were added.  The samples were centrifuged at 4°C for 15 minutes at 
15,000 rpm.  The supernatant was removed, and 500 μL of cold 70% ethanol was added 
and centrifuged at 4°C at 15,000 rpm for 5 minutes.  The liquid was removed and the 
pellet was allowed to air dry before being re-suspended in 25 μL of TE buffer (Thermo 
Fisher Scientific Inc.). 
The remaining six species were obtained as purified, freeze-dried, extracted DNA 
(ATCC), and were prepared by incubating the dried DNA overnight at 4ºC, then for 1 
hour at 65ºC before being rehydrated with either 100 μL or 200 μL deionized water 
(depending on the initial starting concentration).  All microbial DNA samples were 
quantified using the Qubit® 2.0 fluorometer (Thermo Fisher Scientific Inc.) following the 
manufacturer’s protocol. 
Buccal swabs were collected from three human volunteers (Indiana University IRB 
Approval Protocol #1507469161) and extracted using a phenol-chloroform extraction (as 
above, except lysozyme was not added) and quantified in duplicate following the 
manufacturer’s protocol using the Quantifiler® Human DNA Quantification kit (Thermo 
Fisher Scientific Inc.) on a 7500 Real Time PCR System (Thermo Fisher Scientific Inc.).  
In order to examine the analytical effects of microbial DNA on human DNA profiles, 1.0 
ng of one sample of human DNA was mixed with 10.0 ng, 50.0 ng, and 100.0 ng of each 
of the 17 microbial DNA samples (Table 4.1). 
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Table 4.1 List of microbial species used to spike human DNA samples, chosen because of their 
association in human decomposition. 
Species 
Bacillus subtilis 
Bacteroides fragilis* 
Candida albicans 
Clostridium perfringens* 
Proteus mirabilis 
Helicobacter pylori* 
Clostridium difficile* 
Enterococcus faecalis 
Escherichia coli 
Lactobacillus acidophilus* 
Lactobacillus casei 
Mycobacterium smegmatis 
Neisseria flava* 
Pseudomonas aeruginosa 
Staphylococcus aureus 
Staphylococcus epidermidis 
Streptococcus mutans 
* = Purchased DNA from ATCC, not extracted from lab culture 
 
The resulting mixtures (human DNA + microbial DNA) were re-quantified, in duplicate, 
using Quantifiler® Human DNA Quantification kit (Thermo Fisher Scientific Inc.).  T-
tests were performed (α=0.05) comparing the average quantitation values among each 
tested human + microbial DNA mixtures tested, and the average of a human DNA sample 
alone, tested in duplicate.  DNA profiles were amplified using the PowerPlex® 16 HS 
system (Promega Corp., Madison, WI) following the manufacturer’s protocol with 1 ng of 
human DNA from 2 of the human samples amplified alone, and also mixed with either 10, 
50, or 100 ng of microbial DNA on a Veriti thermal cycler (Thermo Fisher Scientific Inc.) 
using the 9600 emulation mode.  The fragments were separated and detected using 
capillary electrophoresis with 1 μL PCR product, 9.0 μL Hi-Di™ Formamide (Thermo 
Fisher Scientific Inc.), and 0.5 μL ILS 600 (Promega Corp.) on a 3500 Genetic Analyzer 
(Thermo Fisher Scientific Inc.) following the manufacturer’s protocol.  Data analysis was 
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performed using GeneMarker HID v2.6.0 genotyping software (SoftGenetics, State 
College, PA) with an analytical threshold of 100 RFUs.  Any microbial species that 
produced artifacts were further tested by amplifying with the PowerPlex® Fusion system 
(Promega Corp.) at the same ratios following the manufacturer’s protocol.  The amplified 
fragments were then separated and detected as described above.  Average peak heights 
were determined across all loci for each profile and statistical t-tests with Bonferroni 
correction were performed to look for deviations from the average RFU values of the 
human standard alone.  Average heterozygosity values between species and amount of 
microbial DNA were also calculated among all loci for the combined human samples.  
This was done using Microsoft Excel by dividing the RFU values for the heterozygote 
alleles across all loci, the smaller peak height divided by the larger peak height.  Each 
locus had at least one heterozygous genotype between the two human samples tested, and 
if both samples were heterozygous at the same locus, the average value was reported.  In 
cases where an artifact was observed, the microbial DNA sample was amplified alone (as 
above) and in the third human sample to verify the artifact’s presence.  Buccal swabs were 
also collected and extracted from the two individuals working on this project as 
elimination standards. 
4.4 Results and Discussion 
The microbial species tested were chosen based on either their abundance in main 
locations on the human body such as the skin, mouth, gut, genital region, or anus [13, 161, 
162], predominance at certain stages of decomposition [163], or if they are common 
environmental species, such as those found in soil [164].  The capability to culture some 
of the species was also a factor. 
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Human DNA quantitation was not significantly affected by the presence of 
microbial DNA at any concentration for any species (Table 4.2).  Generally, addition of 
any microbial DNA produced profiles with similar average peak heights as seen in the 
human standard alone (p > 0.05 in all measurements after Bonferroni correction) (Figure 
4.1).  However, two microbial DNA species (with no overlap between the two samples in 
species or quantity of microbial DNA input) had statistically different average peak 
heights across the entire profile without any discernible pattern (Figure 4.1).  For the 
average heterozygosity values calculated with the addition of microbial DNA to a human 
DNA sample, there were no significant differences.  This indicates that the addition of any 
quantity of microbial DNA tested of any of the microbial species tested did not have an 
effect on heterozygosity balance of a human DNA profile (Figure 4.3). 
 
Table 4.2 Average Quantifiler values showed no significant difference between the human DNA 
input values and the human + microbial DNA mixtures. 
 
DNA Sample 
(Human input (ng):Bacteria input (ng)) 
Average concentration (ng/μL) (± S.D.) 
Human only (N = 2) 0.959 (± 0.013) 
1:10 (N = 26) 0.941 (± 0.049) 
1:50 (N = 26) 0.918 (± 0.066) 
1:100 (N = 26) 0.919 (± 0.037) 
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Figure 4.1 Average RFU values.  The peak heights between the 2 human samples, a) Human 1 
(s.d±791) and b) Human 2 (s.d.±856),and all tested microbial species and ratios (N=51). Only 4 
samples showed a significant difference in average peak heights as compared to the human only 
standards.  None of these significant differences were indicative of a trend among the species nor 
concentration of microbe DNA added to the sample. * = significant difference 
 
More importantly, two of the 17 microbial species produced discordant DNA 
profiles (Figure 4.2).  Bacillus subtilis and Mycobacterium smegmatis produced a 
significant artifact at all three microbial DNA input amounts in all three human samples 
tested (3rd sample was tested as confirmation):  a drop-in of allele 5 of the TPOX locus 
(neither elimination standards contain this allele).  The peak height of the artifact 
increased in intensity as the concentration of microbial DNA increased (Figure 4.2).  The 
same peak was observed when the microbial DNA was amplified in the absence of human 
DNA (Figure 4.4).  The two bacteria samples alone were also quantified with the 
Quantifiler® Human kit (Thermo Fisher Scientific, Inc.) to ensure there was no human 
DNA contamination in the samples.  To do this, six species were tested, the two that 
amplified the artifact and four randomly chosen species.  All species were quantified in 
duplicate at 100 ng bacterial DNA input and resulted in either undetermined, or a small 
quantity result, with an average of 0.0017 ng/μL (highest value of 0.002 ng/μL). 
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Figure 4.2 Microbial artifacts (*) at TPOX locus in three human DNA profile samples.  Three human 
samples (1ng) were amplified alone (top panel), and with DNA from B. subtilis and M. smegmatis at 
10ng, 50ng, and 100 ng.  Allelic drop-in was produced at the same size as the ‘5’ allele at the TPOX 
locus.  In one case (Sample 3), the artifact allele of B. subtilis at 100ng is higher (RFU) than that of 
the allele of the actual human genotype at the locus.  The blue boxes indicate reduced (but not 
significant) peak height ratios of the heterozygote genotype when the microbial DNA was present.  
Red boxes are produced by the genotyping software to indicate the detection of an extra allele at the 
locus when only a maximum of two are expected for a single source profile. 
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To test whether this amount of input DNA would produce the allele observed, we 
amplified a human DNA sample, in duplicate, at 0.002ng with the PowerPlex® 16 HS kit 
(Promega Corp.) to ensure no amplification would occur at this quantity to the level seen 
with the artifact.  One human DNA replicate had no amplification, which was the same 
with the negative control.  The second human DNA replicate had a drop-in allele at one 
locus only 13 RFU above the set analytical threshold (D8S1179, 14 allele, 113 RFU).  The 
14 allele at D8S1179 is not found in the tested individual’s known profile (data not 
shown) and therefore attributed as a low template drop-in artifact.  This demonstrates that 
this low level of human DNA input would not cause the level of amplification of the 
TPOX “5” allele seen with the microbial species.  The TPOX “5” allele amplified by the 
two microbial species in the absence of human DNA was seen at 564 RFU in B. subtilis 
and 744 RFU in M. smegmatis (Figure 4.4). 
 We replicated the same experiment for these two species with a different kit, the 
PowerPlex® Fusion system (Promega Corp.), using one of the human samples (Figure 
4.5).  We note that this artifact (the TPOX ‘5’ allele) was only found in the PowerPlex® 
16 HS system, no artifact was produced using the Fusion kit (Figure 4.5). 
Figure 4.3 Average heterozygosity values of spiked human samples among all microbial DNA 
species and all microbial DNA quantities, tested in duplicate.  a) Heterozygosity by microbial 
DNA amounts (N=34, N=2 for human only) and b) heterozygosity by microbial species (N=6, 
N=2 for human).  There were no significant differences (all p > 0.05). 
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Furthermore, no artifact was produced in the absence of human DNA for these two species 
using the Fusion kit (data not shown).  This difference, however, is likely due to the fact 
that there is a different primer set used for the TPOX locus between the two systems 
(personal correspondence, Promega Corp.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 TPOX artifact produced with bacteria samples in the absence of human DNA using 
the PowerPlex ® 16 HS system.  B. subtilis and M. smegmatis were amplified with 100 ng, 
along with a negative control, demonstrating the same artifact is produced in the absence of 
human DNA. 
Figure 4.5 The human sample tested with the PowerPlex® Fusion system at the TPOX locus with 
1:10, 1:50, and 1:100 ratios with B. subtilis and M. smegmatis.  No other alleles other than the 
human profile is produced. 
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4.5 Conclusions 
The possibility of observing exogenous DNA from the environment, specifically 
microbial DNA, affecting human DNA evidence has been shown here for 1 ng of input 
DNA.  STR genotyping kits are designed to be human-specific, but the presence of 
microbes in forensic samples ensures microbial DNA will be co-extracted with the human 
DNA and possibly affect human DNA profile interpretations.  There was little to no effect 
on the DNA quantitation, and little effect on the human DNA profiles with the majority of 
the microbial species tested here.  However, two bacterial species, B. subtilis and M. 
smegmatis, produced a peak the same size as the “5” allele of the human TPOX locus, 
verified in three individual profiles.  Bacillus subtilis is found in the human 
gastrointestinal tract [165, 166], and Mycobacterium smegmatis is found in the genital 
regions of both men and women [167].  Both species are found in soils, water and plants 
[164, 168] and both phyla of these species (Actinobacteria and Firmicutes) have also be 
found during decomposition [163].  Only 17 species of possibly thousands of species were 
tested herein.  With the creation of the Human Microbiome Project (HMP) and more 
recent studies on identifying the microbiome of human decomposition [11, 13, 169], it 
would be important to further test for effects of additional decomposition bacteria on 
human DNA profiles.  One other consideration of possible microbial species is the stage 
of decomposition of the body from which evidence is collected, as it has been found that 
the microbial profile shifts throughout the process, generally from aerobic to anaerobic 
bacterial species [163].  Additionally, low DNA concentrations were not tested here; it 
remains unknown whether their quantitation and DNA profile interpretations would be 
impacted by the presence of environmental DNA, and this should be further investigated.  
Furthermore, as additional loci are incorporated into DNA genotyping kits, other 
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commercially available kits should be evaluated – this study simply highlights how a 
single kit produced an artifact that could be used in the interpretation of a DNA profile. 
Worst case scenario in this situation might lead to the possible exclusion of a 
suspect due to their lack of the ‘5’ allele at the TPOX locus.  As the most extreme 
example: a forensic sample is recovered, microbial DNA is co-extracted, and the sample is 
genotyped to produce a heterozygote locus (5,8, as seen in Figure 4.2 for sample #3 at 
50ng input microbial DNA).  The true contributor, or suspect, in this scenario (sample #3) 
is homozygous at the TPOX locus (8,8).  If all alleles fall above stochastic threshold for 
the remainder of the profile, which may be rare occurrence but cannot be ruled out, then, 
an analyst would need to exclude the suspect as a contributor due to the inconsistencies in 
the TPOX locus genotypes (Carl Sobieralski, Indiana State Police, personal 
communication).  Thus, we urge caution in DNA profile interpretation in any instances 
where human decomposition has occurred and the possibility of co-extracted microbial 
DNA exists, especially when using PowerPlex® 16 HS amplification kits. 
A better knowledge of microbial genomes that have a propensity to interfere with 
the interpretation of human DNA can help overcome these quality effects.  Information 
regarding the effects of foreign DNA on human sources suggests that STR genotyping kits 
that are designed to be human specific may be negatively affected by the presence of 
bacterial DNA.  We can speculate that with new technologies, such as the use of 
massively parallel sequencing for DNA profiling, these artifacts would be designated as 
such (presumably the artifacts would have different sequences), however, we do not have 
any data to support this.  Having knowledge of these effects provides the analyst with a 
system of categorizing DNA profiles from samples with possible extraneous microbial 
DNA contamination, such as with decomposition.  It is not likely possible to eliminate 
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microbes (and therefore microbial DNA) from human DNA samples, but recognizing the 
effects they cause allows additional information for an analyst to assess and explain 
artifacts found in a sample, especially those involved in decomposition cases. 
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CHAPTER 5. ESTIMATING NUMBER OF CONTRIBUTORS IN 
THEORETICALLY GENERATED MIXTURE PROFILES 
5.1 Introduction 
Mixtures are a common challenge in DNA STR profile interpretation.  DNA 
mixtures are more frequently encountered in forensic casework than in the earlier years of 
STR typing.  This is mainly because of increased kit sensitivity and increased cycle 
number, and also because there are more requests for ‘touch’ or low copy number (LCN) 
DNA samples to be tested (Carl Sobieralski, Indiana State Police, personal 
communication).  One laboratory published a study where they retroactively reviewed 
1547 cases for the 4 years (1997-2000).  Out of 2424 samples reviewed in the study, 163 
(6.7%) showed a mixture profile, where only 8 of the 163 (0.3%) samples were mixtures 
of more than two contributors [170].  A decade later, a survey study initiated by 
SWGDAM in 2008 collected case data from 14 laboratories on 4541 samples, where 
45.2% showed a mixture profile, and 33.6% of those samples had 2 contributors and 526 
(11.6%) samples were mixtures of more than two contributors [171].  This survey was the 
basis of the 2010 SWGDAM DNA interpretation guidelines to focus on single source and 
two person mixture samples [171], although updated SWGDAM guidelines do include 
criteria for more than 2 contributors [172]. 
The first step in interpreting a DNA profile is identifying the presence of a 
mixture, or, a profile with more than one individual.  This is typically determined by 
analyzing the number of allelic peaks, and peak height ratios, while considering stochastic 
effects, especially stutter products.  According to SWGDAM guidelines, if one or more 
loci have 3 or more alleles present, excluding tri-allelic loci, then the sample is assumed to 
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be a mixture [172].  The next logical step is determining the number of contributors in that 
mixture.  This is a key step to begin deconvolution of the mixture to assign genotypes to 
each individual present and providing statistical weight to the evidence.  The most 
common approach for estimating number of contributors in a mixture profile is maximum 
allele count [171].  Maximum allele count is used to estimate the number of minimum 
contributors to the mixed sample by evaluating the locus that has the greatest number of 
allelic peaks [172].  This is because a single individual will only have a maximum of 2 
alleles at a locus.  For example, if a locus in a profile has 5 allele peaks (all above the 
stochastic threshold), there has to be a minimum of 3 contributors because for a two 
person mixture, you would expect the maximum number of alleles to be seen at a locus to 
be 4. 
 There have been some previous studies to characterize the number of contributors 
according to maximum allele count.  Paoletti et al. [173] generated conceptual 3 and 4 
person mixtures from an FBI database which contained genotypes from the 13 common 
CODIS STR loci from 959 individuals.  Based on maximum allele count, they found that 
3% of the 146,536,159 three-person mixtures could be mischaracterized as two-person 
mixtures, and that 76% of the 57,211,376 four-person mixtures could be mischaracterized 
as two- or three-person mixtures [173].  Haned et al. [174] also conducted simulations 
from published genotypes of individuals with 15 STR loci (13 of which are the core 
CODIS loci) by generating 1000 mixtures comprised of 2-5 contributors to compare 
maximum allele count with maximum likelihood [174].  They concluded that mixtures of 
2 or 3 contributors was greater than 90% for both methods, but with mixtures of 4 or 5 
contributors, maximum likelihood yielded greater success rates (2-15 fold higher) [174]. 
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 To the authors’ knowledge, there have not been any published studies to evaluate 
how well the number of contributors can be determined for mixture profiles using the 
expanded core STR loci, which has increased to 20 loci.  The PowerPlex® Fusion 6C 
system (Promega Corp., Madison, WI) incorporates 27 loci, which includes the expanded 
20 CODIS core loci [175].  This kit was recently internally validated for use by the 
Indiana State Police (ISP) laboratory in 2016.  It was the objective of this work to evaluate 
how the maximum allele count method would determine number of contributors for 
theoretically generated combined 2-, 3-, 4-, 5-, and 6-person mixtures (4,976,355 total 
mixture profiles) using the PowerPlex® Fusion 6C kit (Promega Corp.). 
5.2 Material and Methods 
Single source reference DNA profiles were amplified from non-related anonymous 
volunteers collected by the Indiana State Police Laboratory.  The automated DNA sample 
processing using the BioMek NX and BioMek 3000 Automated Workstations standard 
casework operating procedures of the Indiana State Police Laboratory were used to 
generate the DNA profiles [176].  For amplification, the PowerPlex® Fusion 6C System 
(Promega Corp.) was used following standard casework operating procedures which 
follow the manufacturer’s protocol.  The genotypes, each designated with a random 
number identifier, were entered into an electronic database using Microsoft Excel for 
theoretical mixture generation and analysis.  There was a total of 236 profiles used to 
generate the 4,976,355 mixture combinations. 
A macro using Visual Basic in Microsoft Excel was used to generate all possible 
combinations of 2- and 3-person mixtures.  The macro was also used to generate 
combinations for the 4-, 5-, and 6-person mixtures, however, due to the large number of 
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possible combinations and the limitation in number of rows possible in Excel (1,048,576 
rows), only a random subset of all possible combinations were analyzed (see Results).  
Two separate sample sets were generated for the 4 person combinations to ensure allele 
count distributions were representative of the whole set (see Results).  For analysis of all 
the mixture combinations, all statistics were performed in Microsoft Excel.  As the kit has 
3 Y-STR markers, a separate analysis of the Y-STRs was performed whereas the 
generated mixture combinations were filtered to analyze those between males only. 
5.3 Results and Discussion 
 The number of profiles generated can be seen in Table 5.1.  The distribution of the 
two separate sets of 4-person mixtures can be seen in Table 5.2.  For all the mixture 
combinations, the profiles were considered under assumed ideal conditions where 
contributors are in equal input ratio (1:1, 1:1:1, etc.), there was no stutter or artifacts, and 
all alleles were above the stochastic threshold.  Therefore, allele count analysis was 
calculated based on the assumed presence of all possible allelic peaks from all individuals 
in the mixture.  This does not reflect the possibilities of mixed ratios, stutter, or allele-
dropout, which are not unexpected in casework mixtures [177, 178].  Each set of mixtures 
were analyzed with the following defined parameters.  The minimum allele count is the 
count across all loci per profile that had the lowest number of alleles observed in at least 
one locus.  The maximum allele count is the count across all loci per profile that had the 
highest number of alleles observed in at least one locus.  The overall count is the 
frequency distribution of all allele counts across all loci of all possible n person profile 
combinations. 
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Table 5.1 Number of mixture combinations. 
Number of Contributors Number of mixtures generated 
(number of database samples used) 
2 person 27,730 (236) 
3 person 2,162,940 (236) 
4 person 916,895 (70)* 
5 person 962,598 (43)* 
6 person 906,192 (32)* 
TOTAL 4,976,355 
                  *= subset of total possible combinations 
 
Table 5.2 Comparison of allele distributions between two separately generated combinations of 4-
person mixtures (N=916,895).  There was no significant difference (p > 0.5). 
4-person Mixture Combinations: 
Allelic Distribution 
Allele Group 1 Group 2 
1 5555 11204 
2 533410 623641 
3 3467181 3671196 
4 6601424 6289826 
5 5805377 5596867 
6 3236480 3307998 
7 1194533 1302849 
8 244625 285004 
TOTAL 21088585 21088585 
 
5.3.1 Two-Person Mixtures 
 For the 27,730 two-person mixtures, the minimum allele count was 2 alleles in 
70% of mixtures, and 1 allele in the remaining 30% of profiles (Figure 5.1a).  Although it 
was still possible to see loci with only 1 allele, which is more typical in single source 
profiles, when you consider maximum allele count (Figure 5.1b), 99.99% of the time there 
is at least one locus that has 4 alleles.  There were 4 (0.01%) profiles that had a 3 allele 
maximum in at least one locus.  In either case of a 3 or 4 maximum allele count, a 
minimum of 2 contributors would still be indicated (Figure 5.1b).  Based on maximum 
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allele count, 2-person mixtures could accurately be determined as having 2 contributors in 
all cases.  SE33, D1S1656, and Penta E are among the loci that have the highest frequency 
of the highest allele count of 4 (Figure 5.2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Figure 5.1 Two-person mixture allele counts.  a) The minimum allele count distribution; and b) the maximum allele count distribution. 
Figure 5.2 Frequency of allele counts by locus of the 2-person mixtures (N= 27,730). 
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5.3.2 Three-Person Mixtures 
 For the 2,162,940 three-person mixtures, the majority (80%) exhibited at least one 
locus with a minimum of 2 alleles (Figure 5.3a).  There were still 100,831 (4.7%) profiles 
where there was at least one locus with a minimum allele count of 1 allele (Figure 5.3a).  
One 3-person mixture (0.0005%) was shown to have a minimum of 4 alleles, meaning no 
other loci had less than 4 alleles across the whole profile.  Over 2 million profiles were 
generated and only one profile exhibited this pattern indicating how rare it is for three 
individuals to have at least 4 unique alleles between them at every locus.  The maximum 
allele count method is accurate for 3-person mixtures in that 99.99% of the time (21.5% 
with 5 alleles, 78.5% with 6 alleles) there was at least one locus in the mixture profile that 
had 5 or 6 alleles, both of which indicate a minimum of 3 contributors (Figure 5.3b); there 
were 277 (0.01%) profiles which may have been confused as a mixture with only 2 
contributors.  SE33, D1S1656, and Penta E remain the loci with the highest frequencies of 
the highest allele count of 6, whereas TPOX had the highest frequency of only 2 alleles 
(Figure 5.4). 
 
 
 
 
 
 
 
Figure 5.1 Three-person mixture allele counts. a) The minimum allele count 
distribution; and b) the maximum allele count distribution.  
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Figure 5.2 Frequency of allele counts by locus of the 3-person mixtures (N= 2,162,940). 
 
5.3.3 Four-Person Mixtures 
 Minimum allele counts in the 916, 895 four-person mixture profiles were nearly 
evenly split between 2 and 3 alleles, 52% and 46.7%, respectively (Figure 5.5a).  There 
were 11,174 (1.2%) of profiles that still showed at least one locus with only 1 allele within 
the profile (Figure 5.5a).  At least one locus exhibited 7 or 8 alleles in approximately 90% 
(61% and 28.7%, respectively) of observed 4-person mixtures (Figure 5.5b).  However, 
there were 94,880 profiles (10.3%) that would be confused as a 3-person mixture as there 
was only a maximum count of 5 or 6 alleles in at least one locus across the profile.  The 
loci that have higher allele count frequencies for the highest possible allele count of 8 
remain SE33, D1S1656, and Penta E as seen for the two- and three- person mixtures, 
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although the frequencies are relatively lower here, indicating there are fewer profiles for 4-
person mixtures that exhibit the maximum number of unique alleles at these loci (Figure 
5.6). 
 
 
 
Figure 5.4 Frequency of allele counts by locus of the 4-person mixtures (N= 916,895). 
Figure 5.3 Four-person mixture allele counts.  a) The minimum allele 
count distribution; and b) maximum allele count distribution. 
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5.3.4 Five-Person Mixtures 
 It was shown to be more difficult to discriminate a minimum of 5 contributors than 
mixtures with fewer contributors.  The majority (72.5%) of the 962,598 profiles had at 
least one locus with a minimum of 3 alleles, followed by 24.5% with 2 alleles (Figure 
5.7a).  There were 3216 (0.3%) profiles that had at least one locus with only 1 allele.  In 
terms of maximum allele count, 42.9% of profiles had at least one locus with 9 alleles, 
which is indicative of a 5-person mixture (Figure 5.7b).  However, the next highest 
distribution of profiles (37.4%) were observed to have a maximum allele count of 8, 
which would indicate a 4-person mixture (Figure 5.7b).  Approximately 57% of observed 
5-person mixtures had at least one locus with 9 or 10 alleles, thereby making estimations 
of  the number of contributors inaccurate for nearly half of the profiles generated here 
(Figure 5.7b).  Per locus, SE33 still had the highest distribution exhibiting a maximum of 
10 alleles with 204,446 (21%) profiles (Figure 5.8).  The second and third highest loci 
with a maximum allele count of 10 were at a much lower distribution: D12S391 with 
26,974 (2.8%) profiles, and Penta E with 16,964 (1.8%) profiles (Figure 5.8). 
 
 
 
Figure 5.5 Five-person mixture allele counts.  a) The minimum allele count 
distribution; and b) maximum allele count distribution. 
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Figure 5.6 Frequency of allele counts by locus of the 5-person mixtures (N= 962,598)
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5.3.5 Six-Person Mixtures 
 Six-person mixtures, as expected, were the most difficult to discriminate by allele 
count as compared to the 2-, 3-, 4-, and 5-person mixtures.  The minimum allele count was 
similar to the 5- person mixtures with only approximately a 5% increase in profiles with at 
least one locus with a minimum of 3 alleles (72.5% to 77.3%, Figure 5.9a).  There were 98 
(0.01%) profiles where at least one locus only showed 1 allele (Figure 5.9a); conversely, 
there were 6. 
 
 
 
 
 
 
 
The maximum count that would distinguish a 6-person mixture from a 5-person mixture 
would be 11 or 12 alleles, and only 71,176 (7.8%) of profiles had at least one loci with 
either 11 or 12 alleles (7.1% and 0.7%, respectively, Figure 5.9b).  The most common 
maximum allele count was 9 with 411,324 (45.4%) profiles (Figure 5.9b).  Based on these 
low frequencies, there is a low probability of accurately estimating the correct number of 
contributors from a 6-person mixture, they are most likely to be assumed 5-person 
mixtures.  In terms of specific loci, only 3 were observed to produce profiles with 12 
alleles, all with low frequency: SE33 with 6,332 profiles (0.07%), D12S91 with 68 
(0.0008%) profiles, and D18S51 with 22 (0.0002%) profiles (Figure 5.10). 
Figure 5.7 Six-person mixture allele counts.  a) The minimum allele count 
distribution; and b) maximum allele count distribution. 
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The two loci with the highest profile counts with 11 alleles were SE33 with 60,676 (0.7%) 
profiles and D12S391 with 2,464 (0.03%) profiles (Figure 5.10). 
5.3.6 Overall by locus 
 As previously discussed, SE33 was the most polymorphic locus, with the greatest 
number of profiles with the maximum allele counts for mixtures with all number of 
contributors (Figure 5.11).  This is not surprising considering SE33 has 58 distinguishable 
alleles, which is twice the number of unique alleles compared to FGA, which is the next 
most variable STR [179].  If SE33 is considered as the only locus, 97.7% of profiles have 
3 or 4 alleles for 2-person mixtures, and with 3-person mixtures, 85.3% of profiles have 5 
or 6 alleles which would indicate minimally 2 and 3 contributors, respectively (Table 5.2).  
Looking at allele count distribution across number of contributors, 70% of profiles with 4 
alleles is observed at SE33 is a 2-person mixture, 44% of profiles with 5 alleles is a 3-
person mixture, with much smaller percentages of 5 alleles seen in other mixtures (Table 
5.2).  The locus is less informative with the higher count of alleles, where 59% of profiles 
with 8 alleles could be a 5- or 6-person mixture, and if this is the maximum allele count, it 
would be incorrectly assumed a 4-person mixture (Table 5.2).  For 5-person mixtures, 
58% of profiles showed 9 or 10 alleles.  For 6-person mixtures, only 7% of profiles at 
SE33 had 11 or 12 alleles observed.  The majority of allele distribution for 6-person 
mixtures was 8 or 9 alleles (Table 5.2).  All of this from a single locus, however, SE33 is 
not one of the expanded core loci.  In fact, it is not included in many of the current 
amplification kits [180].  An issue also arises in successfully genotyping SE33, as it is 
susceptible to allele drop-out and mobility shifts due to mutations in the primer binding 
sites, causing discordant genotyping results between different kits [181].
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Figure 5.8 Frequency of allele counts by locus of the 6-person mixtures (N= 906,192). 
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 When considering other loci, D12S391, which is one of the newly expanded core 
loci, and D18S51 were the only other loci to have a maximum of 12 alleles for the 6-
person mixtures (Figure 5.11).  Conversely, TPOX had the lowest allele maximum counts 
especially for 4-, 5-, and 6- person mixtures; there were only a maximum count of 5 
alleles (Figure 5.11).  This is not surprising as TPOX is considered the least polymorphic 
of 24 of the most commonly used STR loci [182] and has one of the highest allele 
frequencies of the autosomal loci (0.54 for allele 8 in the Caucasian population) [183].  
All loci exhibited the possibility of maximum allele count of 4 for 2-person mixtures, and 
all loci but D3S1358 exhibited the maximum possibility of 6 alleles for 3-person 
mixtures (Figure 5.11).  The maximum possible counts for 4-, 5-, and 6- person mixtures 
were more variable between all loci, with fewer loci exhibiting the higher possible counts 
(Figure 5.11).  This is not a surprising trend as it is inherently difficult to deconvolute 
higher count mixtures. 
 
Table 5.2 Frequency of 2-, 3-, 4-, 5-, and 6-person mixtures based on number of alleles seen at 
the SE33 locus among all observed mixture profiles. 
Alleles 2 person (%) 3 person (%) 4 person (%) 5 person (%) 6 person (%) 
1 0.03 0.00005    
2 2.3 0.03    
3 28.2 1.3 0.02   
4 69.5 13.4 0.75 0.002 0.001 
5  44.0 7.8 0.14 0.1 
6  41.3 29.4 2.2 1.7 
7   42.2 13.1 9.7 
8   19.8 33.8 25.4 
9    37.0 33.4 
10    20.9 12.4 
11     6.7 
12     0.7 
Bold = highest distribution of alleles per n-person mixture 
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Figure 5.9 Maximum alleles per loci for all mixtures. 
 
5.3.7 Total Allele Count Distributions 
 A DNA profile is considered as a whole and not just by a single locus.  Another 
overall observation to make with all these mixture profiles is the average number of 
alleles seen across all 23 autosomal loci in the profile.  Maximum allele count is 
important for assuming number of contributors, but if there are trends in number of 
overall allele counts and number of contributors, that could be important too.  For 2-
person mixtures across all loci in the profile, 49% of all alleles had 3 alleles, and 27.3% 
had 4 alleles (Figure 5.12a).  When comparing 3-person mixtures to the 2-person mixture 
distributions, there is a decrease in the number of loci that exhibit 3 alleles, and an 
increase in those that exhibit 4 alleles (Figure 5.12a,b).  Also, 7.2% and 5.8% of loci 
show 5 or 6 alleles, respectively (Figure 5.12b).  When considering total allele count 
across a 4-person mixture compared to a 3-person mixture, there is a decrease in loci that 
exhibit 4 alleles and increase in those exhibiting 5 and 6 alleles (Figure 5.12b,c).  
However, when comparing between 4-, 5-, and 6-person mixtures, the distribution of loci, 
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other than the increase of the highest 2 allele counts between each, is very similar 
demonstrating that discriminating a 4-, 5-, and 6-person mixture based on allele counts 
from this set of 23 autosomal loci would be very difficult (Figure 5.12c,d,e). 
 
Figure 5.10 Total allele count distributions across all the autosomal loci across all observed 
profiles for a) 2-person mixtures, b) 3-person mixtures, c) 4-person mixtures, d) 5-person 
mixtures, and e) 6 person mixtures. 
 
5.3.8 Y-STR Analysis 
 The PowerPlex® Fusion 6C system (Promega Corp.) includes three Y-STR 
markers, two of which were an addition since the PowerPlex® Fusion system (Promega 
Corp.).  As stated previously (see Methods), the Y-STR data was analyzed separately and 
only for mixtures that had all male contributors (e.g., 2-person mixtures with 2 males, 3-
person mixtures with 3 males, etc.).  The purpose was to determine how often a 2-, 3-, 4-, 
5-, and 6-person male mixtures would be correctly identified based solely on the Y-STR 
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loci.  The trends are similar with the Y-STRs as with the autosomal loci for the 2 person 
mixture, where approximately 97% of 2-person -male mixtures exhibit at least one Y-
STR with 2 alleles (Table 5.3).  For 3-person male mixtures, approximately two-thirds of 
all profiles (67%) exhibited at least one locus with 3 alleles (Table 5.3).  Similarly to 3-
person male mixtures, most 4-person male mixtures (64%) exhibited 3 or less alleles. 
Considering 5- and 6-person male mixtures, approximately 50% for both sets exhibited 4 
or less alleles (Table 5.3).  Therefore the 3 Y-STR markers were informative for number 
of contributors in the 2-person male mixtures, and for the majority of 3-person male 
mixtures, but are not very discriminating for number of contributors in the 4-, 5-, and 6-
person male mixtures.  DYS576 was found to be the most diverse of the 3 YSTRs 
analyzed. 
Table 5.3 Y-STR Distributions per n-person male mixtures. 
Mixture Number of 
Mixtures 
Max Alleles Frequency (%) 
2 males 6,105 1 3.3 
  At least one locus with 2 96.7 
3 males 221,815 1 0.1 
  2 or less 32.9 
  At least one locus with 3 67.0 
4 males 40,919 2 or less 11.0 
  3 or less 64.0 
  At least one locus with 4 25.0 
5 males 4,278 2 or less 1.5 
  3 or less 40.0 
  4 or less 52.5 
  At least one locus with 5 6.0 
6 males 5,005 2 or less 0.2 
  3 or less 10.8 
  4 or less 51.0 
  5 or less 35 
  At least one locus with 6 3.0 
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5.4 Conclusions 
 This study shows that using maximum allele count with profiles generated with 
the PowerPlex® Fusion 6C (Promega Corp.), which includes the expanded core STR 
loci, is accurate for estimating number of contributors for 2- and 3-person mixtures.  
Maximum allele count has already been shown just as efficient as maximum likelihood 
for 2- and 3- person mixtures based on 15 autosomal loci [174]; it is shown here to not be 
much more improved when expanded to 23 autosomal loci.  The capability for 
estimations are less accurate as number of contributors increase, even with the expanded 
panel of standard loci.  SWGDAM mixture interpretation guidelines state that there are 
essentially two approaches to determining the statistical weight of inclusions: 1) binary or 
2) probabilistic [172].  Binary statistical models (i.e., random match probability (RMP), 
likelihood ratio (LR), and combined probability of exclusion/inclusion (CPE/CPI)) are 
still very common in practice, however, they are limited to cases where at least one 
contributor can be deconvoluted from the mixture.  They also require the analyst to 
assume the number of contributors in order to perform the statistic, with the exception of 
CPE/CPI [171].  However, the CPE/CPI is also limited in that it can only be calculated 
when all alleles are present within the profile; there cannot be any allele drop-out [177].  
For this calculation, in many cases then, not all the profile information can be used and 
the statistical result is not as informative.  Furthermore, according to the recently released 
PCAST report, the CPE/CPI statistic was deemed inadequate and subjective [184].  The 
PCAST report also points to the fact that probabilistic genotyping methods are an 
improvement, but further testing should be done to ensure the scientific validity on 
reliability and on the algorithms being implemented [184]. 
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 While the future of mixture interpretation is heading towards these computer-
based probabilistic genotyping methods, current practices in many laboratories still 
implement maximum allele count in their standard operating procedures.  This study 
highlights that caution still needs to be given when assuming the number of contributors 
in suspected mixtures of greater than 3 individuals as even with the expanded core STR 
loci, discrimination for 4-. 5-, and 6-person mixtures is complex and difficult.  Highly 
variable STRs, such as SE33, can be more useful for these higher order mixtures as seen 
here, however, there are still limitations in the successful typing of this locus and it is not 
available in all genotyping kits.  Other genotype factors are taken into consideration when 
interpreting a profile besides the presence or absence of alleles, such as the peak height 
ratios and stutter etc.  The analyses reported here were based on theoretical 1:1 mixtures 
under ideal conditions and unrelated individuals, and therefore further empirical testing 
with different ratios of contributors and possibly related individuals (which would have 
alleles in common than unrelated individuals) would be valuable to perform as it would 
simulate more realistic conditions of casework mixture samples. 
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CHAPTER 6. CONCLUSIONS AND FUTURE DIRECTIONS 
 The overall scope of the work presented was to address some of the limitations of 
current forensic DNA-based identification technologies.  For example, one of those 
limitations was when a conventional STR profile from biological evidence does not 
provide a match to a suspect or database hit.  Additional information can be determined 
from the evidence that will be useful to gain intelligence for the investigation by 
developing a SNP assay to provide a phenotypic profile of the contributor.  Pigmentation 
contributes to many externally visible traits including eye, hair, and skin color, and since 
many pigmentation traits are related (they all stem from the melanogenesis pathway), 
there is a relationship between the elucidation of many of the components of 
melanogenesis and the SNPs found responsible for the expression of different 
pigmentation traits.  This is especially true for some characteristic phenotypes such as red 
hair, blue and brown eyes, and light skin in Europeans, as these traits have at least one 
SNP/gene (MC1R, rs12913832, rs1426654, respectively) that contributes much of the 
variance in their expression.  However, intermediate color categories (e.g., green and 
hazel eye colors) are known to be difficult to predict from previous studies [20, 40], and 
were not improved by the selected SNPs in this work.  Therefore, optimization of 
prediction models that combine the possible traits into groups (e.g., blue or intermediate 
eye colors) results in likelihood calculations that reduce inaccuracy by providing 
information that is still reliable for use in an investigation, albeit a less specific 
prediction.  Further studies into completing elucidation of all components related to the 
melanogenesis pathway and GWAS with larger cohorts of individuals with these traits 
will provide more guidance on identification of additional genes and SNPs that may 
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contribute to the expression of these traits.  Furthermore, as more studies are heading 
towards quantitative color measurements as opposed to a single individual’s visual 
determination for color assignment, intermediate colors can be more objectively defined 
and consistently identified for more accurate prediction analyses.  The quantitative color 
prediction model developed here is a step in that direction. 
 Skin color pigmentation can also implicate ancestry due to the dispersal of 
melanin is correlated to geography; there are higher levels of melanin expression (i.e., 
darker skin, darker hair) in regions closer to the equator because of higher levels of UV 
(sun) exposure [185, 186].  Skin color is not a sole indication of ancestry, and therefore 
many of the additional ancestry SNPs selected for the panel developed in this work were 
not related to melanin expression, but were SNPs with alleles found to be in high 
frequencies in a specific population.  The ancestry predictions in this work of the 5 main 
continental groups seen in the U.S. had greater than 50% correct predictions.  A 
limitation of this work was that the sample size of each reported ancestry was very small, 
especially for East Asians, and therefore predictions were not as accurate as those with 
higher reported numbers of individuals, such as Europeans.  Additionally, further 
development of prediction models to be able to account for admixed or biracial 
individuals is necessary, as the models built in this work could only assign a single 
ancestry category. 
 DNA phenotyping is not limited to pigmentation and ancestry.  Age is one trait 
that has gained much interest in prediction studies recently.  The main technology used 
for these studies has been bead chip microarrays, for example, the Infinium 
HumanMethylation arrays.  However, these arrays suffer from bias in selection of region 
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coverage, typically targeting CpG islands in promoter regions and disease-causing genes 
[142].  The novel method developed here reduced the association to disease, included 
three forensically relevant fluids, and resulted in genome-wide coverage.  Further 
analysis of the genes and features identified in the candidate CpG sites shows that these 
sites are likely involved in the regulation of many of the biological processes affected by 
aging, especially cell communication, metabolism, and immune response.  Further testing 
of these sites with a larger sample population of healthy individuals, including females to 
eliminate and/or correct any influence of sex, would be necessary for validation.  
However, once validated, they can be incorporated into the FPP assay to add age to the 
predicted phenotype of an individual, furthering the information that can be gained for an 
investigation from a DNA sample that otherwise was a dead-end from its STR profile. 
 The other major consequence of current DNA technologies is the increased 
probability of mixture profiles due to increased sensitivity of amplification kits.  Mixtures 
are inherent for certain crimes (e.g., sexual assaults); but the ability to deconvolute a 
mixture to individual genotypes of each contributor is essential to identifying the 
contributors correctly.  Typically, mixture separation can accurately be determined for 
most 2-person mixtures and some 3-person mixtures by allele counting.  It was also 
hypothesized that increasing the number of loci in forensic DNA profiles would improve 
the accuracy of the determination of the number of contributors.  However, the millions 
of 2-, 3-, 4-, 5-, and 6-person mixture profiles generated in this work suggests that with 
the expanded core STR loci does not offer much improvement in accuracy.  One locus, 
SE33, improved the determination of the number of contributors, however, it is a large 
locus, and suffers from a greater probability of drop out in forensic samples that have 
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degraded [171].  Furthermore, SE33 is not in the newly expanded core STR loci and 
therefore not all amplification kits include it in their panel of loci.  It is also difficult to 
successfully amplify.  When using Y-STRs for determining the number of male 
contributors, discrimination greater than a 3-person mixture was difficult.  Furthermore, 
the mixture data generated here was assumed under ideal conditions: 1:1 ratios, no 
stutter, and all alleles above the stochastic threshold.  Additional work can be done to 
analyze more realistic conditions such as differing ratios of each contributor with 
differing amount of input DNA.  Practicing laboratories have mixture protocols to follow, 
and it should be cautioned that allele counting is not the best method for all mixture 
cases.  More recently, computer-based probabilistic genotyping has gained recent 
attention as a more accurate method, considering all aspects of the genotype (e.g., peak 
height ratios, probability of drop-out, stutter, etc.).  Although this is the future of mixture 
interpretation, some laboratories do not have the resources to implement these methods 
and therefore reliance on the allele-counting method is not yet obsolete.  Another 
potential option is generating DNA profiles using NGS methods, as they have the 
capability of producing additional variant information that can discriminate individuals 
by mutations in flanking regions [187]; however, this technology is not cost effective for 
many laboratories yet and requires additional validation work to implement for common 
practice. 
 Besides a higher probability of developing human DNA mixtures, issues from 
non-human, extraneous DNA may also arise from crime scene evidence.  Amplification 
and quantitation kits for forensic DNA analysis are designed to be human-specific to 
purposely avoid amplifying extraneous sources of DNA from a crime scene.  However, 
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the amount of non-human DNA that may be present is not known in an evidence sample.  
When validating current forensic DNA genotyping kits, sources of common extraneous 
DNA such as domestic animals and common bacteria are included to ensure little or no 
artifactual amplifications.  However, there are many more species of bacteria present on a 
living human body than is currently included during validation, and the proportion 
increases once decomposition sets in.  Furthermore, if a body is found in an outdoor 
setting, there are many more microbial species that are found in soil and water that may 
be collected.  This work sought to determine the effect of common microbial DNA on 
DNA profiles generated using the PowerPlex® 16 HS kit (Promega Corp.).  Two species 
produced an allelic artifact at the TPOX locus, mimicking a true allele of the locus, and 
thereby interfering with the interpretation of the DNA profile.  In one case, the microbial 
artifact amplified at equal ratio to the human allele.  In a worst case scenario, this could 
lead to the possible exclusion of the actual contributor due to an inconsistent genotype at 
TPOX. Expanding the microbial species tested could be beneficial to extend this catalog 
of possible interfering bacterial sources.  Again, the artifact allele was recognized with 
one kit, and not reproduced when repeated with another (personal communications with 
Promega revealed primer differences at the TPOX locus between kits).  Additional 
testing of currently used amplification kits will help gauge how often this interference 
occurs.  Furthermore, there was only three amounts of DNA reported here: 10ng, 50ng, 
and 100ng.  An additional study into how much microbial DNA is actually collected from 
a decomposing body in different environments would be able to further guide the species 
and ratios tested during developmental validation of future amplification kits. 
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 Advancements in technology have rapidly developed the area of DNA-based 
identification, this is evident especially in the last 30 years since the development of 
DNA fingerprinting and PCR.  Overall, the work presented here addresses aspects of 
modern DNA-based identification.  It is the hope that the work here provides proof of 
some of the limitations and consequences of these modern methods.  Furthermore, this 
work provides guidance for ways these limitations can be overcome in future research as 
technologies continue to advance. 
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APPENDIX C. SEQUENCING PRIMERS 
Table A.1 Sequencing primers designed for genotype validation. 
SNP Primer Sequence Size (bp) 
SLC45A2_F_2 AGTTTTTCCTGACGTCCATAGATT 
235 SLC45A2_R_2 GTGCACACAACTCCACAGAG 
HERC2_F_2 AGTCTTGTAATCAACATCAGGGT 
259 HERC2_R_2 TCAAAGAAACGACAAGTAGACCA 
P.OCA2F TGAAAGGCTGCCTCTGTTCT 
191 rs1800407Rseq ATGGTCACAGGCGTGAAGAG 
SLC24A4-F CTGGCGATCCAATTCTTTGT 
104 SLC24A4-R CTTAGCCCTGGGTCTTGATG 
IRF4-F ACAGGGCAGCTGATCTCTTC 
250 rs12203592Rseq AGACTGACAGCCGAAGCATT 
rs1229984F CACGTGTTCCCTGAGTGTGA 
362 rs1229984R GAAGGGAAGGTAGAGAAGGGC 
rs12498138F ACATAGGATTTGCGAGAAACAGA 
190 rs12498138R TCTGAGGTACATTGTGGGCTC 
rs1426654F2 TCAGCCCTTGGATTGTCTCAG   
rs1426554R2 AAATCACACTGAGTAAGCAAGAAGT 130 
rs3737576LF AGTGTAGGGAACAAGAGATCGG 
155 rs3737576LR AAGCTGGGAGAGATAGGAGGA 
rs3827760F TGCTGATGCGGTCAAAGAGT 
142 rs3827760R ACTAGCCGAATGCTCAGCTC 
rs3916235F CACTCCACTTCACCCATCCC 
356 rs3916235R TGGGCAAAGACTCTTAGTTCAGT 
rs4918664F AGGCAGGAATGGGAGAAAGC 
172 rs4918664R TGGCAAGAGTTCTGACCAAA 
rs7657799F AGTTCTTGACACAAGGCCCA 
462 rs7657799R GTACATTGAGAAATGCTGTAGGAA 
rs1408799LF AGATATTTGTAAGGTATTCTGGCCT 
179 rs1408799LR AGTGCTATGAGGACAGGACC 
rs3829241F CCTTTAGAGGCCCCTGTGTG 
92 rs3829241R TGGCTCAGCCTCTCTGTGA 
rs12821256F ATGCCCAAAGGATAAGGAAT 
118 rs12821256R GGAGCCAAGGGCATGTTACT 
rs4959270F TGAGAAATCTACCCCCACGA 
140 rs4959270R GTGTTCTTACCCCCTGTGGA 
rs2378249F CGCATAACCCATCCCTCTAA 
136 rs2378249R CATTGCTTTTCAGCCCACAC 
rs683F CACAAAACCACCTGGTTGAA 138 
353 
 
Table A.1 continued 
rs683R TGAAAGGGTCTTCCCAGCTT  
rs885479F CTGGTGAGCTTGGTGGAGA 
789 rs1805007R CACCTCCTTGAGCGTCCTG 
rs6119471F GAAGTGTGATTCTCTTGGCTTGT 
404 rs6119471R GAAGGCACTTGAGAGGAGGC 
rs10777129F CTGGACAACCAAGCCCTTAAA 
525 rs10777129R CAGAGGCCTAGTGTTGTTGT 
rs1800414F TGCCAGGGACAAACGAATTG 
182 rs1800414R TGTCGTGATTCCAGTTGCGTA 
rs28777F TACTCGTGTGGGAGTTCCAT 
150 rs28777R TCTTTGATGTCCCCTTCGAT 
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APPENDIX E. ALL RGB QUANTITATIVE PREDICTIONS 
Table A.2 RGB quantitative skin color predictions for all 4 BN models. 
Sample R G B Actual 
Pigmentation 
SNPs only, 
Error % 
All SNPs, 
Error % 
Trait SNPs 
only, Error % 
Ancestry + 
Pigmentation, 
Error % 
1370 200 156 125   10.47% 9.60% 8.47% 10.56% 
1654 212 174 133   3.76% 7.96% 2.37% 3.85% 
1736 187 134 83   12.56% 14.51% 17.81% 11.54% 
1784 200 161 123   4.84% 5.07% 6.69% 5.39% 
1892 228 183 128   4.07% 4.02% 4.95% 3.95% 
1902 172 121 68   10.06% 8.86% 14.78% 10.04% 
1905 231 201 170   10.65% 8.57% 7.45% 10.62% 
2079 224 175 120   5.01% 5.22% 4.98% 5.23% 
2093 208 168 127   3.44% 3.56% 4.75% 3.55% 
2435 207 178 159   5.45% 4.59% 3.77% 5.37% 
3187 213 155 131   4.71% 5.69% 6.08% 4.77% 
3471 217 178 146   3.40% 4.21% 0.82% 3.23% 
3542 216 164 113   8.19% 8.06% 6.89% 8.48% 
4063 194 154 110   14.24% 18.06% 23.30% 14.56% 
4069 200 175 140   4.36% 4.41% 4.62% 4.39% 
4258 225 192 156   8.24% 8.96% 4.66% 7.52% 
4389 207 165 118   7.43% 4.15% 6.66% 7.60% 
4635 196 158 124   8.62% 11.23% 7.98% 8.67% 
4710 148 87 53   16.09% 14.31% 24.58% 16.41% 
4819 212 174 164   4.95% 5.07% 5.05% 4.93% 
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Table A.2 continued 
5168 203 155 115   1.79% 2.00% 2.44% 1.74% 
5230 208 174 148   7.03% 3.34% 10.23% 8.22% 
6084 239 206 166   10.29% 12.39% 9.88% 11.84% 
6149 208 165 133   3.48% 3.73% 3.55% 3.37% 
6305 238 206 173   5.33% 7.01% 10.47% 5.32% 
6329 212 158 119   8.60% 8.60% 5.33% 8.70% 
6347 228 194 167   9.08% 6.09% 5.80% 9.25% 
6789 217 179 147   3.91% 5.33% 1.62% 3.44% 
7181 178 140 99   2.48% 10.43% 3.19% 3.30% 
7263 234 198 156   3.52% 1.40% 5.89% 3.59% 
7280 206 165 131   4.14% 6.30% 5.47% 4.48% 
7294 213 182 148   0.88% 0.82% 2.42% 0.77% 
7482 193 157 119   7.98% 11.08% 11.19% 7.98% 
7632 207 165 133   4.32% 2.87% 4.44% 4.13% 
7659 223 191 171   5.30% 5.84% 7.80% 4.99% 
7814 193 153 101   28.72% 27.45% 36.56% 28.66% 
7890 228 184 144   8.83% 0.45% 12.12% 9.63% 
8395 134 89 55   17.53% 15.72% 24.35% 17.66% 
8539 147 87 57   7.34% 8.05% 5.50% 6.81% 
8709 224 189 155   7.43% 8.06% 3.94% 7.39% 
8730 182 136 116   23.04% 23.94% 13.74% 22.88% 
8934 222 183 151   2.65% 3.45% 2.24% 2.51% 
8972 225 176 120   5.27% 5.47% 5.41% 5.43% 
9167 204 171 132   7.64% 5.59% 4.03% 7.83% 
9345 212 166 113   11.04% 8.13% 6.84% 11.13% 
9451 208 167 125   4.86% 4.42% 5.84% 5.33% 
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Table A.2 continued 
9628 238 199 148   4.37% 5.18% 6.59% 4.36% 
9717 231 199 163   6.05% 5.27% 5.71% 5.19% 
9785 211 173 132   2.51% 2.20% 3.06% 2.50% 
9981 204 155 129   10.94% 9.54% 6.62% 10.92% 
 
Table A.3 RGB quantitative eye color predictions for all 4 BN models. 
Sample R G B Actual 
Pigmentation 
SNPs only, 
Error % 
All SNPs, 
Error % 
Trait SNPs 
only, Error % 
Ancestry + 
Pigmentation, 
Error % 
1370 57 29 21   7.65% 8.01% 6.07% 7.96% 
1654 41 13 14   3.34% 4.11% 3.29% 3.12% 
1736 31 9 10   6.74% 6.90% 5.57% 3.55% 
1784 33 10 8   4.42% 3.36% 2.56% 3.19% 
1892 60 61 62   2.55% 2.80% 1.93% 2.31% 
1902 5 4 4   6.54% 4.41% 6.42% 6.49% 
1905 68 60 59   2.21% 3.92% 0.85% 2.31% 
2079 52 25 24   8.58% 8.73% 8.49% 9.13% 
2093 49 41 44   8.94% 8.51% 7.88% 9.19% 
2435 40 38 46   11.63% 11.69% 10.80% 10.39% 
3187 48 51 60   4.95% 2.46% 4.90% 5.19% 
3471 59 63 73   3.78% 3.60% 3.67% 4.02% 
3542 84 54 45   8.81% 8.85% 8.71% 8.08% 
4063 14 11 11   9.27% 5.80% 3.74% 10.83% 
4069 48 26 23   7.40% 7.59% 4.73% 7.99% 
4258 44 37 38   5.97% 6.73% 5.12% 8.38% 
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Table A.3 continued 
4389 42 19 18   11.32% 8.09% 11.22% 11.79% 
4635 37 39 40   10.13% 11.02% 10.01% 10.36% 
4710 24 15 13   2.39% 1.64% 1.62% 3.70% 
4819 49 46 51   7.34% 7.65% 7.57% 7.39% 
5168 47 18 19   2.68% 6.15% 1.74% 1.87% 
5230 86 68 65   7.71% 7.99% 6.71% 11.74% 
6084 52 28 27   5.10% 3.01% 4.83% 1.74% 
6149 71 55 48   5.65% 5.60% 4.57% 5.39% 
6305 62 36 35   3.84% 3.31% 4.40% 3.89% 
6329 34 16 17   2.35% 4.85% 2.12% 3.04% 
6347 58 56 58   5.94% 6.77% 4.86% 5.39% 
6789 50 35 34   3.39% 3.22% 3.13% 1.85% 
7181 36 18 20   3.16% 5.01% 3.92% 0.97% 
7263 89 69 56   12.69% 12.69% 12.85% 13.18% 
7280 12 3 4   9.95% 12.61% 8.96% 12.28% 
7294 67 46 38   6.56% 6.59% 6.29% 6.11% 
7482 88 84 83   3.12% 1.77% 8.30% 3.13% 
7632 50 41 43   8.96% 4.91% 8.21% 8.40% 
7659 47 25 17   4.20% 4.30% 3.03% 5.03% 
7814 50 27 27   1.19% 1.64% 7.77% 0.96% 
7890 48 23 22   2.89% 4.74% 3.63% 3.83% 
8395 15 7 5   4.82% 1.70% 4.17% 5.52% 
8539 4 3 3   9.50% 11.11% 10.99% 7.85% 
8709 98 79 69   8.21% 11.92% 8.24% 8.05% 
8730 83 50 41   10.82% 11.72% 9.17% 11.48% 
8934 98 89 92   12.99% 12.37% 13.07% 12.51% 
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Table A.3 continued 
8972 44 44 48   8.29% 8.77% 7.88% 8.75% 
9167 71 61 59   10.65% 11.83% 10.71% 9.99% 
9345 27 9 12   8.62% 8.56% 9.09% 8.88% 
9451 61 31 27   6.41% 11.47% 4.98% 8.19% 
9628 63 35 29   4.49% 4.47% 4.76% 4.61% 
9717 28 13 12   5.88% 1.13% 0.47% 7.99% 
9785 105 103 106   18.90% 18.29% 17.63% 18.93% 
9981 91 69 61   13.54% 17.17% 12.73% 13.60% 
 
 
Table A.4 RGB quantitative hair color predictions for all 4 BN models.  Blank rows indicate no hair sample was analyzed. 
Sample R G B Actual 
Pigmentation 
SNPs only, 
Error % 
All SNPs, 
Error % 
Trait SNPs 
only, Error % 
Ancestry + 
Pigmentation, 
Error % 
1370 103 63 41   4.87% 5.42% 3.35% 5.12% 
1654 40 30 30   4.65% 11.46% 5.80% 4.44% 
1736 10 11 13   19.45% 20.01% 17.03% 16.65% 
1784 16 13 19   11.22% 12.39% 9.63% 10.15% 
1892 203 185 165   42.83% 41.96% 42.72% 43.06% 
1902 56 34 31   6.47% 9.98% 6.07% 6.51% 
1905 125 104 81   12.51% 16.75% 10.06% 12.42% 
2079 115 87 65   3.44% 3.30% 2.59% 3.00% 
2093 64 32 23   17.16% 17.83% 23.69% 17.35% 
2435 167 150 126   28.55% 27.79% 27.15% 29.54% 
3187 181 157 122   19.97% 12.64% 23.09% 19.76% 
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Table A.4 continued 
3471 111 81 64   4.19% 2.42% 2.03% 3.65% 
3542              
4063 12 10 18   4.50% 7.30% 4.04% 5.67% 
4069 83 53 36   8.16% 7.55% 7.84% 8.64% 
4258 81 62 50   5.47% 5.31% 2.05% 7.40% 
4389              
4635 119 92 71   1.51% 3.73% 2.09% 1.38% 
4710 9 9 13   2.71% 2.78% 3.56% 2.73% 
4819 102 68 49   5.17% 5.78% 7.31% 5.20% 
5168 50 30 27   4.02% 9.02% 3.76% 4.96% 
5230 102 64 35   6.81% 5.58% 7.44% 6.29% 
6084 31 16 19   23.73% 24.98% 26.15% 18.54% 
6149 79 42 41   7.81% 8.87% 14.79% 7.55% 
6305 132 82 57   4.13% 4.09% 3.75% 4.13% 
6329 12 15 19   2.84% 4.01% 1.78% 2.83% 
6347 189 195 191   41.65% 41.18% 38.92% 42.07% 
6789 176 154 132   26.10% 27.31% 27.43% 27.40% 
7181 15 15 18   15.70% 8.26% 18.20% 13.82% 
7263 171 140 110   27.09% 26.64% 27.45% 27.47% 
7280 96 64 52   7.98% 14.02% 14.05% 6.22% 
7294 64 41 30   8.77% 9.56% 10.74% 9.14% 
7482 133 112 96   12.10% 12.04% 13.97% 12.08% 
7632 175 160 145   19.59% 19.42% 17.45% 20.05% 
7659 130 89 51   10.22% 9.20% 9.08% 9.58% 
7814 38 23 23   2.70% 1.26% 3.94% 2.91% 
7890              
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Table A.4 continued 
8395 22 17 20   2.20% 3.30% 0.62% 2.02% 
8539 50 37 32   2.37% 6.44% 2.58% 3.57% 
8709 63 45 41   11.04% 14.76% 17.13% 11.17% 
8730 125 88 61   2.56% 2.99% 4.66% 2.56% 
8934 136 105 74   5.16% 4.36% 5.06% 4.80% 
8972 97 73 57   8.36% 8.70% 8.98% 8.74% 
9167 113 82 60   4.76% 1.75% 5.76% 4.19% 
9345              
9451 64 33 21   4.66% 6.20% 4.22% 4.57% 
9628 92 55 35   12.48% 13.09% 12.47% 12.62% 
9717 9 9 17   7.19% 11.45% 6.01% 8.88% 
9785 164 148 136   25.48% 24.66% 23.50% 25.50% 
9981 130 94 73   10.69% 7.62% 12.33% 10.73% 
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APPENDIX F. ALL CANDIDATE CPG SITES 
Table A.5 Candidate age CpG sites.  Those highlighted in blue had more than one possible CpG 
site in the mapped read. 
Chromosome CpG Site NCBI Refseq 
Gene 
r2 Methylation 
Pattern 
Non-gene Genomic 
Feature 
chr1 4063800  -- 0.95 hypo n/a 
chr1 4196025  -- 0.89 hyper AluSc -SINE 
chr1 14977413 KAZN 0.71 hypo  
chr1 18256473 IGSF21 0.90 hypo  
chr1 18442677  -- 0.90 hyper AluJr -SINE 
chr1 41891046 HIVEP3 0.87 hypo  
chr1 42354692  -- 0.91 hyper AluY -SINE 
chr1 50116466 ELAVL4 0.82 hypo  
chr1 59107862  -- 0.97 hypo LINC01358 
chr1 68242601  -- 0.96 hyper n/a 
chr1 88035578  -- 0.95 hyper MER61C -LTR 
chr1 930012437  -- 0.97 hypo  
chr1 107261767 NTNG1 0.98 hyper AluY-SINE 
chr1 112264284  -- 0.78 hyper n/a 
chr1 116532957 CD58 0.94 hyper  
chr1 143665699  -- 0.94 hypo n/a 
chr1 143747286  -- 0.90 hypo AluSz -SINE 
chr1 143765020  -- 0.88 hypo MER66C- LTR 
chr1 146053356 LOC101928979 0.86 hyper LINC01719; AluYk3- 
SINE 
chr1 153615176 S100A14 0.89 hypo  
chr1 153796804  -- 0.71 hyper L2c- LINE 
chr1 158790497  -- 0.81 hyper AluY-SINE 
chr1 161692317  -- 0.98 hyper AluSx1-SINE 
chr1 163416999  -- 0.72 hyper AluY-SINE 
chr1 165582202 LOC400794 0.78 hyper  
chr1 185020039  -- 0.75 hypo n/a 
chr1 192209826  -- 0.80 hyper AluSp-SINE 
chr1 195783494  -- 0.80 hyper AluY-SINE 
chr1 202705741 SYT2 0.85 hypo AluJo - SINE 
chr1 210668395 HHAT 0.94 hypo THE1B-LTR 
chr1 217066347 ESRRG 0.81 hyper  
chr1 222521710  -- 0.97 hypo LTR8B- LTR 
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Table A.5 continued 
chr1 223885109  -- 0.88 hyper AluY-SINE 
chr1 228063253  -- 0.79 hypo n/a 
chr1 236123570  -- 0.90 hypo n/a 
chr1 238494677  -- 0.89 hyper AluY- SINE 
chr1 243952428 LOC339529 0.87 hyper  
chr1  ZNF695 0.94 hyper AluY- SINE 
chr10 3472563 LOC105376360 0.93 hypo  
chr10 3995341  -- 0.79 hypo L1PA8-LINE 
chr10 17501725  -- 0.92 hypo AluSq2 - SINE 
chr10 21084829 NEBL 0.89 hypo  
chr10 27526362 RAB18 0.76 hypo  
chr10 43779805  -- 0.90 hypo n/a 
chr10 86103582 GRID1 0.86 hypo  
chr10 110567780 SMC3 0.79 hypo CpG island 
chr10 116785385  -- 0.90 hypo n/a 
chr10 119275373 GRK5 0.87 hypo LFSINE_Vert - SINE 
chr10 125082211 CTBP2 0.77 hypo  
chr10 128642775  -- 0.95 hypo MLT1C - LTR 
chr10 131825744  -- 0.97 hypo n/a 
chr11 11999029 DKK3 0.87 hyper MIR- SINE 
chr11 12724900 TEAD1 0.71 hypo  
chr11 19941856 NAV2 0.89 hypo L3 - LINE 
chr11 35603992  -- 0.85 hyper AluY- SINE 
chr11 3809028  -- 0.82 hyper MER11A - LTR 
chr11 39022561  -- 0.92 hyper AluYb8 - SINE 
chr11 41410487 LRRC4C 0.90 hyper AluY- SINE 
chr11 48429548  -- 0.99 hyper AluSg- SINE 
chr11 69008985 MRGPRF 0.88 hypo  
chr11 73367989 ARHGEF17 0.90 hyper  
chr11 73752429 RAB6A 0.96 hypo AluSx1-SINE 
chr11 81009321  -- 0.92 hyper AluSc8-SINE 
chr11 93740945 TAF1D 0.81 hypo CpG island 
chr11 101448620  -- 0.95 hypo n/a 
chr11 105573991  -- 0.77 hypo LTR54- LTR 
chr11 118145091 SCN4B 0.72 hyper  
chr11 120910116 GRIK4 0.71 hypo MSTD-LTR 
chr11 127956596  -- 0.78 hypo AluSx- SINE 
chr11 129702075  -- 0.89 hypo n/a 
chr12 6337976 TNFRSF1A 0.92 hypo  
chr12 6975299 EMG1 0.89 hypo  
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Table A.5 continued 
chr12 14162352  -- 0.83 hyper AluSp-SINE 
chr12 16112299  -- 0.90 hypo n/a 
chr12 20402242 PDE3A 0.95 hypo AluSz6-SINE 
chr12 27244066 STK38L 0.96 hypo CpG island 
chr12 42671522 LOC105369738 0.80 hyper MER50-LTR; 
LINC02451 
chr12 43409409 ADAMTS20 0.94 hyper AluYa5- SINE 
chr12 52439302  -- 0.82 hypo AluJb-SINE 
chr12 78794187  -- 0.94 hyper n/a 
chr12 80429596  -- 0.90 hyper AluYc- SINE 
chr12 93573848 SOCS2 0.91 hypo  
chr12 10020204 ACTR6 0.70 hyper AluSg- SINE 
chr12 106113901 NUAK1 0.97 hypo  
chr12 107197597  -- 0.70 hyper AluSc- SINE 
chr12 110339453 ATP2A2 0.95 hypo  
chr12 121906347 PSMD9 0.86 hypo  
chr12 125397132 TMEM132B 0.82 hypo AluSx3- SINE 
chr12 130286919  -- 0.90 hypo n/a 
chr13 29539635 SLC7A1 0.84 hypo  
chr13  COG6 0.92 hypo CpG island 
chr13 41047562 ELF1 0.95 hypo L1PA5- LINE 
chr13 48838575  -- 0.84 hypo n/a 
chr13 58859813  -- 0.94 hypo HUERS-P2-int - LTR 
chr13 78101976 RNF219-AS1 0.97 hyper AluYb9- SINE 
chr13 89483285 LINC01040 0.94 hyper MLT1E2- LTR 
chr13 106375143  -- 0.79 hyper n/a 
chr13 110129547  -- 0.71 hypo n/a 
chr13 112620712  -- 0.86 hyper AluSp-SINE 
chr14 19169193  -- 0.84 hyper AluY- SINE 
chr14 20601879 LOC254028 0.97 hypo HERVL 18-int LTR 
chr14 21525829 SALL2 0.98 hypo  
chr14 27726354  -- 0.77 hypo n/a 
chr14 34147401  -- 0.91 hypo n/a 
chr14 42419944  -- 0.93 hypo L1PA15- LTR 
chr14 64760474 SPTB 0.94 hypo  
chr14 69728941 SRSF5 0.76 hypo MER41B - LTR 
chr14 74892948 DLST 0.81 hypo  
chr14 74916943 RPS6KL1 0.92 hypo  
chr14 84502166  -- 0.99 hypo HERVH-int - LTR 
chr14 93186029 TMEM251 0.73 hyper AluY- SINE 
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Table A.5 continued 
chr14 98000632  -- 0.90 hypo n/a 
chr14 101029421 MIR494 0.80 hypo microRNA 494 
chr14 105249899 BRF1; BTBD6 0.79 hyper CpG island 
chr14   -- 0.93 hyper CpG island 
chr15 23965186  -- 0.97 hyper AluY- SINE 
chr15 40333450 C15orf52 0.75 hyper AluJb- SINE 
chr15 53222767  -- 0.96 hyper n/a 
chr15 57897471  -- 0.80 hyper n/a 
chr15 65410294 IGDCC4 0.73 hypo  
chr15 74049311  -- 0.76 hyper AluSc8-SINE 
chr15 79284038 ANKRD34C 0.98 hypo CpG island north shore 
chr15 84717135  -- 0.93 hypo n/a 
chr15 868928876 AGBL1 0.80 hypo  
chr15 87761896  -- 0.91 hypo n/a 
chr15 89005093  -- 0.88 hypo n/a 
chr15 94157803  -- 0.95 hyper LTR17- LTR 
chr15 96367880  SPATA8 0.91 hypo  
chr15 101347166 PCSK6 0.94 hypo  
chr16   -- 0.94 hypo SVA_D retroposon 
chr16 6010345  -- 0.99 hypo LTR16C- LTR 
chr16 11757206 ZC3H7A 0.95 hypo AluY- SINE 
chr16 13200344 SHISA9 0.87 hyper LTR16E1- LTR 
chr16 18373911  -- 0.91 hypo AluSx4- SINE 
chr16 18958377  -- 0.72 hypo AluSg-SINE 
chr16 23509475 GGA2 0.88 hypo L2c - LINE 
chr16 24627310  LCMT1 0.83 hyper  
chr16 27485251 GTF3C1 0.79 hypo  
chr16 32670516  -- 0.97 hyper n/a 
chr16   -- 0.75 hypo AluSx1- SINE 
chr16 51767907 LINC01571 0.88 hypo  
chr16 57462658 POLR2C 0.78 hypo  
chr16 64944282 CDH11 0.91 hypo L2a-LINE 
chr16 65117897 CDH11 0.81 hyper  
chr16 66065995  -- 0.87 hypo n/a 
chr16 71353879  -- 0.94 hypo n/a 
chr16 83817394 HSBP1 0.92 hypo  
chr16 83918165 MLYCD 0.95 hyper CpG island south shore 
chr16 84114686 MBTPS1 0.74 hyper AluSx1-SINE 
chr16 86670506  -- 0.79 hyper n/a 
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Table A.5 continued 
chr16 87661630 JPH3 0.96 hypo  
chr16 89614823 DPEP1 0.85 hypo  
chr17 3911939 P2RX1 0.99 hypo MLT1K -LINE 
chr17 7477472 ZBTB4 0.70 hyper  
chr17 9786768 DHRS7C 0.87 hypo MIR-SINE 
chr17   -- 0.83 hyper AluY- SINE 
chr17 18270847  -- 0.97 hypo n/a 
chr17 20064834 SPECC1 0.78 hyper  
chr17 20708532  DHRS7B 0.76 hyper AluSx1- SINE 
chr17 30390004 CPD 0.90 hypo  
chr17 36396863  -- 0.70 hyper AluY- SINE 
chr17 39151146 PLXDC1 0.96 hypo CpG island north shore 
chr17 43734456  -- 0.70 hyper n/a 
chr17 45949280 MAPT 0.98 hypo CpG island 
chr17   -- 0.92 hyper n/a 
chr17 50365019  -- 0.83 hypo n/a 
chr17 56831991 C17orf67 0.73 hyper AluSg7- SINE 
chr17 59107008 TRIM37 0.96 hypo CpG island 
chr17 61371775 BCAS3 0.73 hyper  
chr17 72364500  -- 0.81 hyper n/a 
chr17   -- 0.92 hyper AluY- SINE 
chr17 79670160  -- 0.99 hypo n/a 
chr17 80662935 RPTOR 0.98 hyper LTR8B- LTR 
chr18 5028355  -- 0.85 hyper AluY- SINE 
chr18 7501277  -- 0.92 hyper n/a 
chr18 10472966 APCDD1 0.80 hypo  
chr18 11284112  -- 0.98 hypo n/a 
chr18 14962783 LINC01443 0.78 hypo  
chr18 15315932  -- 0.89 hyper HERVIP10F-int - LTR 
chr18 16280392  -- 0.71 hyper ALR/Alpha- Satellite 
chr18 45782822  SLC14A1 0.91 hypo  
chr18 64765447  -- 0.93 hyper n/a 
chr19 3054479 AES 0.86 hypo  
chr19 5517943  -- 0.71 hyper n/a 
chr19 13059944 NFIX 0.83 hypo  
chr19 16121759 RAB8A 0.97 hypo  
chr19 16570110 SLC35E1 0.90 hypo  
chr19 18292644  -- 0.80 hypo MIR3- SINE;         
CpG island south shore 
chr19 28946814  -- 0.75 hypo n/a 
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Table A.5 continued 
chr19 30204514  -- 0.94 hyper n/a 
chr19 32719581  -- 0.89 hyper CpG island 
chr19 38791549 LGALS7B 0.86 hypo CpG island 
chr19 44209881  -- 0.74 hyper AluY- SINE 
chr19 46777016 SLC1A5 0.98 hyper  
chr19 47919710  -- 0.82 hypo AluSx1- SINE 
chr19  SLC6A16 0.89 hypo AluY-SINE 
chr19 50099738  -- 0.74 hypo AluSx1- SINE 
chr2 355785  -- 0.71 hyper n/a 
chr2 1813951 MYT1L 0.88 hypo AluY- SINE 
chr2 3422322 TRAPPC12 0.96 hypo  
chr2 3559211 RNASEH1-AS1 0.93 hyper AluSg- SINE 
chr2   -- 0.86 hypo n/a 
chr2 5407160  -- 0.88 hyper AluY- SINE 
chr2 7472236  -- 0.97 hyper AluY- SINE 
chr2 8224700 LINC00299 0.87 hyper L2b- LINE 
chr2 9797707  -- 0.98 hypo L2b- LINE 
chr2 11598412 LPIN1 0.73 hypo  
chr2  TRIB2 0.98 hypo CpG island 
chr2 17909503 KCNS3 0.92 hypo L1PA5- LINE 
chr2 18048445  -- 0.97 hypo n/a 
chr2 22105966  -- 0.81 hyper AluYc3- SINE 
chr2 27293431 TRIM54 0.77 hypo  
chr2 49198224  -- 0.83 hypo n/a 
chr2 57085962  -- 0.75 hyper MER50- LTR 
chr2 59065629  -- 0.97 hyper AluYa5- SINE 
chr2 60352130  -- 0.90 hypo n/a 
chr2 64312183  -- 0.97 hypo n/a 
chr2 70303874  -- 0.78 hypo n/a 
chr2 73720245  -- 1.00 hypo n/a 
chr2 81822755  -- 0.97 hypo AluY- SINE 
chr2 84407393  -- 0.84 hypo n/a 
chr2 84915328  -- 0.89 hyper AluSq2- SINE 
chr2 91883623  -- 0.97 hyper n/a 
chr2 94943394 LOC442028 0.86 hyper AluY- SINE 
chr2 96505661 NEURL3 0.83 hypo  
chr2 96639541 KANSL3 0.83 hyper CpG island south 
shore; AluSg- SINE 
chr2 103495113  -- 0.84 hyper n/a 
chr2 115261238 DPP10 0.78 hyper  
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Table A.5 continued 
chr2 119478869 SCTR 0.99 hypo  
chr2 121069189  -- 0.86 hypo n/a 
chr2 123245386  -- 0.82 hypo L1PA10- LINE 
chr2 128238962  -- 0.78 hyper AluSx1- SINE 
chr2 130574299 TISP43 0.92 hypo  
chr2 133567301 NCKAP5 0.77 hypo  
chr2 137420985 THSD7B 0.82 hypo MLT1D - LTR 
chr2   -- 0.99 hypo L1P2- LINE 
chr2 138931502  -- 0.91 hyper L1PA8A- LINE 
chr2 153202145  -- 0.76 hyper AluYb8- SINE 
chr2 162996026  -- 0.94 hypo n/a 
chr2 171153761 TLK1 0.98 hyper  
chr2 186962582  -- 0.85 hyper LTR12C- LTR 
chr2 189204054  -- 0.81 hyper AluY- SINE 
chr2 197165374 ANKRD44 0.71 hyper CpG island south shore 
chr2 206252430 GPR1-AS 0.77 hyper AluSc8- SINE 
chr2 227872705 DAW1 0.89 hyper  
chr2 233473583  -- 0.92 hypo n/a 
chr2 242070223 LINC01237 0.94 hypo  
chr20 2042748  -- 0.71 hypo MIR3- SINE 
chr20 2103419 STK35 0.86 hypo CpG island 
chr20 4199373  -- 0.95 hyper AluY- SINE 
chr20 5508262 LOC101929207 0.98 hypo LINC01729 
chr20 17055088  -- 0.74 hyper L1PA12- LINE 
chr20 21020228  -- 0.86 hypo CpG island 
chr20 21990770  -- 0.93 hyper n/a 
chr20 24134912  -- 0.72 hyper n/a 
chr20 28520706  -- 0.79 hyper ALR/Alpha- Satellite 
chr20 29816832  -- 0.74 hypo L1P1- LINE 
chr20 30169025  -- 0.98 hyper SST1- satellite 
chr20 35269494 MMP24 0.94 hypo  
chr20 41176226 PLCG1 0.91 hypo  
chr20 52791043  -- 0.89 hypo LTR33- LTR 
chr20 57464328  -- 0.77 hypo AluSx3- SINE 
chr20 60481072  -- 0.79 hyper n/a 
chr20 62768607  -- 0.91 hypo n/a 
chr20 63475434  -- 0.94 hypo n/a 
chr21 8238040  -- 0.95 hyper n/a 
chr21 8421064  -- 0.98 hyper CpG island south shelf; 
CpG island north shore 
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chr21 9015849  -- 0.70 hyper n/a 
chr21 13052629 ANKRD30BP2 0.78 hyper HERVIP10F-int - LTR 
chr21   -- 0.70 hyper AluSz- SINE 
chr21 22190657  -- 0.95 hyper AluY- SINE 
chr21 31175084 TIAM1 0.92 hyper AluJb- SINE 
chr21 33720267 ITSN1 0.88 hypo  
chr21 38775976  -- 0.97 hypo n/a 
chr21 41715789 LINC00479 0.97 hypo LINC 47 
chr21 42234622 ABCG1 0.89 hypo CpG island north shore 
chr21 45421692 COL18A1 0.87 hypo  
chr21 45950327  -- 0.87 hypo n/a 
chr22 15854768  -- 0.76 hyper n/a 
chr22 25995622 MYO18B 0.95 hypo  
chr22 31805593 DEPDC5 0.86 hypo AluSx1- SINE 
chr22 32702402 SYN3 0.78 hyper AluY- SINE 
chr22 36550935  -- 0.70 hypo n/a 
chr22 41495548 ACO2 0.79 hyper  
chr22 43659516 EFCAB6 0.85 hypo AluJb-SINE 
chr22 44232700  -- 0.96 hyper AluSp-SINE 
chr22 47551087  -- 0.83 hypo MER31-int - LTR 
chr22  C22orf34 0.87 hypo n/a 
chr3 6323747  -- 0.84 hyper AluY-SINE 
chr3 15378337  -- 0.81 hypo MER66C-LTR 
chr3 20662005  -- 0.89 hyper AluYf1-SINE 
chr3 21010301  -- 0.83 hypo MLT2A2- LTR 
chr3 26671108 LRRC3B 0.87 hyper AluYa5- SINE 
chr3 28014819  -- 0.85 hyper AluSz- SINE 
chr3 32296344 CMTM8 0.77 hyper L2c- LINE 
chr3 37736642 ITGA9 0.96 hypo  
chr3 38958253  -- 0.84 hypo LTR33- LTR 
chr3 40868938  -- 0.96 hypo n/a 
chr3 42159397 TRAK1 0.96 hypo  
chr3 46276720  -- 0.95 hypo n/a 
chr3 46567076 LRRC2 0.79 hyper AluSx1- SINE 
chr3 50243396 GNA12 0.98 hypo  
chr3 50359681 CYB561D2 0.70 hypo CpG island 
chr3 54626604 CACNA2D3 0.71 hyper  
chr3 60377246 FHIT 0.84 hyper AluSc- SINE 
chr3 82608153  -- 0.96 hypo L1PA4- LINE 
chr3 83160968  -- 0.75 hyper AluSx- SINE 
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chr3 94345443  -- 0.81 hyper LTR17- LTR 
chr3 98732314 ST3GAL6 0.94 hypo  
chr3 109776215  -- 0.73 hyper HERVL-int- LTR 
chr3 122284610 CASR 0.95 hyper  
chr3 127392674  -- 0.94 hyper MIRb- SINE 
chr3 127652072 PODXL2 0.98 hypo  
chr3 128686010  -- 0.98 hypo AluSp- SINE 
chr3 141127667 SPSB4 0.91 hypo  
chr3 143374349 SLC9A9 0.90 hyper AluY- SINE 
chr3 170826454  -- 0.96 hypo n/a 
chr3 173585557 NLGN1 0.94 hypo  
chr3 173820103 NLGN1 0.74 hyper AluY- SINE 
chr3 178037440  -- 0.93 hyper AluSp- SINE 
chr3 179681694 USP13 0.93 hyper LTR6A- LTR 
chr3   -- 0.77 hypo AluSq2- SINE 
chr3 185446348 MAP3K13 0.71 hyper AluYh3- SINE 
chr3 185560278  -- 0.74 hyper AluY- SINE 
chr4 46241  -- 0.75 hyper AluSq2-SINE 
chr4 4736422  -- 0.99 hypo n/a 
chr4 7309145 SORCS2 0.88 hypo  
chr4 7973393 ABLIM2 0.73 hypo AluSg-SINE 
chr4 12783904  -- 0.93 hyper AluY-SINE 
chr4 13626245 BOD1L1 0.77 hyper AluSc- SINE 
chr4 24401179  -- 0.88 hyper AluY- SINE 
chr4 32679934  -- 0.92 hyper AluY- SINE 
chr4 37375661 NWD2 0.91 hyper AluY- SINE 
chr4  PGM2 0.83 hypo AluSx1- SINE 
chr4 38462903 LINC01258 0.92 hypo  
chr4 41467606 LIMCH1 0.94 hypo  
chr4 53734272 LOC100506444 0.95 hyper L1PA6- LINE 
chr4 63219060  -- 0.98 hypo L1PA11- LINE 
chr4 66561899  -- 0.94 hyper LTR12C- LTR 
chr4 89979495  -- 0.83 hypo AluSg4-SINE 
chr4 91267014 CCSER1 0.99 hyper  
chr4 117576099 LINC01378 0.96 hyper  
chr4 129091174 SCLT1 0.80 hyper  
chr4 130042473  -- 0.71 hyper AluSz- SINE 
chr4 130433474  -- 0.79 hyper MER50- LTR 
chr4 133852268  -- 0.71 hypo THE1D- LTR 
chr4 135835605  -- 0.96 hyper AluSx1- SINE 
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chr4 139950667 MAML3 0.95 hypo  
chr4 155072381  -- 0.98 hypo MLT2B5- LTR 
chr4 156435901  -- 0.87 hyper AluSc8- SINE 
chr4 156943171 PDGFC 0.99 hypo  
chr4 156972103  -- 0.79 hypo CpG island 
chr4 161875569 FSTL5 0.73 hyper MER51A- LTR 
chr4 172122671 GALNTL6 0.92 hypo  
chr4 184989517  -- 0.91 hyper LTR12C- LTR 
chr4 185065844  -- 0.97 hyper AluYe5- SINE 
chr4 185821121 SORBS2 0.93 hyper  
chr5 320741 AHRR 0.96 hypo CpG island 
chr5 9374929 SEMA5A 0.96 hypo  
chr5 16181842  -- 0.79 hyper n/a 
chr5 17237268 BASP1 0.97 hyper AluY- SINE 
chr5 20295611 CDH18 0.77 hyper AluSc- SINE 
chr5 29481037  -- 0.71 hypo L1PA15-16- LINE 
chr5 34293457  -- 0.94 hypo n/a 
chr5 35760219 SPEF2 0.82 hyper AluY- SINE 
chr5 39575351  -- 0.78 hyper AluY- SINE 
chr5 41958227  -- 0.99 hyper AluY- SINE 
chr5 44860573  -- 0.85 hypo n/a 
chr5 63940282  -- 0.98 hypo n/a 
chr5 67165616 MAST4 0.92 hypo  
chr5 76396503  -- 0.95 hypo AluSq2- SINE 
chr5 80487492  -- 0.91 hyper AluSz- SINE 
chr5 83938549  -- 0.94 hyper AluSz- SINE 
chr5 96309881 LOC101929710 0.89 hyper L1PA7- LINE 
chr5 123099609 PRDM6 0.85 hypo CpG island 
chr5 124597019  -- 0.82 hypo n/a 
chr5 126057037  -- 0.92 hypo AluSx- SINE 
chr5 131267215 CDC42SE2 0.70 hyper AluSc- SINE 
chr5 135996517  -- 0.99 hypo n/a 
chr5 139365068 PAIP2 0.99 hypo AluSp- SINE 
chr5 142753415 LOC101926975 0.95 hypo LINC01844 
chr5 142819987 ARHGAP26 0.95 hypo  
chr5 149779845 PPARGC1B 0.77 hypo  
chr5 149810882 PPARGC1B 0.84 hyper  
chr5 151504961 FAT2 0.96 hypo L2a- LINE 
chr5 155757656  -- 0.95 hypo n/a 
chr5 158690335  -- 0.81 hypo n/a 
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chr5 170603504 KCNIP1 0.83 hypo  
chr5 172836036 ERGIC1 0.73 hyper  
chr5 173304859  -- 0.96 hypo n/a 
chr5 174022730  -- 0.84 hypo n/a 
chr5 181429458  -- 0.97 hypo n/a 
chr6 1554788  -- 0.93 hypo n/a 
chr6 11607556  -- 0.81 hypo n/a 
chr6 15897287  -- 1.00 hypo n/a 
chr6 27545064  -- 0.86 hypo n/a 
chr6 36789906 CPNE5 0.97 hypo  
chr6 54737066  -- 0.72 hyper L1PA14- LINE 
chr6 56954118 DST 0.82 hypo CpG island 
chr6 60758588  -- 0.83 hyper AluYk3- SINE 
chr6 61299572  -- 0.83 hyper ALR/Alpha- Satellite 
chr6 65838577  -- 0.99 hyper n/a 
chr6 71485562  -- 0.90 hypo AluSz- SINE 
chr6 77173762  -- 0.90 hypo L1PA15-16 - LINE 
chr6 84227467 CEP162 0.93 hypo CpG island 
chr6 88588292  -- 0.86 hyper n/a 
chr6 125346778  -- 0.94 hyper n/a 
chr6 143455353 PEX3 0.74 hyper AluY- SINE 
chr6 159253354 FNDC1 0.90 hypo MamRTE1- LINE 
chr6 160616504 LPA 0.74 hyper  
chr6 161308483  -- 0.83 hypo LTR9B- LTR 
chr6 161476111 PARK2 0.91 hyper AluY- SINE 
chr6 163740403  -- 0.78 hypo n/a 
chr6   -- 0.94 hypo n/a 
chr7 1784596  -- 0.90 hyper AluSp- SINE 
chr7 6139834 USP42 0.93 hypo  
chr7 10610635  -- 0.88 hyper AluY- SINE 
chr7 19548524  -- 0.92 hypo L1PA7- LINE 
chr7 23701332 FAM221A 0.94 hyper AluY- SINE 
chr7 51079767 COBL 0.94 hypo  
chr7   -- 0.90 hypo AluY- SINE 
chr7 665002780  -- 0.86 hypo MLT1F1- LTR 
chr7 72397228 CALN1 0.94 hyper  
chr7 76999555 1-UPK3BP1-
PMS2P11 
0.77 hyper pseudogene 
chr7 98956156 TRRAP 0.89 hypo  
chr7 108171197 NRCAM 0.97 hyper  
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Table A.5 continued 
chr7 131044567 LINC-PINT 0.94 hypo AluY- SINE 
chr7 135721405 SLC13A4 0.89 hyper  
chr7 140017247 TBXAS1 0.82 hypo  
chr7 142457036  -- 0.94 hyper n/a 
chr7 148597916 C7orf33 0.74 hyper AluY- SINE 
chr7 150720791 GIMAP1 0.87 hyper CpG island 
chr7 152427666 KMT2C 0.94 hypo  
chr7 158586396 PTPRN2 0.78 hyper  
chr7 130734372 KLF14 0.43 hyper CpG island south shore 
chr8 5977722  -- 0.92 hypo n/a 
chr8 7091379  -- 0.87 hyper L2b- LINE 
chr8 7596631  -- 0.85 hyper AluSx3- SINE 
chr8 10041145  -- 0.85 hypo n/a 
chr8 12568233 LOC729732 0.86 hyper uncharacterized 
chr8 30028038  -- 0.88 hyper n/a 
chr8 32928270  -- 0.91 hypo n/a 
chr8   -- 0.97 hypo CpG island 
chr8 40813656 ZMAT4 0.94 hypo  
chr8 54187430  -- 0.94 hypo n/a 
chr8 54558490  -- 0.96 hypo n/a 
chr8 58991982 TOX 0.76 hyper  
chr8 64499252  -- 0.97 hyper AluY- SINE 
chr8 66626477  -- 0.82 hyper AluSg- SINE 
chr8 68505655 C8orf34 0.74 hyper  
chr8 74006322 LY96 0.87 hypo AluSx1- SINE 
chr8 91214003 LRRC69; 
SLC26A7 
0.91 hypo  
chr8 95008667 NDUFAF6 0.88 hypo AluSq- SINE 
chr8 95082870  -- 0.86 hyper AluYa5- SINE 
chr8 96452284  -- 0.93 hyper LTR12C- LTR 
chr8 100560334  -- 0.74 hyper AluSx3- SINE 
chr8 107047420  -- 0.79 hyper THE1D- LTR 
chr8 107459396 ANGPT1 0.90 hyper AluSz- SINE 
chr8 111470502  -- 0.74 hyper MER52A- LTR 
chr8 114011598  -- 0.96 hypo n/a 
chr8 11434279  -- 0.87 hyper MER50B-LTR 
chr8 116146678 LINC00536 0.82 hyper HERVL-int - LTR 
chr8 116949780  -- 0.97 hyper LTR12C- LTR 
chr8 119207197 MAL2 0.99 hypo  
chr8 124426306  -- 0.92 hypo n/a 
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Table A.5 continued 
chr8 131457944  -- 0.97 hyper AluY- SINE 
chr8 132672809 LRRC6 0.88 hyper MIR3-SINE 
chr8 139493896  -- 0.78 hyper AluY- SINE 
chr8 139561834  -- 0.76 hyper AluSg- SINE 
chr8 144183050 MROH1 0.81 hypo AluSz6- SINE 
chr9 4496182 SLC1A1 0.72 hyper  
chr9 38672611  -- 0.93 hypo n/a 
chr9 38769009  -- 0.73 hyper n/a 
chr9 39666078  -- 0.92 hyper AluYc- SINE 
chr9 39807190 GLIDR 0.94 hyper AluSc- SINE 
chr9 40522056 LOC102724580 0.99 hyper AluSg4- SINE 
chr9 41016947 PGM5P2 1.00 hyper  
chr9 60526557  -- 0.92 hyper CER- satellite 
chr9 65285785  -- 0.75 hyper AluYh3- SINE 
chr9 78125693  -- 0.82 hypo n/a 
chr9   -- 0.84 hyper n/a 
chr9 92618787 IPPK 0.99 hypo  
chr9 94780865 C9orf3 0.86 hyper n/a 
chr9 104258663  -- 0.75 hypo MER4A1- LTR 
chr9 108385902  -- 0.99 hyper AluYk11- SINE 
chr9 111068348  -- 0.93 hyper AluSg- SINE 
chr9 113085081  -- 0.97 hypo L1MA7- LINE 
chr9 121491473 GGTA1P 0.91 hypo L2b- LINE 
chr9 131256702  -- 0.95 hypo n/a 
chr9 133793132 VAV2 0.96 hypo  
chr9 137858603  -- 0.83 hyper AluY- SINE 
 
